Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,A1BG,Alpha-1B-glycoprotein,22555,24,4.10 [0.39-43.47],0.2412367563749239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AAMDC,Mth938 domain-containing protein,21934,25,2.12 [1.10-4.09],0.0251182521750046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,25691,26,1.80 [1.03-3.15],0.0396639540729159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,21807,24,3.42 [1.98-5.89],9.854844932341096e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABHD14B,Protein ABHD14B,25559,25,1.13 [0.64-2.02],0.6736348835860277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABL1,Tyrosine-protein kinase ABL1,25691,26,1.51 [0.95-2.41],0.0841285110765528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABO,Histo-blood group ABO system transferase,22523,24,1.12 [0.85-1.47],0.417141299113294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABRAXAS2,BRISC complex subunit Abraxas 2,21807,24,1.80 [1.05-3.09],0.033743383537235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",25213,25,1.50 [1.06-2.14],0.0234958907304567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",22092,25,1.31 [0.88-1.94],0.1830293873083481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",22521,25,1.18 [0.79-1.78],0.422488708088478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAN,Aggrecan core protein,25592,27,0.59 [0.17-2.00],0.3954708939050171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE,Angiotensin-converting enzyme,22523,24,3.41 [0.97-11.96],0.055280574647919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,25337,26,1.89 [1.16-3.09],0.0102595572178858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACHE,Acetylcholinesterase,22039,23,2.95 [1.18-7.37],0.0205270543759817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOT13,Acyl-coenzyme A thioesterase 13,22409,24,1.27 [0.90-1.80],0.17743410236001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,25813,27,1.29 [0.88-1.90],0.1902985735247926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,21882,23,2.08 [1.18-3.68],0.0114156789867307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,25928,27,2.14 [1.26-3.63],0.0047446556585316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP6,Lysophosphatidic acid phosphatase type 6,25983,27,1.22 [0.72-2.08],0.4658161322820807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRBP,Acrosin-binding protein,22389,25,2.23 [1.10-4.51],0.0261856705107195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRV1,Acrosomal protein SP-10,21882,23,0.40 [0.12-1.35],0.1404118228522408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,21807,24,0.83 [0.25-2.75],0.7605041715415708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",25337,26,2.25 [1.54-3.28],2.7052212697314583e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,21807,24,1.95 [1.24-3.08],0.0039978762471905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN4,Alpha-actinin-4,25307,25,1.31 [0.47-3.62],0.604142257507082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,25601,25,15.57 [6.28-38.58],3.043837434143232e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,25813,27,1.83 [1.14-2.94],0.0124450876594884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,21807,24,2.08 [1.18-3.65],0.0109827127525357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACYP1,Acylphosphatase-1,21948,23,1.56 [0.86-2.80],0.1399318423496169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA,Adenosine deaminase,26083,26,2.20 [0.95-5.12],0.0667631936074834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,25645,26,5.10 [2.86-9.09],3.3767814326314376e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,21882,23,2.70 [1.74-4.21],1.0852442681137736e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,25337,26,1.02 [0.33-3.16],0.9708356078668878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,25641,25,1.30 [0.47-3.55],0.6110639670965351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,26083,26,1.34 [0.47-3.86],0.5855903406063384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,25992,26,6.89 [2.64-17.97],7.933318647623678e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22409,24,6.44 [3.55-11.67],8.610609761531834e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,21882,23,2.15 [1.05-4.41],0.0361825282216101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,26127,27,0.86 [0.21-3.58],0.8367629651116286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,25691,26,2.77 [1.47-5.20],0.0015390102598864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,25337,26,1.23 [0.57-2.64],0.595761837771726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,21882,23,3.32 [1.59-6.94],0.0014139380698659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,25902,27,0.39 [0.19-0.79],0.008952803511454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,22510,25,9.30 [4.28-20.22],1.808084570025451e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL4,ADAMTS-like protein 4,21934,25,1.72 [0.34-8.79],0.5128148104796799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL5,ADAMTS-like protein 5,22521,25,1.56 [0.59-4.17],0.372100775981674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,25213,25,0.87 [0.58-1.31],0.517183581247691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADD1,Alpha-adducin,22039,23,1.77 [1.01-3.12],0.0471672618984967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,25601,25,2.91 [1.04-8.18],0.0426349884405328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,22039,23,5.66 [2.47-12.95],4.020234265080852e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,22409,24,2.30 [1.39-3.82],0.0012663230135003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,25944,25,5.65 [2.05-15.59],0.0008254670322876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,25997,26,4.30 [2.74-6.76],2.4535223938018244e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,22521,25,3.85 [1.22-12.16],0.0218493736686836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,25691,26,2.47 [1.89-3.23],2.982358635579599e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,25813,27,0.58 [0.35-0.96],0.0355185569225396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRV1,Adhesion G-protein coupled receptor V1,21797,24,0.76 [0.38-1.52],0.4345384137808367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH1B,All-trans-retinol dehydrogenase,22039,23,0.95 [0.56-1.61],0.8537541857046382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,25337,26,0.93 [0.62-1.42],0.7498006949974858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADIPOQ,Adiponectin,22555,24,0.54 [0.31-0.96],0.0349320531301043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,26026,27,26.84 [6.41-112.44],6.774467283214127e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADRA2A,Alpha-2A adrenergic receptor,21807,24,0.85 [0.45-1.60],0.6063657209097083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFAP1,Actin filament-associated protein 1,22039,23,1.44 [0.95-2.18],0.084155460836473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFM,Afamin,22555,24,0.43 [0.06-3.11],0.4013773712008485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,25566,25,0.66 [0.38-1.16],0.1499927696260445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGBL2,Cytosolic carboxypeptidase 2,21797,24,1.43 [0.93-2.20],0.1048092312055087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGER,Advanced glycosylation end product-specific receptor,25774,25,0.60 [0.24-1.47],0.2593330051833684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,24975,25,2.05 [1.58-2.66],6.269381585371107e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,25167,25,1.62 [1.00-2.63],0.0499828544552648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,25944,25,5.01 [2.43-10.33],1.241452996621213e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,26083,26,2.30 [1.35-3.94],0.002306030416919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGT,Angiotensinogen,22523,24,1.71 [0.67-4.37],0.2584746874325864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,25813,27,1.42 [0.96-2.09],0.0790807059801473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHCY,Adenosylhomocysteinase,25813,27,1.50 [0.93-2.44],0.0977165291148279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,21934,25,3.16 [1.74-5.74],0.0001589304589076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,21934,25,4.47 [1.97-10.16],0.0003478446945189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,22389,25,1.26 [0.79-1.99],0.3274142459495403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSG,Alpha-2-HS-glycoprotein,22523,24,0.82 [0.20-3.31],0.7786957686995601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSP,Alpha-hemoglobin-stabilizing protein,25770,26,0.94 [0.63-1.38],0.7353795985407521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIDA,"Axin interactor, dorsalization-associated protein",21886,25,1.11 [0.72-1.71],0.6315012135361072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1,Allograft inflammatory factor 1,25213,25,1.45 [0.73-2.90],0.2902051968813695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1L,Allograft inflammatory factor 1-like,21934,25,1.50 [0.99-2.26],0.053719824440893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",25643,26,1.25 [0.92-1.71],0.1613175467555861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK1,Adenylate kinase isoenzyme 1,25813,27,0.98 [0.59-1.64],0.9485271552092384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK2,"Adenylate kinase 2, mitochondrial",22469,25,1.25 [0.86-1.80],0.2379011936754352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKAP12,A-kinase anchor protein 12,22039,23,1.79 [0.42-7.72],0.433492523488771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B1,Aldo-keto reductase family 1 member B1,25213,25,1.67 [1.16-2.41],0.005648650638462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,21886,25,1.85 [1.33-2.59],0.0003151727078405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1C4,Aldo-keto reductase family 1 member C4,25337,26,1.50 [0.98-2.30],0.0635651506948163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,21882,23,0.80 [0.43-1.50],0.4948196293495241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT1S1,Proline-rich AKT1 substrate 1,25203,25,1.53 [0.89-2.62],0.1234820072172471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT2,RAC-beta serine/threonine-protein kinase,22479,24,1.31 [0.95-1.81],0.0990698294514463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT3,RAC-gamma serine/threonine-protein kinase,25094,25,0.99 [0.53-1.85],0.9748828207244236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,26127,27,9.27 [2.20-39.00],0.002395869303751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH1A1,Retinal dehydrogenase 1,25809,26,1.09 [0.60-1.96],0.7791022264752727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",22389,25,0.93 [0.42-2.06],0.8523363251868035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",25736,24,1.41 [1.00-1.99],0.0481801196627428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",22479,24,1.54 [0.75-3.17],0.2425750336724872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALMS1,Alstrom syndrome protein 1,22092,25,1.41 [0.80-2.48],0.2407335472406808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPI,Intestinal-type alkaline phosphatase,21882,23,1.06 [0.76-1.48],0.7338349577739556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPP,"Alkaline phosphatase, placental type",25691,26,1.36 [0.97-1.91],0.0715278712437301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBN,Ameloblastin,25307,25,0.69 [0.20-2.38],0.5530080410386633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,25991,27,17.86 [6.57-48.59],1.6462990427561125e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,22510,25,1.29 [0.29-5.64],0.7386956878581934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMFR,E3 ubiquitin-protein ligase AMFR,25203,25,1.38 [0.89-2.15],0.1474642987734953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO1,Amphoterin-induced protein 1,21886,25,0.69 [0.26-1.86],0.4618211441836709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,25691,26,4.54 [1.03-19.98],0.0455360117062712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMN,Protein amnionless,25307,25,0.79 [0.37-1.68],0.5362134033303816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOT,Angiomotin,22039,23,1.01 [0.36-2.80],0.99107694290557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOTL2,Angiomotin-like protein 2,22317,25,1.53 [0.89-2.65],0.1254448141458591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMPD3,AMP deaminase 3,22469,25,1.39 [0.85-2.27],0.1960837027433731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,21079,23,0.99 [0.45-2.15],0.977964921455071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,24809,26,0.39 [0.19-0.80],0.0103976063680194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2B,Alpha-amylase 2B,24067,24,0.77 [0.56-1.04],0.0923090805850559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,25724,27,2.62 [1.16-5.93],0.0204239184958726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT1,Angiopoietin-1,25724,25,1.06 [0.69-1.62],0.78907188731685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,26026,27,4.00 [1.87-8.56],0.0003617588865993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,25471,27,4.48 [1.46-13.76],0.008845524396614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL2,Angiopoietin-related protein 2,25861,24,1.89 [0.82-4.36],0.1331004792003904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL3,Angiopoietin-related protein 3,25808,27,0.34 [0.14-0.83],0.0176608538171925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,25901,25,4.18 [1.89-9.23],0.0004025254683789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,26026,27,3.58 [1.96-6.52],3.1117349607859474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANK2,Ankyrin-2,21807,24,0.94 [0.53-1.67],0.8350487001000938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,21882,23,1.55 [0.96-2.50],0.0707572574829997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRA2,Ankyrin repeat family A protein 2,21705,24,0.72 [0.33-1.56],0.406590571922074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRD54,Ankyrin repeat domain-containing protein 54,25213,25,1.26 [0.76-2.09],0.3708901051452465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,21934,25,1.64 [0.97-2.79],0.0653057473421288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANPEP,Aminopeptidase N,25854,27,1.00 [0.32-3.14],0.999183828707392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA1,Annexin A1,21899,23,1.89 [1.02-3.48],0.0415919977914164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,25203,25,1.58 [1.15-2.19],0.0053487820315735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA11,Annexin A11,25735,24,1.53 [0.83-2.83],0.1719608598001694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA2,Annexin A2,21589,25,1.51 [1.03-2.21],0.0338001337389397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA3,Annexin A3,25992,26,1.07 [0.65-1.76],0.7993552380645443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA4,Annexin A4,25684,27,1.10 [0.69-1.77],0.6852149330536044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,25125,24,2.67 [1.11-6.38],0.027593402753785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],25307,25,0.78 [0.37-1.67],0.5261814163741774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,25899,27,6.49 [2.15-19.58],0.0009097429854862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP1G2,AP-1 complex subunit gamma-like 2,22389,25,1.44 [0.94-2.20],0.0919468648763344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP2B1,AP-2 complex subunit beta,21886,25,2.03 [1.21-3.42],0.0077843869178857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3B1,AP-3 complex subunit beta-1,22409,24,1.88 [1.17-3.01],0.0085371231176338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3S2,AP-3 complex subunit sigma-2,22469,25,2.31 [1.21-4.44],0.0117176736138992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,25691,26,1.79 [1.01-3.20],0.0478646694299989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APCS,Serum amyloid P-component,22353,24,0.59 [0.22-1.57],0.2911742050062259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,25938,27,1.06 [0.58-1.91],0.8585735414502043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,25813,27,0.43 [0.22-0.86],0.0167590518852121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA1,Apolipoprotein A-I,22555,24,0.77 [0.43-1.38],0.3732269283430668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA2,Apolipoprotein A-II,22523,24,2.59 [1.33-5.03],0.0051503023242203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,22555,24,3.23 [2.11-4.94],6.308612700851118e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOB,Apolipoprotein B-100,22523,24,1.39 [0.24-8.08],0.7156166586386377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOBR,Apolipoprotein B receptor,21934,25,0.62 [0.26-1.47],0.2800630336256279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,22508,24,0.66 [0.42-1.03],0.0646058004196289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOD,Apolipoprotein D,21511,23,0.73 [0.50-1.08],0.1130027179494398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOE,Apolipoprotein E,22555,24,0.66 [0.31-1.42],0.2858950974839493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,22523,24,0.72 [0.48-1.08],0.1091092032067161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOH,Beta-2-glycoprotein 1,25809,26,0.61 [0.23-1.63],0.3219558857083093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOL1,Apolipoprotein L1,22523,24,0.48 [0.23-1.01],0.0538208854058485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,25854,27,0.48 [0.29-0.81],0.0058907229037552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APP,Amyloid-beta precursor protein,25772,26,1.18 [0.71-1.95],0.5339447501606225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APPL2,DCC-interacting protein 13-beta,22039,23,1.21 [0.84-1.75],0.3119436216085544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APRT,Adenine phosphoribosyltransferase,25603,25,1.64 [0.74-3.65],0.2235650459329688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARAF,Serine/threonine-protein kinase A-Raf,22092,25,1.03 [0.59-1.78],0.9212485259971714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,25691,26,3.41 [2.30-5.06],1.117455273113932e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARF6,ADP-ribosylation factor 6,22409,24,1.15 [0.79-1.67],0.4716710344787764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARFIP1,Arfaptin-1,22479,24,1.22 [0.70-2.14],0.4857207580080387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG1,Arginase-1,25665,26,0.63 [0.33-1.21],0.1645759087213964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG2,"Arginase-2, mitochondrial",22389,25,1.16 [0.55-2.44],0.6957491140003266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP1,Rho GTPase-activating protein 1,25213,25,1.42 [0.64-3.16],0.3945147137447562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP25,Rho GTPase-activating protein 25,25213,25,1.26 [0.73-2.19],0.4093815358966693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP30,Rho GTPase-activating protein 30,22092,25,0.53 [0.12-2.34],0.4057411278412833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP45,Rho GTPase-activating protein 45,22039,23,1.39 [0.86-2.24],0.1796901624503818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP5,Rho GTPase-activating protein 5,21705,24,0.80 [0.45-1.41],0.4350168879597758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,22469,25,1.53 [0.98-2.37],0.0593774894616422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,22479,24,1.73 [1.20-2.48],0.0032273330110417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,25772,24,1.27 [0.89-1.80],0.1832112251370466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,21797,24,1.74 [1.23-2.45],0.0016186680323429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID3A,AT-rich interactive domain-containing protein 3A,21797,24,1.61 [0.73-3.55],0.2399639071988671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID4B,AT-rich interactive domain-containing protein 4B,25203,25,1.08 [0.51-2.27],0.8465216734708245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL13B,ADP-ribosylation factor-like protein 13B,21807,24,1.26 [0.77-2.07],0.3642360378181417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,21807,24,1.60 [0.63-4.08],0.3218688201597796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,21797,24,1.05 [0.58-1.89],0.8744804331297756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,25307,25,1.18 [0.47-2.98],0.7277713354431868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,21807,24,0.44 [0.14-1.40],0.1642569121479144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSA,Arylsulfatase A,25809,26,1.26 [0.59-2.66],0.5534283545781575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSB,Arylsulfatase B,25691,26,0.98 [0.52-1.86],0.9621016056559848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,25899,27,4.12 [1.64-10.37],0.0026459794968019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART5,Ecto-ADP-ribosyltransferase 5,21797,24,1.26 [0.81-1.94],0.300544964656142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARTN,Artemin,25307,25,1.46 [0.98-2.18],0.0656581941193714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH1,Acid ceramidase,22294,25,1.60 [0.89-2.90],0.119404216383598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH2,Neutral ceramidase,25641,25,1.18 [0.58-2.39],0.6549017888017944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,25641,25,13.82 [6.66-28.69],1.8034038532526096e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,22523,24,12.37 [5.07-30.19],3.306207237577856e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPN,Asporin,22521,25,1.31 [0.36-4.76],0.6797111911140048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPSCR1,Tether containing UBX domain for GLUT4,22479,24,1.72 [0.97-3.03],0.0612857574182893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,21934,25,1.06 [0.72-1.55],0.7791466285055906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASS1,Argininosuccinate synthase,21807,24,0.72 [0.43-1.21],0.2212047242439295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,25203,25,1.03 [0.65-1.64],0.8853276703790651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,21705,24,0.46 [0.12-1.77],0.2584031409887763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG16L1,Autophagy-related protein 16-1,22409,24,1.68 [1.06-2.66],0.0259690325427849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG4A,Cysteine protease ATG4A,25213,25,1.47 [0.85-2.54],0.1696569117156979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATOX1,Copper transport protein ATOX1,25902,27,1.79 [1.04-3.07],0.034697452009536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,21807,24,1.07 [0.52-2.18],0.854518700590689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,21807,24,1.98 [1.21-3.24],0.0067383836682573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,21807,24,1.46 [0.69-3.11],0.3243138974614988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B4,Protein ATP1B4,21705,24,1.29 [0.58-2.86],0.5291925502840888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,21807,24,0.79 [0.36-1.73],0.5526010650288884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",21807,24,0.88 [0.64-1.21],0.4194987908753885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5IF1,"ATPase inhibitor, mitochondrial",25944,25,1.29 [0.93-1.79],0.1312193167528673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5PO,"ATP synthase subunit O, mitochondrial",25203,25,0.74 [0.29-1.88],0.5211206367103973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,25213,25,1.60 [0.91-2.81],0.0993926003335618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1D,V-type proton ATPase subunit D,25691,26,0.75 [0.18-3.15],0.6912732465699447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1F,V-type proton ATPase subunit F,25155,25,1.61 [1.01-2.58],0.0463154431580622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G1,V-type proton ATPase subunit G 1,21934,25,1.56 [0.93-2.59],0.0890843663593612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G2,V-type proton ATPase subunit G 2,21807,24,1.11 [0.77-1.60],0.5782808529356309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,22409,24,2.13 [1.65-2.74],5.436940262143655e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRN,"Attractin, Isoform 2",22555,24,4.94 [0.53-46.10],0.1610341107855527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN10,Ataxin-10,25203,25,1.23 [0.75-2.02],0.4193911537784471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2,Ataxin-2,21797,24,1.15 [0.88-1.51],0.291996025218573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2L,Ataxin-2-like protein,22479,24,1.83 [1.06-3.13],0.0287133414745746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN3,Ataxin-3,22469,25,1.53 [0.85-2.73],0.1526392248255271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXIN1,Axin-1,25772,24,1.40 [0.96-2.05],0.0795884254843796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,25899,27,4.80 [1.81-12.75],0.0016509759808064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZI2,5-azacytidine-induced protein 2,22479,24,1.61 [0.86-3.00],0.1348841446538697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZU1,Azurocidin,24975,26,0.94 [0.59-1.49],0.7883300801011686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,22555,24,2.17 [1.70-2.76],3.8556254526862254e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,21807,24,0.66 [0.08-5.10],0.6873584195646371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",21934,25,7.58 [3.05-18.86],1.3138896452517052e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",25944,25,8.98 [3.38-23.85],1.046565319980716e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",25809,26,0.75 [0.17-3.22],0.6956713933574072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BABAM1,BRISC and BRCA1-A complex member 1,21882,23,0.41 [0.09-1.92],0.2587868529152693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BACH1,Transcription regulator protein BACH1,25772,24,1.42 [0.88-2.29],0.1538245417919505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG3,BAG family molecular chaperone regulator 3,25601,25,1.60 [0.63-4.04],0.3187350340418601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG4,BAG family molecular chaperone regulator 4,21882,23,1.96 [1.06-3.61],0.0306111176610469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG6,Large proline-rich protein BAG6,25337,26,1.80 [0.69-4.74],0.2326275574864467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,25213,25,1.88 [1.26-2.81],0.0020779186089878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,25213,25,3.49 [2.00-6.08],1.103525188477826e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BANK1,B-cell scaffold protein with ankyrin repeats,25772,24,1.23 [0.86-1.75],0.2508967330788511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAP18,Chromatin complexes subunit BAP18,22469,25,1.10 [0.61-1.96],0.7583112852155667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BATF,Basic leucine zipper transcriptional factor ATF-like,21886,25,1.25 [0.90-1.75],0.1862941812134604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAX,Apoptosis regulator BAX,25161,25,1.34 [0.90-1.99],0.1472260310205473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,25809,26,3.04 [0.94-9.81],0.063534417104982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,25641,25,0.60 [0.40-0.91],0.015237076401062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",22521,25,2.85 [1.14-7.13],0.02491948573998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",21797,24,0.75 [0.32-1.78],0.5200161098735594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCHE,Cholinesterase,22100,23,1.18 [0.26-5.28],0.8318221822698633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,22409,24,1.74 [1.18-2.57],0.0055037609876473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L1,Bcl-2-like protein 1,22469,25,1.48 [0.99-2.20],0.0561055556624141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",25772,24,3.10 [1.19-8.03],0.0200847227632088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L15,Bcl-2-like protein 15,21882,23,1.59 [0.97-2.61],0.0654992524178784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,21705,24,0.75 [0.36-1.56],0.4407077241578042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,22389,25,0.81 [0.30-2.20],0.6725266649668099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCR,Breakpoint cluster region protein,25772,24,1.48 [1.00-2.20],0.0517209573547387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BDNF,Brain-derived neurotrophic factor,22510,25,1.16 [0.73-1.86],0.5283725605843131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BECN1,Beclin-1,21934,25,1.90 [1.13-3.20],0.0161620818958813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BEX3,Protein BEX3,21705,24,1.10 [0.54-2.25],0.7901184844561369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGLAP,Osteocalcin,22510,25,1.12 [0.72-1.74],0.6130688556560333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGN,Biglycan,25170,25,0.79 [0.57-1.08],0.1350092412009742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHLHE40,Class E basic helix-loop-helix protein 40,21797,24,1.40 [0.90-2.17],0.1347956934104981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,21807,24,1.03 [0.21-5.01],0.9725488379476258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BID,BH3-interacting domain death agonist,25772,24,1.13 [0.67-1.90],0.6538225194724492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIN2,Bridging integrator 2,25809,26,1.06 [0.72-1.54],0.7765372556357699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIRC2,Baculoviral IAP repeat-containing protein 2,25213,25,1.77 [1.04-3.00],0.0357865418850145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLMH,Bleomycin hydrolase,26127,27,1.14 [0.39-3.30],0.8069590748712238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLNK,B-cell linker protein,21882,23,1.58 [0.73-3.40],0.2426346692045788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,21797,24,1.15 [0.75-1.79],0.5188320408172262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,22469,25,2.03 [0.90-4.58],0.0875584227625502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLVRB,Flavin reductase,25809,26,1.13 [0.70-1.81],0.6276300879808623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,22039,23,4.39 [1.05-18.32],0.0423880811653766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP4,Bone morphogenetic protein 4,25601,25,1.28 [0.62-2.62],0.5045441338786818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP6,Bone morphogenetic protein 6,25296,26,1.70 [0.75-3.89],0.2050244855848365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,22039,23,1.76 [1.03-2.99],0.0372317765046956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,22521,25,2.14 [1.02-4.49],0.0432716966258021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,21882,23,2.70 [1.44-5.07],0.0019766732912727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,25337,26,4.00 [0.94-17.01],0.0609066017083195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA1,BolA-like protein 1,21797,24,1.91 [1.32-2.76],0.000600428783198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA2_BOLA2B,BolA-like protein 2,21934,25,1.64 [0.81-3.34],0.168787364421503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFA2,BPI fold-containing family A member 2,21114,24,1.07 [0.76-1.52],0.6872382434987467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB1,BPI fold-containing family B member 1,25751,26,0.50 [0.32-0.79],0.0027921189997339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB2,BPI fold-containing family B member 2,22476,25,1.06 [0.67-1.70],0.792842014420429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRAP,BRCA1-associated protein,22220,24,1.33 [0.91-1.95],0.1350154914649559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD1,Bromodomain-containing protein 1,22092,25,0.62 [0.15-2.54],0.5092291323827152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD2,Bromodomain-containing protein 2,21797,24,0.84 [0.23-3.06],0.7922936151872468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD3,Bromodomain-containing protein 3,21807,24,1.26 [0.68-2.34],0.4642994631065713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRDT,Bromodomain testis-specific protein,21807,24,2.02 [0.81-5.03],0.1297823618522265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRK1,Protein BRICK1,25203,25,2.30 [1.15-4.59],0.0184861102152681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRME1,Break repair meiotic recombinase recruitment factor 1,21797,24,1.25 [0.67-2.32],0.4786856205829993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRSK2,Serine/threonine-protein kinase BRSK2,22479,24,1.36 [0.57-3.21],0.4864728374774193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,26039,26,9.57 [2.21-41.48],0.0025335807890458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSND,Barttin,21705,24,0.57 [0.15-2.18],0.4103875134611051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,26036,26,2.28 [0.71-7.30],0.1657283260410174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,26036,26,1.51 [0.98-2.35],0.0645157525299708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTC,Probetacellulin,25213,25,1.19 [0.76-1.87],0.4487469112020235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTD,Biotinidase,22555,24,1.75 [0.24-12.65],0.5792185925915082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTLA,B- and T-lymphocyte attenuator,21705,24,1.15 [0.79-1.67],0.4633707530750368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN1A1,Butyrophilin subfamily 1 member A1,22347,25,0.92 [0.35-2.43],0.8634200654294012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,25944,25,14.30 [5.85-34.92],5.242299681672806e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,25772,24,2.00 [1.25-3.19],0.0039495696755448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTNL10,Butyrophilin-like protein 10,21705,24,1.43 [0.78-2.64],0.2476563076384883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C19orf12,Protein C19orf12,25203,25,1.10 [0.69-1.77],0.6810804446667378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1GALT1C1,C1GALT1-specific chaperone 1,21807,24,1.57 [0.62-3.98],0.3398414549176197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,25949,26,2.82 [0.59-13.43],0.1942730509834726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",22479,24,0.96 [0.52-1.77],0.8981286720937759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QL2,Complement C1q-like protein 2,21882,23,0.46 [0.18-1.18],0.1060712292099872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,25899,27,2.53 [1.50-4.26],0.0005161153414217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,22039,23,2.81 [1.00-7.91],0.0502902071157446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,22479,24,1.67 [0.67-4.21],0.2728853267130868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,21993,23,2.05 [0.80-5.27],0.1352816891400037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1R,Complement C1r subcomponent,22555,24,0.49 [0.04-6.03],0.5742271174475175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1RL,Complement C1r subcomponent-like protein,22519,24,4.11 [0.54-31.23],0.1724307148861689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1S,Complement C1s subcomponent,22555,24,0.50 [0.07-3.47],0.484703216591965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,25854,27,7.94 [1.96-32.14],0.0037031951376451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2CD2L,Phospholipid transfer protein C2CD2L,25155,25,1.48 [0.80-2.73],0.2107138582013034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2orf69,UPF0565 protein C2orf69,21886,25,1.33 [0.81-2.19],0.2626988160261042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C3,Complement C3,21402,24,1.00 [0.44-2.27],0.995983125053606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C4BPB,C4b-binding protein beta chain,25902,27,1.39 [0.62-3.12],0.4234626770139886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C5,Complement C5,22555,24,4.97 [1.23-20.11],0.0245825761720766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,22019,23,11.21 [4.27-29.46],9.45709792705663e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7orf50,Uncharacterized protein C7orf50,22469,25,1.68 [0.52-5.45],0.3890677055201283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C8B,Complement component C8 beta chain,22555,24,0.82 [0.23-2.90],0.7582875841384673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9,Complement component C9,22523,24,0.78 [0.37-1.64],0.5149116383344728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9orf40,Uncharacterized protein C9orf40,22409,24,1.02 [0.65-1.60],0.943438906268794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA1,Carbonic anhydrase 1,25206,25,0.80 [0.46-1.40],0.4371734625732304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA11,Carbonic anhydrase-related protein 11,25213,25,1.62 [0.86-3.06],0.1391275961664896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,25691,26,4.88 [3.20-7.44],1.537207911113632e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA13,Carbonic anhydrase 13,25544,26,1.24 [0.87-1.77],0.2316388251700076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA14,Carbonic anhydrase 14,26026,27,1.02 [0.40-2.59],0.9653260179505672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA2,Carbonic anhydrase 2,25722,26,1.05 [0.66-1.68],0.8429770666208345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,26079,27,2.42 [1.56-3.77],8.428800889512948e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA4,Carbonic anhydrase 4,26127,27,9.01 [2.79-29.04],0.000233184745102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",25337,26,1.61 [1.21-2.15],0.0011859751257234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,25730,26,0.45 [0.26-0.78],0.0045706032009779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA7,Carbonic anhydrase 7,22092,25,1.46 [0.66-3.23],0.3552906408152235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA8,Carbonic anhydrase-related protein,21882,23,0.87 [0.15-4.98],0.8715444399418213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,26026,27,1.69 [0.92-3.11],0.0907003740986539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CABP2,Calcium-binding protein 2,21886,25,1.24 [0.71-2.16],0.4457359308839349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,21797,24,0.88 [0.25-3.04],0.8365485474408417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,21807,24,0.61 [0.22-1.64],0.3226442912725539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,21797,24,0.47 [0.19-1.13],0.0915100550863059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,22479,24,1.52 [0.95-2.43],0.0805388231640302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACYBP,Calcyclin-binding protein,21995,23,1.31 [0.88-1.97],0.1874987589431595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CADPS,Calcium-dependent secretion activator 1,21886,25,0.79 [0.29-2.14],0.6392473799539146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,25691,26,2.19 [1.03-4.64],0.0406966863898912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,25203,25,1.84 [1.30-2.60],0.0005084386129988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,25593,25,1.76 [1.21-2.57],0.003436019613965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,22469,25,1.99 [1.11-3.56],0.0202002565111715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,25946,27,1.14 [0.82-1.58],0.4254067709113526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,21934,25,1.60 [0.99-2.56],0.0530501292010697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALY,Neuron-specific vesicular protein calcyon,21807,24,0.78 [0.24-2.55],0.6845744618346954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,25213,25,1.35 [0.63-2.90],0.4440239280462663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,21886,25,0.87 [0.41-1.84],0.7113927536967801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,22479,24,1.14 [0.80-1.62],0.4783392140389078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,25744,27,45.68 [9.74-214.16],1.246430876575814e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPG,Macrophage-capping protein,25611,27,1.88 [1.13-3.15],0.0158006546786349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPN3,Calpain-3,22389,25,1.35 [0.60-3.02],0.4694436819558927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPS,Calcyphosin,22469,25,1.19 [0.90-1.58],0.2140586000329072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,25203,25,0.83 [0.42-1.65],0.5945562806853936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASC3,Protein CASC3,21886,25,1.97 [1.04-3.72],0.0368315084995509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP1,Caspase-1,25203,25,0.80 [0.46-1.37],0.4147133699280572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP10,Caspase-10,25203,25,1.06 [0.63-1.79],0.8187789778957195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP2,Caspase-2,25772,24,1.42 [0.86-2.35],0.1729670167058901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP3,Caspase-3,26127,27,1.26 [0.85-1.88],0.2525423539238267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP4,Caspase-4,22092,25,1.15 [0.97-1.38],0.114122107170833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP7,Caspase-7,22469,25,1.48 [0.94-2.33],0.0939626677945231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP8,Caspase-8,25948,27,1.02 [0.58-1.77],0.957219162505668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP9,Caspase-9,21882,23,0.89 [0.48-1.68],0.7224148043122147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASQ2,Calsequestrin-2,21807,24,0.61 [0.20-1.86],0.3869090630839539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAT,Catalase,22182,24,1.21 [0.63-2.35],0.5671178222162578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,25769,27,1.25 [0.81-1.95],0.3160918758160397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN1,Cerebellin-1,21797,24,0.98 [0.65-1.47],0.913796676932635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN4,Cerebellin-4,26026,27,0.41 [0.19-0.85],0.0176097365293516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBS,Cystathionine beta-synthase,21934,25,0.89 [0.41-1.94],0.7699626574853738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBX2,Chromobox protein homolog 2,21807,24,0.65 [0.22-1.94],0.4406701190950403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,25641,25,1.34 [0.85-2.10],0.2098640010359646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCAR2,Cell cycle and apoptosis regulator protein 2,22469,25,0.84 [0.37-1.91],0.6776596365970073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC134,Coiled-coil domain-containing protein 134,22389,25,1.11 [0.52-2.40],0.7811415629993156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC28A,Coiled-coil domain-containing protein 28A,21886,25,1.87 [0.49-7.06],0.3578867342431964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC50,Coiled-coil domain-containing protein 50,22479,24,1.23 [0.81-1.89],0.3329186415307718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,25813,27,4.24 [2.45-7.35],2.576374927578956e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,21934,25,2.27 [1.46-3.52],0.0002748322656615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,26083,26,3.56 [1.45-8.76],0.0056172252610763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL13,C-C motif chemokine 13,26035,26,1.34 [0.82-2.19],0.2387280300949278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,25724,27,2.21 [1.25-3.91],0.0062757204064687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,26127,27,5.43 [3.13-9.40],1.5679416060164371e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,26127,27,3.99 [2.20-7.23],5.169209946192686e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL17,C-C motif chemokine 17,25783,25,1.23 [0.83-1.81],0.3038348299082897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL18,C-C motif chemokine 18,25427,27,1.63 [1.17-2.28],0.0037830509767876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL19,C-C motif chemokine 19,26036,26,1.28 [1.07-1.54],0.0076080150163952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL2,C-C motif chemokine 2,25601,25,1.05 [0.57-1.94],0.8720483917464048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,26083,26,1.52 [1.19-1.94],0.0008190947012522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,25944,25,1.92 [1.28-2.88],0.001728386461968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,25579,25,2.06 [1.26-3.36],0.0039170576577887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL23,C-C motif chemokine 23,25944,25,1.39 [0.60-3.23],0.4394239696310993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL24,C-C motif chemokine 24,25901,25,0.87 [0.56-1.35],0.5418745928650468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,26083,26,2.62 [1.31-5.26],0.0067120018176854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL26,C-C motif chemokine 26,25772,24,0.73 [0.46-1.16],0.1779405867839442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL27,C-C motif chemokine 27,25813,27,1.49 [0.83-2.66],0.1790780581452405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL28,C-C motif chemokine 28,25697,24,1.24 [0.68-2.27],0.4791868864438685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,25772,24,1.34 [0.94-1.93],0.108103240746459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL4,C-C motif chemokine 4,25860,25,1.03 [0.65-1.65],0.8866264039805192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL5,C-C motif chemokine 5,25899,27,1.30 [0.93-1.82],0.1242453466675727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,25772,24,1.83 [1.38-2.43],3.2099915607040034e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL8,C-C motif chemokine 8,25991,27,1.45 [0.81-2.61],0.2115950545387687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN1,CCN family member 1,25647,26,1.44 [0.88-2.37],0.1464253131773738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN2,CCN family member 2,25814,25,1.08 [0.57-2.01],0.820516675019535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,26095,27,5.68 [3.33-9.66],1.5906606808280554e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,26026,27,2.22 [1.09-4.50],0.0276402223262774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,25809,26,4.54 [2.26-9.09],2.0153304991037456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCND2,G1/S-specific cyclin-D2,22092,25,1.29 [0.44-3.78],0.640483384494102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCNE1,G1/S-specific cyclin-E1,21882,23,0.61 [0.23-1.63],0.3261799929937568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,25641,25,0.69 [0.32-1.48],0.3346660116912976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCT5,T-complex protein 1 subunit epsilon,25213,25,1.08 [0.52-2.28],0.8316255398294797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD101,Immunoglobulin superfamily member 2,22409,24,1.98 [0.88-4.42],0.0966823502192967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,25809,26,4.06 [1.60-10.28],0.0031642073013191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,25242,27,3.61 [1.74-7.49],0.0005812325352666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,26083,26,4.58 [2.67-7.86],3.323367521793199e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,25899,27,3.13 [1.64-5.98],0.0005334188599523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,25809,26,1.79 [1.12-2.86],0.015315850701278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164L2,CD164 sialomucin-like 2 protein,21886,25,1.29 [0.49-3.40],0.6006745836853061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD177,CD177 antigen,25770,26,1.31 [0.97-1.77],0.0799129337076047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD1C,T-cell surface glycoprotein CD1c,25902,27,0.44 [0.12-1.60],0.2107860687918959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2,T-cell surface antigen CD2,21807,24,1.60 [0.85-2.98],0.1431865108040446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200,OX-2 membrane glycoprotein,25772,24,1.28 [0.33-5.00],0.7248494997158025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,25690,24,2.16 [0.82-5.70],0.1195595775959211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,25257,26,3.61 [1.82-7.17],0.0002411107873045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD209,CD209 antigen,25877,26,0.89 [0.36-2.18],0.7922834187227087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,26083,26,2.75 [1.37-5.54],0.0046236506009541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD226,CD226 antigen,21882,23,2.21 [0.92-5.28],0.0745090802374035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,26083,26,4.64 [1.40-15.41],0.0121444307210122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD248,Endosialin,22510,25,0.58 [0.22-1.54],0.2775617308063124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,25902,27,8.03 [5.05-12.78],1.4767278358575813e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,25641,25,3.36 [1.76-6.42],0.0002431288852617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,25823,25,9.72 [4.71-20.07],7.975700922695713e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,25213,25,0.34 [0.12-0.98],0.0451570791585851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2AP,CD2-associated protein,25813,27,1.49 [0.90-2.44],0.1197828947249179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,22039,23,15.59 [6.32-38.48],2.521114738087892e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,26036,26,3.57 [2.04-6.27],9.06389089632692e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,25932,27,5.03 [2.59-9.75],1.7613433090614383e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,26026,27,1.65 [0.89-3.07],0.1124831268553978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LG,CMRF35-like molecule 9,25809,26,2.07 [0.84-5.13],0.1148992805144897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,25691,26,8.72 [4.69-16.21],7.472389919432795e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD33,Myeloid cell surface antigen CD33,25902,27,1.41 [0.88-2.24],0.1497121139068631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD34,Hematopoietic progenitor cell antigen CD34,25950,26,0.80 [0.45-1.42],0.4423597320749053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,21882,23,2.55 [1.17-5.54],0.0179120440756655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,25691,26,10.71 [5.68-20.20],2.342963969402999e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3D,T-cell surface glycoprotein CD3 delta chain,21797,24,0.92 [0.27-3.12],0.8978847231491522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,22092,25,0.80 [0.24-2.62],0.7111310367246902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,21882,23,0.85 [0.49-1.47],0.5642604066508325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,25733,24,2.24 [1.38-3.64],0.0011828796381191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,25817,25,2.78 [1.56-4.95],0.000540196622499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40LG,CD40 ligand,26083,26,1.16 [0.73-1.84],0.536187391563312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,25636,27,4.39 [2.53-7.61],1.3420069590692636e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,25901,25,9.76 [4.29-22.20],5.4597230566874176e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,25991,27,1.38 [1.02-1.87],0.0373198867993322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,24906,27,3.65 [2.05-6.50],1.1192477475692794e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD58,Lymphocyte function-associated antigen 3,25786,25,0.35 [0.05-2.37],0.2794349087331872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,24851,26,2.03 [1.30-3.18],0.0018322073335272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5L,CD5 antigen-like,22421,24,1.34 [0.58-3.10],0.4932073877194354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD6,T-cell differentiation antigen CD6,26039,26,1.49 [0.76-2.92],0.2408942576297322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD63,CD63 antigen,25601,25,2.18 [1.07-4.42],0.0317989420382139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD69,Early activation antigen CD69,25691,27,1.34 [0.90-1.99],0.1498879584823872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,21838,23,3.33 [2.33-4.76],4.5004469302936786e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,25772,24,2.26 [1.09-4.71],0.0292558022434471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,22039,23,3.33 [1.57-7.09],0.0017642382868969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,26036,26,7.01 [3.51-14.01],3.5310189600153185e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,26083,26,4.87 [3.27-7.25],6.504794909930212e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,22521,25,4.80 [2.21-10.42],7.225310290631467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD82,CD82 antigen,22092,25,1.23 [0.57-2.66],0.6050937918469321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,25772,24,6.00 [2.95-12.21],7.820774842608789e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD84,SLAM family member 5,25772,24,2.25 [0.69-7.39],0.1803895637785559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD86,T-lymphocyte activation antigen CD86,22409,24,1.09 [0.29-4.12],0.8954568417483034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,26036,26,2.03 [1.09-3.78],0.0262883152074907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,24817,25,2.69 [0.92-7.87],0.070914577963982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,25809,26,8.82 [1.97-39.41],0.0043795108526123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,25809,26,1.59 [0.37-6.87],0.5380801957397504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDA,Cytidine deaminase,22473,25,1.26 [0.58-2.72],0.5559148000549008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDAN1,Codanin-1,22469,25,0.73 [0.13-3.95],0.7136167818559986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC123,Cell division cycle protein 123 homolog,21705,24,1.16 [0.65-2.05],0.6212860256847277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC25A,M-phase inducer phosphatase 1,21705,24,0.95 [0.35-2.58],0.9125351355219936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC26,Anaphase-promoting complex subunit CDC26,22372,24,1.81 [1.10-3.00],0.0200079987063761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,25213,25,1.63 [1.01-2.63],0.0443602269383339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC37,Hsp90 co-chaperone Cdc37,25902,27,1.38 [0.92-2.06],0.1193474697901814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,22409,24,1.26 [0.88-1.79],0.2019612651391359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,25641,25,4.64 [2.82-7.64],1.7215558928194175e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,24951,27,3.07 [2.09-4.51],1.0865013770680209e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,25988,26,1.73 [1.05-2.85],0.0327498368653518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,25813,27,2.04 [1.32-3.17],0.0014569671087809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,25813,27,6.34 [2.49-16.13],0.0001053762682539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH22,Cadherin-22,22092,25,0.89 [0.21-3.81],0.8765595819002928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH23,Cadherin-23,22469,25,1.53 [0.39-5.99],0.5409365341644391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,26036,26,2.62 [1.20-5.70],0.015487566719684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH4,Cadherin-4,21797,24,1.47 [0.83-2.61],0.1854548168041492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH5,Cadherin-5,26127,27,1.20 [0.40-3.61],0.7484456297067779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,25813,27,2.41 [1.03-5.62],0.0415161381667538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR1,Cadherin-related family member 1,25203,25,0.61 [0.24-1.56],0.3063242693298765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR2,Cadherin-related family member 2,25691,26,1.01 [0.63-1.61],0.9779594961155532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR5,Cadherin-related family member 5,25813,27,0.52 [0.23-1.20],0.1250076489547511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK1,Cyclin-dependent kinase 1,21705,24,0.78 [0.27-2.27],0.6436745493489346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,22479,24,1.71 [0.98-2.98],0.057912017143802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKL5,Cyclin-dependent kinase-like 5,21797,24,0.97 [0.44-2.11],0.9346439493603158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,25691,26,1.54 [1.11-2.15],0.009593637682256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,25691,26,1.24 [0.83-1.84],0.2935601546411083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,25691,26,2.31 [1.33-4.01],0.0028041749232643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,25867,25,3.48 [0.88-13.78],0.075498923578017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDSN,Corneodesmosin,26000,26,2.00 [0.93-4.30],0.0766959803039797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,25863,27,0.86 [0.20-3.68],0.8425323752712012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,22409,24,1.53 [0.89-2.62],0.1229793643143326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,22092,25,0.69 [0.31-1.51],0.3511795714065456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,22409,24,3.62 [1.89-6.94],0.0001037789645111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,22092,25,0.72 [0.27-1.94],0.5149349558959734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,25772,24,1.27 [0.86-1.88],0.2288911973773696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,25213,25,0.42 [0.19-0.92],0.0307621843034624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,24879,24,1.66 [1.02-2.69],0.0417190203202374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22510,25,2.74 [1.25-6.04],0.0121241063320141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,25337,26,2.62 [1.58-4.34],0.000187358180046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPA,CCAAT/enhancer-binding protein alpha,21882,23,0.96 [0.28-3.30],0.942817326222426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPB,CCAAT/enhancer-binding protein beta,25337,26,1.23 [0.51-2.96],0.6505365576550725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA2A,Chymotrypsin-like elastase family member 2A,22510,25,0.49 [0.29-0.84],0.0090021394011285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA3A,Chymotrypsin-like elastase family member 3A,26081,27,0.37 [0.22-0.62],0.0001238028716979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,22039,23,2.83 [0.95-8.44],0.0616807543464443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEMIP2,Cell surface hyaluronidase,21882,23,1.48 [0.71-3.08],0.2925530163617894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,21797,24,1.40 [0.92-2.15],0.120527141521063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPF,Centromere protein F,22092,25,1.70 [0.97-3.00],0.065790263667577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPJ,Centromere protein J,22092,25,1.31 [0.82-2.07],0.2554514692198673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP112,Centrosomal protein of 112 kDa,21807,24,1.24 [0.58-2.67],0.57906290884927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP152,Centrosomal protein of 152 kDa,21705,24,1.19 [0.46-3.06],0.7173084578260769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP164,Centrosomal protein of 164 kDa,25307,25,1.06 [0.67-1.68],0.8021302818755772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP170,Centrosomal protein of 170 kDa,21934,25,1.20 [0.77-1.87],0.4102225641453967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP20,Centrosomal protein 20,25213,25,1.19 [0.74-1.89],0.4728428974680263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP290,Centrosomal protein of 290 kDa,22092,25,1.21 [0.68-2.14],0.5149670522783929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP350,Centrosome-associated protein 350,21705,24,0.98 [0.34-2.83],0.9759310577392551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP43,Centrosomal protein 43,25132,26,1.65 [1.03-2.65],0.0371169423169773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP85,Centrosomal protein of 85 kDa,25213,25,1.08 [0.63-1.87],0.7772862905304695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CERT,Ceramide transfer protein,25203,25,1.28 [0.71-2.31],0.4030936045522642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,25869,25,1.72 [1.20-2.46],0.0028320309196442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,25691,26,1.70 [0.98-2.97],0.0607539931409053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES3,Carboxylesterase 3,25691,26,1.07 [0.67-1.70],0.7735494050608975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN2,Centrin-2,25203,25,1.22 [0.73-2.04],0.4408548885570112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN3,Centrin-3,22409,24,1.35 [0.84-2.18],0.214452249329601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFB,Complement factor B,22131,24,0.82 [0.24-2.83],0.7507098911294547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,25213,25,1.76 [1.01-3.06],0.0458507649721723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,22555,24,11.54 [5.27-25.27],9.83651812585067e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFH,Complement factor H,21233,23,3.59 [0.61-21.16],0.1585727243050192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR2,Complement factor H-related protein 2,22386,24,2.81 [1.14-6.92],0.0243580209141104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR4,Complement factor H-related protein 4,22516,24,0.92 [0.56-1.53],0.7605128633352161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR5,Complement factor H-related protein 5,22218,24,0.91 [0.37-2.25],0.8337609259905704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFI,Complement factor I,22555,24,5.40 [0.75-38.62],0.0931939463045027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFP,Properdin,22555,24,1.03 [0.53-2.00],0.9383796560138056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,25809,26,0.82 [0.51-1.34],0.4329273707407406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,22523,24,0.44 [0.16-1.18],0.1019828964178861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGN,Cingulin,21886,25,1.21 [0.54-2.69],0.6408462970463551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,25813,27,7.20 [3.58-14.48],3.1308343490931474e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,25213,25,1.31 [0.82-2.10],0.2603639852845502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,22039,23,0.52 [0.25-1.10],0.0874551455616136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22469,25,4.51 [3.17-6.43],8.167144465967927e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,22389,25,2.89 [1.67-5.00],0.0001528167698581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHEK2,Serine/threonine-protein kinase Chk2,25337,26,0.84 [0.28-2.50],0.7592902455321047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,22510,25,1.69 [1.30-2.20],9.24614250838248e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,25939,26,3.55 [1.98-6.36],1.977781448928048e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,25230,27,2.14 [1.59-2.87],4.045843399285898e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHIT1,Chitotriosidase-1,25915,26,1.32 [0.92-1.88],0.1334327830003047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHL1,Neural cell adhesion molecule L1-like protein,25860,27,0.53 [0.17-1.65],0.2712494986460506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHM,Rab proteins geranylgeranyltransferase component A 1,21886,25,1.21 [0.69-2.12],0.5061149959382973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP1A,Charged multivesicular body protein 1a,25641,25,1.36 [0.85-2.17],0.2046641878376342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP6,Charged multivesicular body protein 6,22521,25,1.68 [0.85-3.33],0.1364718230227934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHP1,Calcineurin B homologous protein 1,21797,24,1.07 [0.64-1.80],0.7981392094007371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,25901,25,4.03 [1.44-11.33],0.0081322340891657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL2,Chordin-like protein 2,25813,27,1.07 [0.57-1.98],0.8383437998721299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRM1,Muscarinic acetylcholine receptor M1,21886,25,1.30 [0.56-3.03],0.5351565679330388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIAPIN1,Anamorsin,25902,27,1.59 [0.93-2.72],0.0917956454096947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,22510,25,5.23 [3.26-8.37],5.749094308496361e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CINP,Cyclin-dependent kinase 2-interacting protein,22092,25,0.57 [0.19-1.74],0.3256366741757358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIRBP,Cold-inducible RNA-binding protein,22409,24,1.30 [0.85-1.99],0.2250249205815739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIT,Citron Rho-interacting kinase,21886,25,1.53 [0.79-2.98],0.2072272488536619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,25955,26,2.30 [0.65-8.10],0.1957969822769339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKB,Creatine kinase B-type,22510,25,1.76 [0.98-3.16],0.0586909776163512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",25736,25,2.00 [1.16-3.43],0.012252116829433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLASP1,CLIP-associating protein 1,21705,24,0.68 [0.34-1.34],0.2647164790212309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLC,Galectin-10,25775,27,1.26 [0.78-2.05],0.3425742548346361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,25641,25,4.18 [1.58-11.04],0.0038803529519147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC11A,C-type lectin domain family 11 member A,25761,26,1.22 [0.60-2.49],0.5755315061571675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,21882,23,2.35 [0.53-10.41],0.2602190723083178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,25809,26,4.14 [1.62-10.59],0.0030590755560884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,25337,26,4.91 [2.00-12.07],0.0005293917826177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1B,C-type lectin domain family 1 member B,26036,26,1.18 [0.83-1.69],0.3471089449812621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC2L,C-type lectin domain family 2 member L,21886,25,0.88 [0.37-2.08],0.7729285252491365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,22017,24,0.69 [0.32-1.48],0.3383592737852486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,25772,24,0.32 [0.13-0.78],0.0120162428276938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4C,C-type lectin domain family 4 member C,25772,24,0.58 [0.27-1.27],0.1742510853210141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,25772,24,1.66 [0.95-2.89],0.0725818286443321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4G,C-type lectin domain family 4 member G,25772,24,3.00 [1.02-8.84],0.0464830062739791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4M,C-type lectin domain family 4 member M,22466,25,0.51 [0.22-1.18],0.1157494611462919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,25729,27,6.13 [3.04-12.36],3.931789747321333e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,25213,25,2.03 [1.06-3.88],0.0332470213229273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,26083,26,2.27 [1.02-5.04],0.0449899385352923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,21886,25,2.30 [1.33-3.98],0.0027700358656799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIC5,Chloride intracellular channel protein 5,21886,25,1.03 [0.31-3.45],0.9574978576495335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLINT1,Clathrin interactor 1,21705,24,1.14 [0.51-2.54],0.7438236236772323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIP2,CAP-Gly domain-containing linker protein 2,25772,24,1.21 [0.88-1.68],0.2423911558087822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,26026,27,11.65 [3.92-34.67],1.0112687688705124e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLNS1A,Methylosome subunit pICln,21886,25,1.72 [0.64-4.66],0.2846352463023218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",25593,25,1.31 [0.91-1.88],0.140885131027154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPS,Colipase,25770,26,0.66 [0.41-1.08],0.0987660189047711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSPN,Claspin,25155,25,0.87 [0.57-1.34],0.534764106313431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN1,Calsyntenin-1,25203,25,1.43 [0.86-2.39],0.1678774101593162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,26083,26,1.84 [0.93-3.63],0.0805815693688875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,22469,25,2.58 [1.04-6.36],0.0398931927694573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLTA,Clathrin light chain A,25337,26,1.46 [0.80-2.66],0.2206034548830117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLU,Clusterin,22555,24,1.36 [0.52-3.53],0.5309020717528934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,25778,27,0.31 [0.15-0.66],0.0026020037617141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMC1,COX assembly mitochondrial protein homolog,22521,25,1.23 [0.81-1.87],0.3237656661526821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMIP,C-Maf-inducing protein,22389,25,1.40 [0.90-2.20],0.1383062315586964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNDP1,Beta-Ala-His dipeptidase,25899,27,0.64 [0.34-1.23],0.1801038123585188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,21797,24,0.99 [0.45-2.15],0.9747868248219248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",21894,25,1.57 [0.97-2.54],0.0634935030013203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY2,Protein canopy homolog 2,25337,26,1.10 [0.64-1.89],0.7201446357465375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY4,Protein canopy homolog 4,25691,26,1.54 [0.96-2.47],0.0712493547243475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNST,Consortin,25813,27,1.27 [0.93-1.74],0.1348393106480979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTF,Ciliary neurotrophic factor,21797,24,1.28 [0.41-4.00],0.669519854989866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN1,Contactin-1,26127,27,0.84 [0.26-2.69],0.7644217046408367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,26026,27,1.44 [0.69-3.01],0.3253723407561414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN3,Contactin-3,25809,26,2.24 [0.80-6.24],0.1241176534376289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,25809,26,3.40 [0.91-12.74],0.0694596089905144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,25877,26,0.69 [0.48-0.99],0.0445265056430637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,25772,24,1.08 [0.44-2.64],0.8663660931410352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP4,Contactin-associated protein-like 4,21886,25,0.73 [0.42-1.26],0.2571095076121574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,22521,25,2.72 [1.36-5.41],0.0044931246612065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL15A1,Collagen alpha-1(XV) chain,22510,25,6.49 [2.49-16.90],0.0001279590925318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,25920,26,40.23 [11.75-137.72],4.0099286464638935e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL1A1,Collagen alpha-1(I) chain,26127,27,0.81 [0.20-3.23],0.7619796660741369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL24A1,Collagen alpha-1(XXIV) chain,22409,24,0.87 [0.45-1.67],0.6742605922468197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL28A1,Collagen alpha-1(XXVIII) chain,21886,25,1.27 [0.79-2.03],0.3276848440252691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL2A1,Collagen alpha-1(II) chain,21934,25,1.22 [0.78-1.92],0.3907414399222758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,22510,25,7.19 [2.60-19.89],0.0001464391935465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,25813,27,4.09 [2.07-8.10],5.139095552707269e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A4,Collagen alpha-4(IV) chain,22055,25,0.69 [0.38-1.27],0.2370633091813752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,22039,23,3.52 [1.75-7.05],0.0003948002253761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,26127,27,10.23 [6.06-17.28],3.489176244505104e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A1,Collagen alpha-1(IX) chain,25772,24,1.00 [0.51-1.97],0.9963888031960072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A2,Collagen alpha-2(IX) chain,22092,25,1.32 [0.73-2.41],0.3572630716276564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,25823,25,25.91 [10.70-62.75],5.473604692243916e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD1,COMM domain-containing protein 1,21934,25,1.58 [0.87-2.86],0.1325653304436886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD9,COMM domain-containing protein 9,22389,25,1.48 [0.76-2.88],0.2497436651809297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMP,Cartilage oligomeric matrix protein,25523,26,0.58 [0.21-1.60],0.2937687640852783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMT,Catechol O-methyltransferase,25067,26,1.32 [0.86-2.01],0.2004358816285864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPB2,Coatomer subunit beta',21807,24,1.75 [0.82-3.75],0.1473577716302096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPE,Coatomer subunit epsilon,25203,25,0.74 [0.30-1.81],0.5100538036093537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",21934,25,0.50 [0.17-1.48],0.2096176921979815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO1A,Coronin-1A,25265,26,1.08 [0.75-1.56],0.682519400118618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,21797,24,2.48 [1.51-4.07],0.0003282493467059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",25691,26,1.52 [1.00-2.33],0.0521105156947702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,22521,25,3.93 [1.63-9.45],0.0022455981791403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA1,Carboxypeptidase A1,26127,27,0.46 [0.27-0.78],0.0043941632346855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,25941,26,1.22 [0.73-2.03],0.4411218307603584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA4,Carboxypeptidase A4,21600,23,1.22 [0.47-3.18],0.6779047579388787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB1,Carboxypeptidase B,26127,27,0.51 [0.28-0.93],0.0286602076419067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB2,Carboxypeptidase B2,22508,24,0.91 [0.16-5.11],0.9108916117680084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPE,Carboxypeptidase E,25840,27,0.56 [0.27-1.15],0.1161943922485002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPLX2,Complexin-2,21705,24,1.09 [0.36-3.30],0.8755187162191914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,25915,26,4.54 [2.25-9.16],2.3635422686254643e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",21882,23,0.98 [0.26-3.73],0.9735737376586288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,26036,26,0.74 [0.43-1.26],0.2656641130951879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPQ,Carboxypeptidase Q,22464,25,0.39 [0.19-0.80],0.0094114599484865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPTP,Ceramide-1-phosphate transfer protein,21807,24,1.24 [0.54-2.87],0.6147383024669412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,25991,27,2.47 [1.02-5.97],0.0439775736140313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM1,Probable carboxypeptidase X1,25902,27,1.19 [0.74-1.92],0.479292402132222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,22521,25,4.32 [2.63-7.09],7.394128076234622e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,22432,24,2.69 [1.71-4.23],1.879381766719223e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,25899,27,2.89 [1.42-5.92],0.0035963502234584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,25213,25,0.88 [0.57-1.37],0.5674575524340455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRADD,Death domain-containing protein CRADD,25593,25,1.40 [0.87-2.26],0.1702117477584703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREB3,Cyclic AMP-responsive element-binding protein 3,21705,24,0.46 [0.18-1.15],0.0957112822891961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREBZF,CREB/ATF bZIP transcription factor,21705,24,0.36 [0.07-1.93],0.2341553919869968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREG1,Protein CREG1,25482,27,0.32 [0.12-0.85],0.0219649777257513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,22039,23,9.98 [3.56-27.95],1.193732873381576e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,25901,25,2.47 [1.38-4.40],0.0022452317864155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,25169,24,0.61 [0.39-0.96],0.0312064583023764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,25823,25,7.75 [2.28-26.36],0.0010400241660166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHR1,Corticotropin-releasing factor receptor 1,25337,26,1.44 [0.97-2.12],0.0694865375667114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,25944,25,2.27 [0.44-11.63],0.3240317780495776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,25641,25,3.12 [1.96-4.96],1.5602860620165476e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP2,Cysteine-rich secretory protein 2,26026,27,0.73 [0.45-1.19],0.2043503218084278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP3,Cysteine-rich secretory protein 3,22315,23,0.87 [0.22-3.47],0.8458891991607693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRKL,Crk-like protein,25864,25,1.29 [0.91-1.84],0.1488673573902912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,25944,25,0.65 [0.16-2.62],0.5451500951080037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRNN,Cornulin,25052,25,0.92 [0.55-1.54],0.7514035603053885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAC1,Cartilage acidic protein 1,26127,27,0.44 [0.15-1.29],0.1348507928779365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,25641,25,1.89 [0.96-3.71],0.0644409600825985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAP,Cartilage-associated protein,21886,25,1.23 [0.60-2.54],0.57217436824919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRX,Cone-rod homeobox protein,25337,26,0.65 [0.38-1.12],0.1180229939098986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB1,Beta-crystallin B1,22521,25,2.10 [1.20-3.66],0.0091356777987965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB2,Beta-crystallin B2,22469,25,1.06 [0.69-1.64],0.7765514985794006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYGD,Gamma-crystallin D,22469,25,1.10 [0.75-1.63],0.624958703655249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYM,Ketimine reductase mu-crystallin,21797,24,1.00 [0.59-1.70],0.9962928289655132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYZL1,Quinone oxidoreductase-like protein 1,21934,25,1.33 [0.87-2.04],0.1888539489472102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSDE1,Cold shock domain-containing protein E1,21807,24,1.03 [0.73-1.44],0.877215072504179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,25944,25,12.51 [4.59-34.09],7.726666334261935e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,22523,24,3.40 [1.73-6.68],0.000379129856947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2,Granulocyte-macrophage colony-stimulating factor,21807,24,2.17 [0.93-5.04],0.0733534483064646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,25641,25,1.49 [0.91-2.45],0.1109948229970142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RB,Cytokine receptor common subunit beta,21882,23,1.94 [0.76-4.99],0.1667481748681443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3,Granulocyte colony-stimulating factor,25307,25,0.99 [0.47-2.09],0.9769932719361972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3R,Granulocyte colony-stimulating factor receptor,21882,23,2.38 [1.01-5.64],0.0480394857294942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSH1,Chorionic somatomammotropin hormone 1,22523,24,1.24 [0.41-3.78],0.7034710722164859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK1D,Casein kinase I isoform delta,21882,23,1.23 [0.68-2.23],0.4994804638691552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK2A1,Casein kinase II subunit alpha,22479,24,2.06 [0.90-4.73],0.0884371759448837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG4,Chondroitin sulfate proteoglycan 4,22510,25,2.01 [0.62-6.51],0.243375883780567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG5,Chondroitin sulfate proteoglycan 5,21797,24,0.61 [0.24-1.54],0.293890697619752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,21807,24,1.59 [1.26-2.00],8.701439329155543e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST1,Cystatin-SN,19506,19,1.27 [0.89-1.81],0.182728624632359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,25865,27,14.07 [7.07-27.98],4.8544189498797575e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST5,Cystatin-D,25380,25,1.81 [0.98-3.33],0.0578935924107677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST6,Cystatin-M,25125,26,1.01 [0.50-2.07],0.969042207403484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,25860,25,1.23 [0.90-1.67],0.1900405044583986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,25450,26,4.88 [3.03-7.85],6.982238353956009e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,22051,25,1.13 [0.53-2.41],0.7498479388716235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTBS,Di-N-acetylchitobiase,22195,24,2.46 [0.55-10.99],0.2398719788750976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTF1,Cardiotrophin-1,25337,26,1.17 [0.78-1.76],0.436592020046852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,22510,25,4.88 [2.27-10.50],5.025035214094495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTLA4,Cytotoxic T-lymphocyte protein 4,22510,25,0.84 [0.22-3.27],0.8007405861872434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTNNA1,Catenin alpha-1,21797,24,1.08 [0.44-2.69],0.8634453240996284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRB1,Chymotrypsinogen B,25809,26,0.46 [0.25-0.83],0.0103647866788402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,25825,25,0.33 [0.21-0.51],6.878297227393085e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,22469,25,0.38 [0.24-0.62],0.0001123438302048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSB,Cathepsin B,25841,26,1.47 [0.80-2.70],0.2132917126126668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSC,Dipeptidyl peptidase 1,25779,24,1.91 [0.90-4.07],0.091800828330875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,24093,26,2.57 [1.60-4.12],9.525530996116755e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,22039,23,2.21 [1.06-4.60],0.0343551559401135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSF,Cathepsin F,25902,27,1.59 [0.67-3.78],0.292046383219488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSH,Pro-cathepsin H,25260,26,1.25 [0.80-1.96],0.3260433351824051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,25813,27,12.31 [4.91-30.87],8.633579108221865e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,26083,26,3.64 [1.43-9.22],0.0065153965999142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,20264,21,14.58 [4.34-49.03],1.4897182895358816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSV,Cathepsin L2,25951,27,0.73 [0.54-0.99],0.0439921867247003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,25811,27,9.54 [3.76-24.21],2.048833298122416e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,21886,25,0.57 [0.09-3.53],0.5425356490873914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CWC15,Spliceosome-associated protein CWC15 homolog,22278,24,1.41 [0.85-2.35],0.1834700535931705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,25641,25,1.81 [0.70-4.68],0.2205073258440589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,25772,24,1.58 [0.88-2.85],0.1277923592305426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL1,Growth-regulated alpha protein,25774,25,1.30 [0.98-1.73],0.070821483365675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL10,C-X-C motif chemokine 10,25944,25,1.23 [0.76-1.97],0.3995696051792738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL11,C-X-C motif chemokine 11,26036,26,1.42 [1.01-2.01],0.0436797581446375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL12,Stromal cell-derived factor 1,25307,25,0.89 [0.36-2.18],0.800739569210665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,26036,26,1.40 [1.12-1.76],0.0036032794861479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,25307,25,1.48 [1.07-2.04],0.0191720532650257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,26083,27,6.73 [1.78-25.41],0.0049438176938072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,26083,26,1.59 [0.73-3.47],0.2392294057755282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL3,C-X-C motif chemokine 3,25817,25,1.18 [0.80-1.75],0.4079430962432971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL5,C-X-C motif chemokine 5,25728,27,1.25 [0.93-1.68],0.1405312806934884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,26083,26,2.06 [1.38-3.08],0.0003969657606889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,25601,27,1.47 [1.07-2.01],0.0177505294612038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,25944,25,1.93 [1.32-2.82],0.0006789182801088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5A,Cytochrome b5,21705,24,0.98 [0.56-1.71],0.9385130146710728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5R2,NADH-cytochrome b5 reductase 2,22140,24,1.43 [0.75-2.71],0.2734993076901371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",21807,24,0.45 [0.20-1.02],0.0558833534222303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTH3,Cytohesin-3,21705,24,0.87 [0.46-1.64],0.6703232972236826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTL1,Cytokine-like protein 1,22510,25,2.83 [0.59-13.57],0.1923505393799725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAAM1,Disheveled-associated activator of morphogenesis 1,22039,23,1.33 [0.83-2.13],0.2399057674504399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAB2,Disabled homolog 2,26026,27,1.31 [0.95-1.81],0.1029771557796217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,25944,25,2.01 [0.95-4.25],0.0685935238735832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAND5,DAN domain family member 5,21882,23,1.67 [1.16-2.41],0.0057236593599135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPK2,Death-associated protein kinase 2,21882,23,1.06 [0.51-2.21],0.8749945161583512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,25772,24,1.38 [0.96-2.00],0.0849817798893655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",25593,25,1.39 [0.85-2.28],0.1895926745659389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBH,Dopamine beta-hydroxylase,22475,24,1.07 [0.72-1.59],0.7216988067083643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,25689,25,1.89 [1.20-2.98],0.0062575106166919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBN1,Drebrin,21882,23,1.66 [0.87-3.17],0.1254805271806001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBNL,Drebrin-like protein,25944,25,1.32 [0.89-1.95],0.1707940188150272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",25902,27,13.18 [5.57-31.20],4.499696328923478e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCC,Netrin receptor DCC,21886,25,1.31 [0.32-5.27],0.7075359263672502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCDC2C,Doublecortin domain-containing protein 2C,21705,24,1.09 [0.61-1.95],0.7634172882436199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCLRE1C,Protein artemis,21705,24,0.76 [0.45-1.29],0.315755116362859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,25337,26,19.49 [6.56-57.93],9.147674582882265e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTD,Deoxycytidylate deaminase,22039,23,1.28 [0.83-1.99],0.2643453674423029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN1,Dynactin subunit 1,26026,27,1.19 [0.71-1.97],0.5137924754784271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN2,Dynactin subunit 2,25691,26,1.00 [0.69-1.45],0.9916341341819862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN6,Dynactin subunit 6,25203,25,0.99 [0.60-1.63],0.9701962936521568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTPP1,dCTP pyrophosphatase 1,25813,27,2.08 [0.73-5.98],0.1722679253395092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D1,DCN1-like protein 1,21797,24,0.65 [0.31-1.37],0.2536086820256042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D2,DCN1-like protein 2,21705,24,1.64 [1.25-2.15],0.000379417648067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCXR,L-xylulose reductase,25902,27,0.60 [0.31-1.19],0.14472051538932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDA1,DET1- and DDB1-associated protein 1,21807,24,1.20 [0.54-2.68],0.6528042875023465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",25691,26,3.18 [2.06-4.90],1.680764325841965e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDC,Aromatic-L-amino-acid decarboxylase,25769,27,0.96 [0.48-1.93],0.9180098834366274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDHD2,Phospholipase DDHD2,22479,24,1.47 [0.82-2.64],0.1979382892952765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDI2,Protein DDI1 homolog 2,22039,23,1.28 [0.81-2.02],0.2946923606163506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,26036,26,6.13 [2.12-17.73],0.0008242000974475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDT,D-dopachrome decarboxylase,22510,25,1.76 [0.80-3.90],0.1621786860966708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX1,ATP-dependent RNA helicase DDX1,22409,24,1.58 [0.93-2.70],0.0894395775767537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX25,ATP-dependent RNA helicase DDX25,21886,25,1.38 [0.69-2.78],0.3667290654797623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX39A,ATP-dependent RNA helicase DDX39A,21882,23,1.81 [0.36-9.17],0.4732305271886394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX4,Probable ATP-dependent RNA helicase DDX4,21882,23,0.88 [0.37-2.06],0.7622544874865228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX53,Probable ATP-dependent RNA helicase DDX53,21886,25,2.51 [1.16-5.43],0.0192128715333988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX58,Antiviral innate immune response receptor RIG-I,25213,25,1.06 [0.56-1.99],0.8584782391037075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",25772,24,1.25 [0.86-1.83],0.2444183549404217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,25291,27,2.01 [1.34-2.99],0.0006513710404314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,21708,23,1.93 [1.35-2.78],0.0003566543557992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB104A_DEFB104B,Beta-defensin 104,21797,24,0.75 [0.32-1.74],0.5044294868750167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB116,Beta-defensin 116,21797,24,0.77 [0.41-1.45],0.4215188743718391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB118,Beta-defensin 118,21797,24,0.80 [0.33-1.94],0.626617509275778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,25449,26,1.28 [1.02-1.61],0.0334090789913356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENND2B,DENN domain-containing protein 2B,21807,24,1.46 [0.90-2.37],0.1226362676226601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENR,Density-regulated protein,21882,23,1.55 [0.86-2.79],0.1462287588782904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DFFA,DNA fragmentation factor subunit alpha,26083,26,1.60 [0.99-2.61],0.0567811711438059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGCR6,Protein DGCR6,21797,24,1.42 [0.84-2.40],0.1863458889788686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKA,Diacylglycerol kinase alpha,21882,23,2.11 [1.13-3.94],0.0184687742217968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKZ,Diacylglycerol kinase zeta,25307,25,0.69 [0.24-2.04],0.5071794001524403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHODH,Dihydroorotate dehydrogenase,21807,24,1.43 [0.78-2.62],0.2451885323202909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHPS,Deoxyhypusine synthase,22389,25,1.13 [0.54-2.36],0.7496141877697506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,22469,25,2.06 [1.36-3.11],0.0006698293304192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIABLO,"Diablo homolog, mitochondrial",25729,27,1.11 [0.81-1.52],0.5101433503870381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK1C,Divergent protein kinase domain 1C,21886,25,1.61 [1.05-2.46],0.0291843576366167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK2B,Divergent protein kinase domain 2B,22039,23,1.25 [0.27-5.66],0.7757536821467494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK1,Dickkopf-related protein 1,26036,26,1.30 [0.72-2.33],0.3825697643858854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,26127,27,2.73 [0.89-8.36],0.0783038508500214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,25601,25,2.72 [1.74-4.26],1.156364745656958e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKKL1,Dickkopf-like protein 1,25691,26,1.15 [0.74-1.79],0.5254613686509408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLG4,Disks large homolog 4,22469,25,1.36 [0.83-2.24],0.2230409387936385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLGAP5,Disks large-associated protein 5,22479,24,0.35 [0.08-1.45],0.1475764533574596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLK1,Protein delta homolog 1,26127,27,2.27 [1.23-4.18],0.0086451542861595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,25902,27,13.28 [6.02-29.28],1.4594682967544766e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL4,Delta-like protein 4,21934,25,0.78 [0.37-1.63],0.5035319129060623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,21934,25,1.71 [1.14-2.57],0.0097843719894592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,21934,25,0.54 [0.37-0.78],0.0009130205644459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA1,DnaJ homolog subfamily A member 1,21705,24,0.53 [0.18-1.53],0.2419805440890138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA2,DnaJ homolog subfamily A member 2,25999,26,1.30 [0.84-1.99],0.2359167245926746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA4,DnaJ homolog subfamily A member 4,22469,25,1.19 [0.72-1.96],0.5039567409004764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB1,DnaJ homolog subfamily B member 1,25691,26,1.68 [1.12-2.51],0.0113889726420291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB14,DnaJ homolog subfamily B member 14,22409,24,2.24 [1.48-3.38],0.0001197458099289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB2,DnaJ homolog subfamily B member 2,22039,23,1.59 [0.81-3.12],0.1780063788193345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB6,DnaJ homolog subfamily B member 6,21827,23,1.51 [0.94-2.42],0.0855361099724826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB8,DnaJ homolog subfamily B member 8,25337,26,1.22 [0.74-2.00],0.4379854683842349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC21,DnaJ homolog subfamily C member 21,22469,25,1.79 [0.81-3.95],0.1496422657967416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,21934,25,1.65 [1.06-2.56],0.0250789938400578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC9,DnaJ homolog subfamily C member 9,22409,24,1.63 [0.99-2.69],0.0537021223474873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,25780,25,0.60 [0.35-1.04],0.0684742137660338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNLZ,DNL-type zinc finger protein,21797,24,1.01 [0.65-1.55],0.9740717378932604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM1,Dynamin-1,22409,24,1.27 [0.88-1.82],0.1990616245579276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,22479,24,2.86 [1.88-4.36],9.047159459417308e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNMBP,Dynamin-binding protein,25641,25,1.46 [0.87-2.46],0.1534561886188341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPEP,Aspartyl aminopeptidase,22469,25,1.19 [0.61-2.31],0.6123505769541215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,25907,25,0.96 [0.49-1.88],0.9023452778867808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOC2B,Double C2-like domain-containing protein beta,21886,25,0.80 [0.25-2.57],0.7127825580350802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOCK9,Dedicator of cytokinesis protein 9,21797,24,0.84 [0.55-1.28],0.4047230891540531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK1,Docking protein 1,22469,25,1.30 [0.95-1.77],0.0962227156734532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK2,Docking protein 2,25813,27,1.20 [0.91-1.59],0.2028416207037684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP1,Dipeptidase 1,25593,25,0.77 [0.41-1.45],0.4193795207139763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP2,Dipeptidase 2,25691,26,0.65 [0.19-2.19],0.4843767081625991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,25772,24,1.13 [0.41-3.14],0.8137592242223944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP4,Dipeptidyl peptidase 4,25311,27,0.80 [0.51-1.27],0.3516670788135237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,25691,26,4.83 [1.78-13.15],0.0020289991596563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP7,Dipeptidyl peptidase 2,25593,27,1.18 [0.68-2.03],0.5568933040594723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,26127,27,30.27 [6.25-146.48],2.2461900435176203e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,25938,27,2.30 [1.59-3.32],8.291497987115732e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,25641,25,2.62 [1.33-5.18],0.0055105840111052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRG2,Developmentally-regulated GTP-binding protein 2,25691,26,1.64 [0.92-2.94],0.0964384181631242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,25538,26,4.63 [2.74-7.84],1.1200306122981376e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,22479,24,1.91 [0.64-5.68],0.2456717367761455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG2,Desmoglein-2,25809,26,2.23 [0.74-6.73],0.1566867413131728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG3,Desmoglein-3,25944,27,1.05 [0.40-2.75],0.9271001972428646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,25613,26,0.35 [0.20-0.62],0.0003420170576972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTD1,D-aminoacyl-tRNA deacylase 1,22039,23,1.22 [0.77-1.92],0.4036702149625452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,22352,25,4.22 [2.71-6.58],2.0543407099567668e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,21886,25,0.47 [0.20-1.09],0.0785363205340595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,25691,26,5.02 [1.83-13.77],0.001745567240556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTYMK,Thymidylate kinase,22521,25,1.59 [0.92-2.74],0.0965429905857049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUOX2,Dual oxidase 2,25337,26,0.81 [0.46-1.44],0.4809486724483512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,22389,25,0.95 [0.35-2.58],0.9245451806536962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP29,Dual specificity phosphatase 29,21886,25,1.13 [0.68-1.87],0.6414729492624061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP3,Dual specificity protein phosphatase 3,25203,25,1.15 [0.80-1.65],0.4378304701787142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",22409,24,1.49 [1.03-2.16],0.032438490809326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DXO,Decapping and exoribonuclease protein,22469,25,1.86 [0.84-4.14],0.1269386622563729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,22389,25,1.03 [0.46-2.28],0.9442704742999778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT1,Dynein light chain Tctex-type 1,21886,25,1.51 [1.03-2.20],0.0334592919224815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT3,Dynein light chain Tctex-type 3,22389,25,1.32 [0.58-3.04],0.5092196356080131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,25641,25,1.25 [0.86-1.82],0.2427765139685494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,25983,27,3.38 [1.40-8.17],0.006927091510974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECE1,Endothelin-converting enzyme 1,25203,25,0.33 [0.13-0.88],0.0270955322212748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",22521,25,0.95 [0.56-1.62],0.8559472159601131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",21934,25,1.25 [0.84-1.84],0.2734603150680673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECI2,Enoyl-CoA delta isomerase 2,21807,24,1.45 [0.82-2.54],0.2005706480528763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECM1,Extracellular matrix protein 1,21915,24,1.76 [0.54-5.79],0.3519812664145727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECSCR,Endothelial cell-specific chemotaxis regulator,21797,24,1.12 [0.54-2.29],0.7639178552542331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,26026,27,8.35 [4.84-14.42],2.5108810102021585e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,25772,24,1.16 [0.79-1.71],0.4385659572351564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDDM3B,Epididymal secretory protein E3-beta,22389,25,0.46 [0.18-1.22],0.1205577143408741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,21807,24,1.32 [0.55-3.16],0.534059852811789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDF1,Endothelial differentiation-related factor 1,22479,24,1.10 [0.65-1.85],0.7175529874519144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,25337,26,1.69 [0.68-4.24],0.2621415627307484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,21934,25,5.74 [1.72-19.09],0.0044116578950951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDNRB,Endothelin receptor type B,21882,23,1.13 [0.49-2.63],0.7730122104319638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EEF1D,Elongation factor 1-delta,22521,25,1.39 [0.94-2.05],0.0982617920729246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,22409,24,3.63 [2.43-5.42],2.9170040711317353e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB2,Dynein regulatory complex protein 8,22092,25,1.29 [0.44-3.73],0.6432818911823002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,25855,27,6.88 [2.66-17.76],6.776194133892698e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,22479,24,2.30 [1.21-4.36],0.0106695932318647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,25768,25,13.39 [6.19-28.96],4.2776457639114816e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA4,Ephrin-A4,25601,25,1.77 [1.25-2.52],0.0013379491896755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,21886,25,1.65 [1.14-2.39],0.008303178907534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGF,Pro-epidermal growth factor,25780,25,1.18 [0.83-1.68],0.3507959534750096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,25213,25,1.93 [1.06-3.54],0.0328534347633704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFLAM,Pikachurin,22409,24,1.54 [0.58-4.11],0.3870126512117188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFR,Epidermal growth factor receptor,26127,27,0.50 [0.21-1.18],0.1127627668943423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGLN1,Egl nine homolog 1,25772,24,1.44 [0.90-2.29],0.1281015691267628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHBP1,EH domain-binding protein 1,22521,25,1.38 [0.85-2.25],0.1919792705607168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHD3,EH domain-containing protein 3,21934,25,1.20 [0.86-1.68],0.2871423969748843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",22469,25,1.11 [0.55-2.24],0.7696416068032029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",22329,23,1.30 [0.92-1.85],0.1418234235164654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,21807,24,0.74 [0.38-1.46],0.3863653619319891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,21934,25,0.99 [0.38-2.59],0.9884244075586632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4B,Eukaryotic translation initiation factor 4B,25641,25,1.71 [0.90-3.27],0.1042756582334035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4E,Eukaryotic translation initiation factor 4E,21882,23,1.39 [0.90-2.16],0.1406113991867593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,25813,27,2.07 [1.33-3.22],0.0012005325541639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,26083,26,1.33 [0.92-1.91],0.1271813815346363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,22479,24,0.94 [0.51-1.73],0.8436232332410214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5,Eukaryotic translation initiation factor 5,21807,24,1.86 [1.02-3.40],0.0441918237126762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5A,Eukaryotic translation initiation factor 5A-1,25307,25,0.32 [0.08-1.22],0.0939750658735127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,22479,24,1.62 [1.00-2.62],0.0504534685971454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAVL4,ELAV-like protein 4,21797,24,1.25 [0.88-1.79],0.213557442848999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,22521,25,4.08 [1.52-10.96],0.0053142743991817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOA,Elongin-A,25691,26,1.16 [0.64-2.12],0.6211347704718673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOB,Elongin-B,21807,24,1.36 [0.61-3.02],0.4503019768107015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,25307,25,1.81 [1.05-3.11],0.0322872391756971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENDOU,Poly(U)-specific endoribonuclease,20798,24,1.49 [0.75-2.94],0.2537763479732183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,26127,27,1.11 [0.15-8.15],0.9159601645670707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO1,Alpha-enolase,25771,26,1.24 [0.78-1.95],0.3609714990241122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO2,Gamma-enolase,26036,26,1.40 [0.83-2.35],0.2038076199745332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO3,Beta-enolase,21934,25,0.96 [0.48-1.93],0.9144646804943084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOPH1,Enolase-phosphatase E1,22389,25,0.63 [0.29-1.37],0.2457707411388964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,21807,24,2.94 [1.28-6.76],0.011371089653334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPEP,Glutamyl aminopeptidase,21807,24,0.41 [0.10-1.70],0.2184224596400131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,26127,27,1.60 [0.55-4.65],0.3872550320935674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,25944,25,0.98 [0.40-2.42],0.9653844003296967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,21934,25,0.94 [0.32-2.76],0.9156246366882108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,25018,23,0.89 [0.58-1.35],0.5781603244694321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENSA,Alpha-endosulfine,22389,25,0.98 [0.47-2.02],0.948314946601793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,25213,25,1.12 [0.55-2.30],0.7522697905726398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,25337,26,0.34 [0.07-1.68],0.1858792126965957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,25337,26,2.42 [0.53-11.06],0.2546201865900144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTR1,Endosome-associated-trafficking regulator 1,21934,25,1.16 [0.62-2.18],0.6371229520633522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,21882,23,1.96 [1.20-3.18],0.0068580485961158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPB41L5,Band 4.1-like protein 5,21886,25,0.64 [0.29-1.41],0.2693265247351767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPCAM,Epithelial cell adhesion molecule,25826,25,0.95 [0.66-1.36],0.7827615867741624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPGN,Epigen,22389,25,1.20 [0.55-2.66],0.6450383313904031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,25907,25,4.03 [1.30-12.52],0.0158609866154873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA10,Ephrin type-A receptor 10,25203,25,1.08 [0.65-1.78],0.7700500903513791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,24900,26,3.34 [2.43-4.59],9.218892129710552e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA4,Ephrin type-A receptor 4,22039,23,2.05 [0.51-8.34],0.3146429379642387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,26127,27,10.06 [5.22-19.38],5.1913435384112735e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,25593,25,3.09 [1.07-8.91],0.0368219789760635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHX2,Bifunctional epoxide hydrolase 2,25337,26,0.75 [0.38-1.46],0.3967718310059899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPN1,Epsin-1,22092,25,1.02 [0.42-2.49],0.9674343573287666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,25772,24,1.61 [1.18-2.21],0.0030364453986727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPPK1,Epiplakin,21934,25,1.74 [1.10-2.75],0.0174666937588481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,25981,27,7.19 [3.67-14.09],9.160226313420656e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,25902,27,1.86 [0.48-7.23],0.3679420761116297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,25746,25,1.27 [0.21-7.81],0.7933563380543485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,25902,27,0.62 [0.16-2.43],0.4956579892362917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBIN,Erbin,25691,26,1.31 [0.92-1.86],0.1289325044648314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERC2,ERC protein 2,21886,25,0.92 [0.54-1.56],0.754600276750272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERCC1,DNA excision repair protein ERCC-1,21705,24,1.41 [0.54-3.65],0.4833281662084474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EREG,Proepiregulin,25593,25,1.05 [0.68-1.63],0.8166129693754048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERI1,3'-5' exoribonuclease 1,22092,25,1.60 [0.60-4.27],0.3445153650518727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,21882,23,3.76 [1.88-7.51],0.0001721160160459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,22389,25,0.90 [0.33-2.45],0.8328346242515012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP29,Endoplasmic reticulum resident protein 29,22039,23,1.28 [0.91-1.81],0.1623582497366796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP44,Endoplasmic reticulum resident protein 44,25647,26,3.01 [0.81-11.15],0.0998815100047248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,21807,24,1.29 [0.63-2.66],0.4859708157543362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,26127,27,6.58 [3.06-14.12],1.35770496497289e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESM1,Endothelial cell-specific molecule 1,25823,25,1.01 [0.36-2.86],0.9861050992934024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESPL1,Separin,21705,24,0.92 [0.44-1.93],0.8281203410775084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESR1,Estrogen receptor,21882,23,0.44 [0.15-1.35],0.152878730695742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESYT2,Extended synaptotagmin-2,22469,25,1.59 [1.03-2.44],0.0349507546561376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI2B,Protein EVI2B,21705,24,0.69 [0.21-2.27],0.5471704032543363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI5,Ecotropic viral integration site 5 protein homolog,21882,23,1.63 [1.07-2.47],0.0223047389321464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVPL,Envoplakin,22092,25,0.96 [0.29-3.15],0.948139080670846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXOSC10,Exosome component 10,21807,24,0.78 [0.37-1.65],0.5112404812662539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXTL1,Exostosin-like 1,21807,24,0.85 [0.60-1.20],0.3504443743037038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EZR,Ezrin,26036,26,5.21 [1.93-14.10],0.0011454934795492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F10,Coagulation factor X,22523,24,0.56 [0.15-2.04],0.3777879509731984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11,Coagulation factor XI,22223,24,0.60 [0.14-2.54],0.4837342942933141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,25809,26,1.83 [1.04-3.23],0.0369460195867782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F12,Coagulation factor XII,22555,24,0.61 [0.27-1.35],0.2224762636124991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F13B,Coagulation factor XIII B chain,22421,24,3.06 [0.69-13.54],0.1398237032674099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2,Prothrombin,22555,24,0.47 [0.04-5.83],0.5602377643972912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,25901,25,2.19 [1.18-4.07],0.0128579579270767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F3,Tissue factor,25876,27,0.98 [0.29-3.34],0.9804923453251052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F7,Coagulation factor VII,25859,27,0.69 [0.22-2.17],0.5229787889498445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,25854,27,5.88 [1.00-34.64],0.0500245025562925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",25823,25,2.21 [1.64-2.98],2.134446968086085e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",25813,27,1.62 [1.10-2.39],0.0146361079679872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",22521,25,4.25 [3.00-6.01],3.686967703647343e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",26127,27,5.48 [3.73-8.06],5.219315862309886e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,25950,26,2.22 [1.48-3.33],0.0001105924270713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP6,Gastrotropin,25297,26,1.73 [1.12-2.68],0.0134609845364812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP9,Fatty acid-binding protein 9,25772,24,0.68 [0.35-1.31],0.2475281927016458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FADD,FAS-associated death domain protein,25813,27,1.24 [0.79-1.93],0.3485591245366831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM13A,Protein FAM13A,22409,24,1.51 [0.87-2.61],0.1455586888920592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171A2,Protein FAM171A2,22479,24,0.86 [0.65-1.14],0.2888860210301336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171B,Protein FAM171B,22389,25,2.02 [0.85-4.82],0.1128836837886392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM172A,Cotranscriptional regulator FAM172A,21934,25,1.29 [0.69-2.42],0.4230044967733148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,22521,25,2.78 [1.00-7.75],0.0510485141356921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,25691,26,20.75 [7.73-55.72],1.769197857743111e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,25769,27,26.37 [12.91-53.85],2.6298169906699254e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,22409,24,4.65 [2.69-8.02],3.3877320395620385e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAP,Prolyl endopeptidase FAP,26127,27,0.73 [0.21-2.52],0.6137986896178438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,21886,25,1.26 [0.77-2.06],0.3496365634603667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,26043,27,2.10 [1.39-3.17],0.0004057864640486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FASLG,Tumor necrosis factor ligand superfamily member 6,26083,26,0.47 [0.20-1.12],0.0870768866689394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,22510,25,7.66 [3.60-16.27],1.193037146734144e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBN2,Fibrillin-2,21886,25,1.25 [0.65-2.39],0.4995475309024476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBP1,"Fructose-1,6-bisphosphatase 1",25813,27,1.18 [0.76-1.83],0.4539722859013637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,22521,25,1.82 [1.10-3.01],0.0195729541856724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,25772,24,1.89 [0.91-3.93],0.0894659872101381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,22479,24,2.51 [0.69-9.05],0.1611529659494157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,25809,26,2.38 [1.54-3.67],9.035860709340254e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,25688,27,2.53 [1.20-5.33],0.0147237016804936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,25213,25,1.23 [0.67-2.27],0.4985100789108279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,25814,27,1.09 [0.55-2.16],0.8053109641089276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,22475,24,3.81 [1.70-8.52],0.0011394667166455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN2,Ficolin-2,25691,26,0.57 [0.30-1.09],0.0867626395034854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,25813,27,2.35 [1.19-4.66],0.0142800644092801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,25963,26,2.23 [1.38-3.61],0.0010292839724937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL3,Fc receptor-like protein 3,25307,25,0.97 [0.52-1.81],0.9291197336321184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL5,Fc receptor-like protein 5,25809,26,1.46 [0.81-2.63],0.2141145874852077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,25772,24,1.10 [0.66-1.83],0.7246962564657425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,25213,25,1.65 [1.15-2.38],0.0071306840071996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",21807,24,1.81 [1.29-2.52],0.000517613294255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX2,"Ferredoxin-2, mitochondrial",21807,24,1.69 [1.08-2.66],0.0223162564574906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FEN1,Flap endonuclease 1,25213,25,0.84 [0.45-1.59],0.5973834950232373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FES,Tyrosine-protein kinase Fes/Fps,25213,25,0.75 [0.32-1.77],0.5164381836668925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FETUB,Fetuin-B,25854,27,2.61 [0.82-8.30],0.1028310309701124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGA,Fibrinogen alpha chain,22021,24,2.33 [0.66-8.16],0.1865768818478135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",22479,24,1.45 [0.89-2.36],0.1335343273435008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF12,Fibroblast growth factor 12,21882,23,0.97 [0.43-2.17],0.9340282578000312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF16,Fibroblast growth factor 16,21882,23,1.29 [0.65-2.55],0.4715562620339071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF19,Fibroblast growth factor 19,25944,25,1.22 [0.78-1.91],0.3857075407314947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,25772,24,1.89 [1.16-3.08],0.0103965857189883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF20,Fibroblast growth factor 20,21882,23,0.88 [0.32-2.40],0.8007600713258265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,25983,27,1.88 [1.46-2.42],1.238271579017371e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,25987,27,2.06 [1.50-2.84],8.856630360210711e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF3,Fibroblast growth factor 3,21882,23,1.38 [0.50-3.85],0.5365087538777256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,25307,25,3.35 [1.93-5.82],1.7863596606960017e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF6,Fibroblast growth factor 6,21882,23,1.08 [0.52-2.22],0.8444136539118794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF7,Fibroblast growth factor 7,21705,24,1.17 [0.84-1.62],0.3601974023854097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF9,Fibroblast growth factor 9,21667,24,1.46 [0.57-3.78],0.430610917983577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,25902,27,0.60 [0.39-0.93],0.021526316191504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,22510,25,0.56 [0.26-1.23],0.150695771169174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP3,Fibroblast growth factor-binding protein 3,22469,25,0.52 [0.17-1.55],0.2386897468598323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,25902,27,20.84 [7.21-60.29],2.0931876117787924e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR4,Fibroblast growth factor receptor 4,22039,23,0.91 [0.42-1.97],0.8176101833561782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,22523,24,2.48 [1.39-4.41],0.0019896434736865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGR,Tyrosine-protein kinase Fgr,25203,25,1.20 [0.70-2.04],0.5078415543407875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FH,"Fumarate hydratase, mitochondrial",21797,24,0.76 [0.41-1.39],0.3685432925939735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,21807,24,0.73 [0.29-1.86],0.5141921812780372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIT,Bis(5'-adenosyl)-triphosphatase,25203,25,1.15 [0.71-1.86],0.5762280851661928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FIS1,Mitochondrial fission 1 protein,25823,25,1.33 [0.86-2.05],0.1991607394365316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,22479,24,1.56 [1.05-2.33],0.028511314909232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,25877,26,1.09 [0.80-1.48],0.5882936724561154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,25641,25,3.21 [1.38-7.49],0.0069097323704427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,25641,25,1.27 [0.85-1.88],0.2380433074414469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,25155,25,1.28 [0.73-2.27],0.3890126397304374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBPL,FK506-binding protein-like,22409,24,1.76 [0.95-3.26],0.0727642421490976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLI1,Friend leukemia integration 1 transcription factor,25213,25,1.32 [0.97-1.80],0.0779496815343109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,25641,25,4.11 [1.50-11.25],0.0060476731057287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,25650,26,3.03 [1.32-6.93],0.0087826624107111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,25213,25,1.52 [0.63-3.67],0.3539908767331219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,26083,26,3.50 [1.30-9.38],0.0128294893215966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT4,Vascular endothelial growth factor receptor 3,25902,27,1.43 [0.50-4.08],0.4988919969369131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMNL1,Formin-like protein 1,25203,25,1.40 [0.96-2.02],0.0771100048864518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMR1,Synaptic functional regulator FMR1,25213,25,0.68 [0.24-1.90],0.4599919084825329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FN1,Fibronectin,22555,24,0.93 [0.51-1.68],0.8010493807279443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNDC1,Fibronectin type III domain-containing protein 1,22469,25,1.68 [0.73-3.90],0.2248749061227969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,22389,25,1.67 [0.76-3.67],0.2043582782731123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLH1,Glutamate carboxypeptidase 2,21882,23,0.88 [0.52-1.48],0.6280249069780977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,25775,27,8.44 [3.29-21.65],9.00076354246228e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,26036,26,3.12 [1.07-9.12],0.037325705769267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR3,Folate receptor gamma,25822,27,1.15 [1.00-1.34],0.0544787228091768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOS,Proto-oncogene c-Fos,21667,24,0.67 [0.22-2.01],0.474930102102138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOSB,Protein fosB,25203,25,1.45 [0.74-2.82],0.2769888643279737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXJ3,Forkhead box protein J3,21882,23,1.68 [0.84-3.38],0.1433421463064818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO1,Forkhead box protein O1,25772,24,1.52 [1.00-2.32],0.0508673189805646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO3,Forkhead box protein O3,25213,25,1.27 [0.90-1.81],0.1778652553865472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD4B,FERM domain-containing protein 4B,21807,24,1.06 [0.60-1.88],0.8300170952143977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD7,FERM domain-containing protein 7,21886,25,0.80 [0.23-2.78],0.7235260853757745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRZB,Secreted frizzled-related protein 3,25550,25,0.86 [0.21-3.45],0.8309003312934039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSHB,Follitropin subunit beta,21934,25,1.41 [0.76-2.62],0.2722543473529043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FST,Follistatin,25901,25,0.79 [0.38-1.66],0.5381567338731406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,21934,25,6.09 [3.00-12.33],5.299403205117762e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,25776,25,6.34 [3.08-13.07],5.644597975273171e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FTCD,Formimidoyltransferase-cyclodeaminase,22432,25,1.07 [0.70-1.65],0.7539864117433606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUCA1,Tissue alpha-L-fucosidase,25973,27,0.94 [0.62-1.41],0.74797661169826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUOM,Fucose mutarotase,22039,23,1.00 [0.54-1.84],0.994849174152826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FURIN,Furin,25902,27,0.86 [0.31-2.39],0.7713429905683903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUS,RNA-binding protein FUS,25175,25,2.01 [1.05-3.86],0.0344464257364835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",22049,25,0.98 [0.51-1.87],0.9459132908156824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,26036,26,2.00 [0.98-4.07],0.0565392261673966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT8,"Alpha-(1,6)-fucosyltransferase",25641,25,1.09 [0.59-2.00],0.7848525600153983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXN,"Frataxin, mitochondrial",26026,27,1.20 [0.76-1.88],0.4347033439741374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXYD5,FXYD domain-containing ion transport regulator 5,25307,25,1.50 [0.94-2.40],0.0927801822131784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FYB1,FYN-binding protein 1,25770,26,1.26 [0.86-1.83],0.2305309755089403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD10,Frizzled-10,21886,25,1.16 [0.70-1.92],0.5700659555818737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD8,Frizzled-8,21797,24,1.08 [0.45-2.59],0.8609497441939891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,22389,25,1.03 [0.48-2.23],0.9389189895632316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,22092,25,0.84 [0.42-1.70],0.6371230178512413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,21797,24,1.21 [0.75-1.97],0.4324352763479904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD1,Glutamate decarboxylase 1,21705,24,0.57 [0.13-2.55],0.4580488912410753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,21882,23,1.82 [1.27-2.62],0.0011175448000836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,22092,25,0.73 [0.25-2.12],0.5587918240532901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,21934,25,1.86 [0.99-3.49],0.0556859614402159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAGE2A,G antigen 2A,21705,24,0.78 [0.34-1.76],0.5463498529265791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAL,Galanin peptides,25944,25,0.62 [0.34-1.10],0.1026838342883623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,25691,26,4.67 [1.80-12.12],0.0015381896245717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,26026,27,0.36 [0.10-1.35],0.1311020343987433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,25307,25,1.34 [0.56-3.22],0.5071191630138451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,22521,25,1.94 [0.53-7.12],0.3158557794274342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,25691,26,4.42 [1.18-16.58],0.0276984715204596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAMT,Guanidinoacetate N-methyltransferase,21807,24,0.49 [0.11-2.12],0.3408689180571325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,21567,23,4.02 [0.92-17.62],0.0649127106035075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GART,Trifunctional purine biosynthetic protein adenosine-3,22479,24,0.53 [0.10-2.90],0.4611579629497714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS2,Growth arrest-specific protein 2,22092,25,1.31 [0.88-1.96],0.1833153220591109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS6,Growth arrest-specific protein 6,25949,26,1.76 [0.49-6.36],0.3890347512074625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GASK1A,Golgi-associated kinase 1A,21807,24,0.42 [0.18-1.01],0.0519118028056651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,22469,25,1.36 [1.10-1.68],0.0038462355478687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,21705,24,0.35 [0.08-1.56],0.1694885272752677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",21934,25,1.07 [0.66-1.73],0.7786530910125623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBA,Lysosomal acid glucosylceramidase,21886,25,0.90 [0.43-1.86],0.7714052851205675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP1,Guanylate-binding protein 1,22430,25,1.13 [0.62-2.06],0.690486256477834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP2,Guanylate-binding protein 2,25307,25,0.93 [0.50-1.70],0.801158124679516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP4,Guanylate-binding protein 4,25203,25,2.01 [1.23-3.29],0.0052778821462309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP6,Guanylate-binding protein 6,21807,24,0.86 [0.34-2.19],0.7571058798277701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GC,Vitamin D-binding protein,22555,24,1.46 [0.33-6.58],0.6187662371334928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCC1,GRIP and coiled-coil domain-containing protein 1,22469,25,1.41 [0.98-2.04],0.067833131065128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,25213,25,1.87 [1.42-2.45],6.129473074551882e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21511,23,2.17 [1.38-3.39],0.0007403300554779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCLM,Glutamate--cysteine ligase regulatory subunit,21807,24,1.37 [0.74-2.55],0.3179351605173963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",25691,26,2.85 [1.18-6.89],0.0200131236853058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,26127,27,2.98 [2.39-3.72],3.24033599613216e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF2,Growth/differentiation factor 2,25813,27,1.14 [0.45-2.89],0.7861153425424141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,25203,25,2.72 [1.69-4.39],4.101819873526387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GET3,ATPase GET3,22521,25,1.38 [0.78-2.44],0.2724788553458738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFAP,Glial fibrillary acidic protein,25173,25,0.52 [0.25-1.10],0.0886561820900323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFER,FAD-linked sulfhydryl oxidase ALR,25213,25,1.51 [0.89-2.55],0.1234325406290794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,25213,25,0.81 [0.54-1.21],0.29562262411845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,25983,27,18.86 [8.11-43.87],9.119478678241614e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,25691,26,3.70 [1.25-10.95],0.0182251763659435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA3,GDNF family receptor alpha-3,25563,25,2.00 [0.64-6.23],0.2303276748140629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRAL,GDNF family receptor alpha-like,21778,23,0.77 [0.39-1.49],0.4360150412933922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGA1,ADP-ribosylation factor-binding protein GGA1,25203,25,1.11 [0.67-1.83],0.6835885774054787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGACT,Gamma-glutamylaminecyclotransferase,22521,25,1.35 [0.80-2.28],0.2604788456518315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGCT,Gamma-glutamylcyclotransferase,22474,25,1.72 [0.81-3.66],0.1606383169769289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGH,Gamma-glutamyl hydrolase,25364,27,0.74 [0.26-2.10],0.5774541763533438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,25768,25,1.61 [0.87-2.96],0.1274473287018324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,25641,25,6.41 [3.14-13.11],3.535153626229267e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH1,Somatotropin,25769,27,1.11 [0.91-1.35],0.3185403522523892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH2,Growth hormone variant,25213,25,0.92 [0.73-1.17],0.4926887915657295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHR,Growth hormone receptor,22039,23,0.97 [0.57-1.65],0.9107654632919188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRHR,Growth hormone-releasing hormone receptor,25203,25,0.92 [0.50-1.70],0.7991745106791854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRL,Appetite-regulating hormone,25813,27,0.86 [0.58-1.27],0.4470642892982132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GID8,Glucose-induced degradation protein 8 homolog,22479,24,0.43 [0.09-2.19],0.3120539304083971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,22479,24,1.66 [1.05-2.61],0.0296994584689537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP7,GTPase IMAP family member 7,22039,23,0.70 [0.18-2.75],0.6125911760423883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP8,GTPase IMAP family member 8,21705,24,1.15 [0.61-2.15],0.6670901785354759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,21934,25,1.72 [0.98-3.01],0.0575701905203402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,22469,25,8.62 [4.60-16.14],1.669956367531235e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC3,PDZ domain-containing protein GIPC3,22409,24,1.40 [0.91-2.16],0.1211417795988735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPR,Gastric inhibitory polypeptide receptor,21882,23,0.98 [0.46-2.09],0.95783493090205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIT1,ARF GTPase-activating protein GIT1,21882,23,1.55 [1.02-2.34],0.0390730449353897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GJA8,Gap junction alpha-8 protein,21705,24,0.56 [0.25-1.25],0.1569650537424722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,24713,24,2.94 [1.09-7.91],0.0324068311691205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,21995,23,2.31 [0.88-6.06],0.0877587396924196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLB1,Beta-galactosidase,25641,25,1.32 [0.57-3.09],0.5189766804403557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLI2,Zinc finger protein GLI2,21882,23,1.50 [0.54-4.18],0.4425135756309963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLO1,Lactoylglutathione lyase,25337,26,1.40 [0.79-2.46],0.2491180261934014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLOD4,Glyoxalase domain-containing protein 4,25780,25,1.33 [0.48-3.67],0.5859406925175914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLP1R,Glucagon-like peptide 1 receptor,21797,24,1.51 [0.76-2.98],0.2410446869996702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX,Glutaredoxin-1,25648,27,1.47 [0.85-2.52],0.1671652953236515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",22039,23,1.33 [0.91-1.95],0.1394848305606828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,25203,25,0.99 [0.48-2.05],0.9857794036573568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLYR1,Putative oxidoreductase GLYR1,22389,25,1.32 [0.76-2.30],0.3244423638875729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,21963,25,9.79 [0.01-6519.76],0.4915417356662055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMFG,Glia maturation factor gamma,22521,25,1.48 [0.86-2.55],0.1583095749380242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR,GMP reductase 1,26083,26,1.14 [0.57-2.30],0.7037828181966179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR2,GMP reductase 2,22039,23,1.65 [0.93-2.93],0.0886374079216669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNAS,Neuroendocrine secretory protein 55,22479,24,1.17 [0.79-1.73],0.4372464859579954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,25213,25,1.22 [0.79-1.90],0.3730531884176408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,21886,25,1.04 [0.52-2.10],0.9051244145137556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNLY,Granulysin,25809,26,1.59 [0.83-3.03],0.1629004103536448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,21934,25,0.89 [0.26-3.08],0.8526082459819676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,22039,23,1.13 [0.39-3.26],0.819717873173306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLGA3,Golgin subfamily A member 3,22479,24,1.51 [0.97-2.37],0.0684783481269301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,26036,26,6.38 [2.40-17.00],0.0002084426593162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,25772,24,1.34 [0.93-1.94],0.1142651453636531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GORASP2,Golgi reassembly-stacking protein 2,22409,24,1.74 [0.88-3.46],0.113161669176133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOT1,"Aspartate aminotransferase, cytoplasmic",22510,25,0.70 [0.26-1.86],0.4716956792381007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BA,Platelet glycoprotein Ib alpha chain,25683,26,0.86 [0.29-2.58],0.7884154466516307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BB,Platelet glycoprotein Ib beta chain,21807,24,1.35 [0.75-2.42],0.3181647022044457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,25014,26,1.19 [0.84-1.70],0.3247720819196356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP5,Platelet glycoprotein V,22039,23,1.69 [0.51-5.59],0.3881670518800334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP6,Platelet glycoprotein VI,25770,26,1.19 [0.79-1.80],0.3986253286941891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,25691,26,0.87 [0.68-1.12],0.282774997598385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,26026,27,5.36 [1.84-15.58],0.0020368785598218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,25641,25,0.58 [0.31-1.10],0.0953890237073359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,22389,25,1.53 [0.82-2.84],0.1772418923205615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPHA2,Glycoprotein hormone alpha-2,22409,24,0.94 [0.42-2.12],0.888657017569126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPI,Glucose-6-phosphate isomerase,22523,24,2.31 [1.13-4.70],0.0209727402586197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,22409,24,1.27 [0.68-2.39],0.4561229043424909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPKOW,G-patch domain and KOW motifs-containing protein,25203,25,2.11 [1.15-3.86],0.0159180388260913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,25112,26,13.55 [4.97-36.99],3.599259465330265e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR101,Probable G-protein coupled receptor 101,21797,24,0.78 [0.36-1.73],0.5447742877668326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR158,Probable G-protein coupled receptor 158,22479,24,1.45 [0.66-3.20],0.352767148474521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,22409,24,2.88 [1.79-4.64],1.4113684136999336e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,25337,26,4.67 [3.12-6.98],6.532723135237847e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,22389,25,1.67 [1.05-2.66],0.0308555162247028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRAP2,GRB2-related adapter protein 2,25813,27,1.26 [0.95-1.66],0.1025951899517174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,22521,25,1.46 [0.81-2.62],0.2116266647618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",22479,24,1.04 [0.41-2.60],0.9360526250879048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",21797,24,1.34 [0.82-2.18],0.2450531993221965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRK5,G protein-coupled receptor kinase 5,25337,26,1.07 [0.58-1.97],0.8192259355703758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,25690,25,5.49 [1.48-20.38],0.0108932002925244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRP,Gastrin-releasing peptide,21934,25,1.39 [0.72-2.67],0.3216158098931042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",25691,26,1.91 [1.23-2.97],0.0041657708691785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRSF1,G-rich sequence factor 1,21591,24,1.29 [0.82-2.03],0.2754958984010184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSAP,Gamma-secretase-activating protein,25213,25,1.05 [0.70-1.56],0.8127552405296854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,22446,23,0.43 [0.20-0.94],0.0339624772205627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSR,"Glutathione reductase, mitochondrial",22386,24,1.06 [0.17-6.57],0.947862668784842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA1,Glutathione S-transferase A1,25775,27,0.98 [0.66-1.46],0.9375272383525336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA3,Glutathione S-transferase A3,25213,25,0.99 [0.63-1.55],0.9748829870854387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTM4,Glutathione S-transferase Mu 4,21807,24,0.81 [0.42-1.56],0.5333679210628477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTP1,Glutathione S-transferase P,25041,25,0.56 [0.31-1.03],0.0609212930752002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTT2B,Glutathione S-transferase theta-2B,22469,25,1.04 [0.88-1.22],0.6635968610131004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,22092,25,0.85 [0.44-1.63],0.6202756047460236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTPBP2,GTP-binding protein 2,21886,25,1.34 [0.84-2.14],0.2205307248887839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,25689,26,14.03 [7.60-25.87],2.763839906162279e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCY2C,Heat-stable enterotoxin receptor,22092,25,0.81 [0.46-1.42],0.4593354689523734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUK1,Guanylate kinase,21807,24,1.11 [0.40-3.10],0.8438085218507525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUSB,Beta-glucuronidase,25928,27,1.61 [0.98-2.62],0.0583052101280568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GYS1,"Glycogen [starch] synthase, muscle",25337,26,1.15 [0.79-1.67],0.4663936635108753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMA,Granzyme A,26083,26,1.96 [0.92-4.17],0.0801406665410749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMB,Granzyme B,25772,24,0.96 [0.52-1.77],0.8880181363562285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMH,Granzyme H,25337,26,1.08 [0.69-1.70],0.7331915203876063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,H2AP,Huntingtin-interacting protein M,21705,24,0.66 [0.22-2.01],0.4698237933240311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",21807,24,0.84 [0.41-1.72],0.6296369953317034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",25948,27,1.02 [0.65-1.61],0.9171891461376988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,26026,27,1.33 [1.05-1.69],0.0193582437065056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",25809,26,1.27 [0.80-2.00],0.308424518153281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,25991,27,3.46 [2.35-5.08],3.045821978857345e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,25809,26,7.18 [3.59-14.38],2.63208217733742e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBEGF,Proheparin-binding EGF-like growth factor,25948,27,1.02 [0.64-1.61],0.9477925578064824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,26026,27,0.75 [0.42-1.37],0.3534592517447694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBZ,Hemoglobin subunit zeta,22521,25,0.91 [0.62-1.32],0.6043726397654829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCG22,Protein PBMUCL2,21807,24,1.08 [0.54-2.15],0.8260232971448549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCLS1,Hematopoietic lineage cell-specific protein,26083,26,1.57 [0.81-3.04],0.1842164909155791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC8,Histone deacetylase 8,21882,23,0.72 [0.28-1.85],0.5013334412422001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC9,Histone deacetylase 9,21797,24,0.75 [0.34-1.65],0.4688498948638926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDDC2,5'-deoxynucleotidase HDDC2,22409,24,1.61 [0.71-3.68],0.2567811126262663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGF,Hepatoma-derived growth factor,25993,27,1.03 [0.72-1.48],0.8514158579066201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,22469,25,1.38 [0.78-2.45],0.2680182733199379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEBP1,Heme-binding protein 1,25337,26,0.71 [0.35-1.45],0.3446772026040202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,22039,23,7.31 [1.90-28.09],0.0037602631231898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPACAM2,HEPACAM family member 2,22469,25,1.07 [0.42-2.76],0.8862847525178628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,22521,25,6.68 [1.76-25.35],0.0052315218622892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEXIM1,Protein HEXIM1,25772,24,1.46 [0.95-2.25],0.084718498292455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,26083,26,4.98 [2.61-9.49],1.114811429261704e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGFAC,Hepatocyte growth factor activator,22297,24,0.81 [0.23-2.79],0.7330414871862483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,25213,25,1.44 [0.93-2.22],0.1003001978765854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,22469,25,2.04 [1.25-3.33],0.0041930929704545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIF1A,Hypoxia-inducible factor 1-alpha,21882,23,0.93 [0.49-1.77],0.8270347165687789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1,Huntingtin-interacting protein 1,21807,24,0.57 [0.13-2.43],0.4457899206553197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,22428,25,2.40 [1.71-3.37],3.80938831673512e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,22479,24,1.63 [1.07-2.47],0.0219328147340927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HK2,Hexokinase-2,25337,26,0.81 [0.22-3.01],0.7542059800799027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",22479,24,7.81 [2.13-28.62],0.001919193339943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",25697,24,1.86 [0.73-4.73],0.1944941810921902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",25772,24,5.29 [2.27-12.32],0.0001152537524353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMBS,Porphobilinogen deaminase,26026,27,0.57 [0.27-1.19],0.1334651875817092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMCN2,Hemicentin-2,22000,23,2.54 [1.24-5.23],0.0113124776692624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",21934,25,1.27 [0.64-2.54],0.4988622260675419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",21807,24,0.45 [0.15-1.31],0.1441772103953829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMMR,Hyaluronan mediated motility receptor,21669,24,0.90 [0.37-2.20],0.8237029655981896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX1,Heme oxygenase 1,25512,27,0.82 [0.38-1.77],0.6136705118126613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,25203,25,1.81 [1.05-3.12],0.0316517412045995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNF1A,Hepatocyte nuclear factor 1-alpha,21886,25,1.25 [0.86-1.82],0.2366109059666262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,25512,25,2.94 [1.75-4.94],4.6446405705069375e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,25259,26,1.42 [0.93-2.15],0.1044213460416745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,22479,24,2.01 [1.21-3.35],0.007354176006864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPCAL1,Hippocalcin-like protein 1,26083,26,1.36 [0.82-2.26],0.2396057893020171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,25213,25,0.37 [0.14-0.98],0.0453542742119721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPSE,Heparanase,22199,25,1.40 [0.91-2.14],0.1239063326369612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRAS,GTPase Hras,22049,24,1.27 [1.01-1.60],0.0428820128280863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,21934,25,1.68 [0.95-2.98],0.0756100748360216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRG,Histidine-rich glycoprotein,22421,24,2.12 [0.60-7.50],0.2435040609787068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS1BP3,HCLS1-binding protein 3,21934,25,1.73 [1.12-2.67],0.0134199677563762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,25691,26,2.41 [1.11-5.23],0.0254582706166854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,26026,27,1.24 [0.47-3.27],0.6585644113254684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,21882,23,6.52 [3.47-12.23],5.435954413021946e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSBP1,Heat shock factor-binding protein 1,21934,25,1.21 [0.79-1.86],0.3694216331441345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,25772,24,0.36 [0.16-0.82],0.0152582659120287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,22469,25,1.67 [0.98-2.86],0.059874099143357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,21807,24,1.43 [0.77-2.67],0.2624938723391417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,21934,25,1.56 [0.73-3.32],0.2548587331239648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSP90B1,Endoplasmin,25071,25,0.92 [0.56-1.53],0.7562304174308851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA1A,Heat shock 70 kDa protein 1A,25907,25,1.43 [0.90-2.28],0.1303153694762229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,22389,25,2.53 [1.54-4.16],0.0002673667927502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB1,Heat shock protein beta-1,25395,27,1.52 [0.85-2.72],0.1580968393786594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,26026,27,8.45 [4.87-14.66],3.343418857917255e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,25601,27,7.45 [4.05-13.71],1.110364080343968e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1A,5-hydroxytryptamine receptor 1A,21797,24,1.00 [0.62-1.63],0.990536839070056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1B,5-hydroxytryptamine receptor 1B,21797,24,1.16 [0.50-2.70],0.7305955398637117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTRA2,"Serine protease HTRA2, mitochondrial",25902,27,1.22 [0.71-2.09],0.4742433120425948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,25647,26,2.66 [0.65-10.88],0.1727264338277984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,26127,27,16.62 [4.40-62.82],3.438504540803187e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICA1,Islet cell autoantigen 1,25307,25,1.35 [0.88-2.09],0.1717364394142949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,25690,26,2.71 [0.87-8.43],0.0840131805582658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,26127,27,3.51 [1.19-10.37],0.023191189995368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,26127,27,5.25 [1.92-14.32],0.0012112799136917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,25772,24,0.46 [0.24-0.87],0.0168375710131868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM5,Intercellular adhesion molecule 5,25813,27,1.64 [0.77-3.50],0.202415081658485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICOSLG,ICOS ligand,25691,26,2.23 [0.37-13.27],0.377966810513461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ID4,DNA-binding protein inhibitor ID-4,22092,25,0.97 [0.40-2.35],0.9461623666573852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,25203,25,1.53 [0.88-2.68],0.1316635671296245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDO1,"Indoleamine 2,3-dioxygenase 1",21934,25,1.52 [0.94-2.43],0.0858941570848258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDS,Iduronate 2-sulfatase,26083,26,0.47 [0.09-2.34],0.3561611618492618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,26026,27,3.67 [1.62-8.30],0.0018532808522618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,21861,24,3.59 [1.78-7.25],0.0003547668588085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,22092,25,0.62 [0.28-1.40],0.254774589361435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,22092,25,1.23 [0.46-3.33],0.6810673499929458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNAR1,Interferon alpha/beta receptor 1,22409,24,0.64 [0.12-3.31],0.5933000302888738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNG,Interferon gamma,25307,25,1.19 [0.86-1.64],0.2976035530174378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,25944,25,6.37 [1.35-30.06],0.0194204020624415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,25641,25,1.62 [0.86-3.06],0.1330934588592145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL1,Interferon lambda-1,25203,25,1.74 [0.87-3.50],0.1200763555225186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL2,Interferon lambda-2,21797,24,0.82 [0.41-1.65],0.5816318912387373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,25772,24,2.15 [1.26-3.65],0.0047341463903574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNW1,Interferon omega-1,21807,24,0.85 [0.54-1.35],0.5000772875593362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFT20,Intraflagellar transport protein 20 homolog,21886,25,2.14 [1.06-4.30],0.0339510006092629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGBP1,Immunoglobulin-binding protein 1,22479,24,1.79 [1.01-3.18],0.0472304489425346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,21797,24,1.20 [0.69-2.09],0.5241590481328398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,22510,25,1.37 [0.32-5.93],0.6700766560378243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,25691,26,2.74 [1.45-5.15],0.001822102225469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,21807,24,0.88 [0.34-2.26],0.7889686988773741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,25809,26,9.35 [2.47-35.34],0.000990356074699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP1,Insulin-like growth factor-binding protein 1,26079,27,0.98 [0.74-1.31],0.9141760460423533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,26081,26,2.13 [1.23-3.69],0.006778527440741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,25899,27,0.48 [0.29-0.82],0.0066420354991637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,25464,26,5.52 [3.73-8.16],1.1643507422406912e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,25683,27,8.00 [4.71-13.59],1.3273803312657142e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,26127,27,2.89 [1.69-4.92],9.687934570124835e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,25813,27,6.33 [3.52-11.38],6.71936009485514e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFL4,Insulin growth factor-like family member 4,21882,23,1.12 [0.71-1.78],0.6172294365757512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGHMBP2,DNA-binding protein SMUBP-2,21807,24,0.94 [0.44-2.01],0.8786565548136843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,22511,24,1.71 [1.01-2.91],0.0461487058521279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLON5,IgLON family member 5,21705,24,0.88 [0.52-1.47],0.6132886674188425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF21,Immunoglobulin superfamily member 21,21934,25,0.81 [0.27-2.43],0.7049922643128246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,25691,26,2.97 [1.86-4.73],4.807721326470485e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,25813,27,8.12 [4.65-14.19],1.9369774922038882e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,22521,25,1.93 [1.27-2.92],0.0020710678102179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKBKG,NF-kappa-B essential modulator,25772,24,1.28 [0.86-1.89],0.2238382203079376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKZF2,Zinc finger protein Helios,25213,25,0.77 [0.44-1.35],0.3670646911824931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,25307,25,1.39 [1.11-1.74],0.0044770389995525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RA,Interleukin-10 receptor subunit alpha,25307,25,0.71 [0.33-1.50],0.3650695846781349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,25944,25,0.56 [0.16-2.01],0.3738232593633611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL11,Interleukin-11,25307,25,1.03 [0.59-1.80],0.9133575467222106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,25691,26,2.36 [1.76-3.16],1.0179148501988776e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,26083,26,4.10 [2.39-7.05],3.24235046892226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,25307,25,2.51 [1.73-3.65],1.5329982039790675e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,21882,23,2.29 [1.20-4.37],0.0119047860669041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13,Interleukin-13,25307,25,0.91 [0.38-2.20],0.837182039477387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,25493,27,0.51 [0.10-2.61],0.4204961258172858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,21797,24,1.30 [0.36-4.70],0.6923178243059314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15,Interleukin-15,25772,24,1.61 [0.57-4.52],0.3693934303057261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,25307,25,2.82 [1.06-7.49],0.0372236670593592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,26083,26,2.63 [1.51-4.59],0.0006711234849831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17A,Interleukin-17A,25280,25,1.08 [0.50-2.32],0.8448820616142809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,25307,25,1.45 [1.01-2.10],0.0451766903983801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17D,Interleukin-17D,25307,25,2.18 [1.25-3.80],0.0060011082476897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17F,Interleukin-17F,25307,25,0.90 [0.57-1.43],0.6655200569787507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RA,Interleukin-17 receptor A,25809,26,1.44 [0.65-3.19],0.3631778615168279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RB,Interleukin-17 receptor B,25443,24,1.82 [0.92-3.61],0.0847367392874915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,25738,25,1.92 [1.04-3.52],0.0360502166709611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,25899,27,8.01 [4.21-15.22],2.1749878682844155e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,26083,26,5.22 [2.15-12.67],0.0002635974038038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18RAP,Interleukin-18 receptor accessory protein,25483,25,1.04 [0.86-1.27],0.6832255707205337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,25163,25,2.14 [1.50-3.07],3.0546011307343044e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1A,Interleukin-1 alpha,25307,25,0.77 [0.35-1.70],0.5169432982937479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1B,Interleukin-1 beta,25185,25,0.82 [0.43-1.57],0.5487413059246266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,25768,25,11.73 [4.84-28.38],4.798202283260436e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,25783,25,12.03 [1.91-75.57],0.0079869849786726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RAP,Interleukin-1 receptor accessory protein,25809,26,1.38 [0.63-3.02],0.4270535632438446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,26043,27,1.77 [0.84-3.76],0.1359772982478075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL2,Interleukin-1 receptor-like 2,25307,25,1.57 [0.60-4.06],0.3547218182599793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,25778,25,2.14 [1.41-3.26],0.0003541323167649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2,Interleukin-2,25307,25,1.47 [0.46-4.74],0.5159983271511492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20,Interleukin-20,25307,25,0.96 [0.48-1.95],0.9203557614226712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RA,Interleukin-20 receptor subunit alpha,25307,25,0.88 [0.64-1.21],0.4248721600561054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RB,Interleukin-20 receptor subunit beta,21882,23,1.24 [0.54-2.84],0.6184952542375459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL21R,Interleukin-21 receptor,21882,23,0.50 [0.18-1.38],0.1824326498318865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,22389,25,1.94 [1.38-2.73],0.0001430423350175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,25307,25,0.93 [0.39-2.22],0.868599713471044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL24,Interleukin-24,25307,25,0.61 [0.26-1.46],0.2694869290832478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL25,Interleukin-25,21631,24,1.53 [0.49-4.78],0.4612912533725632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,25605,27,5.88 [3.53-9.78],9.370714694916909e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RB,Interleukin-2 receptor subunit beta,25307,25,1.11 [0.50-2.48],0.7960547193162638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RG,Cytokine receptor common subunit gamma,22389,25,0.99 [0.39-2.49],0.9755594034531978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3,Interleukin-3,21705,24,1.91 [0.94-3.91],0.0741848412836874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31,Interleukin-31,21882,23,1.42 [0.88-2.29],0.1476828763382762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31RA,Interleukin-31 receptor subunit alpha,21795,23,0.98 [0.36-2.70],0.9724512828259853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL32,Interleukin-32,25772,24,1.06 [0.47-2.40],0.879200561508898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL33,Interleukin-33,25307,25,0.84 [0.33-2.13],0.7152842449992061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL34,Interleukin-34,25161,25,0.67 [0.26-1.71],0.4013226035948474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36A,Interleukin-36 alpha,21882,23,1.63 [1.09-2.43],0.018181948931764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,21783,23,1.89 [1.39-2.57],4.720410122066223e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3RA,Interleukin-3 receptor subunit alpha,25307,25,0.63 [0.21-1.89],0.4058394847091569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4,Interleukin-4,25307,25,1.13 [0.72-1.78],0.5935597079166872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,25772,24,2.45 [1.17-5.14],0.0175970656725021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5,Interleukin-5,25307,25,0.74 [0.54-1.01],0.0577816277377872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5RA,Interleukin-5 receptor subunit alpha,25772,24,1.47 [0.79-2.74],0.2253825748816686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,25691,26,1.42 [1.06-1.90],0.0185550524432239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6R,Interleukin-6 receptor subunit alpha,25641,26,1.00 [0.36-2.78],0.9976855764214868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,25813,27,4.09 [1.61-10.42],0.0031110072891861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7,Interleukin-7,25772,24,0.83 [0.47-1.48],0.5311137215992567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,25809,26,0.45 [0.24-0.84],0.0117592729698628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL9,Interleukin-9,22092,25,1.15 [0.66-2.00],0.6227468726412382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,25169,25,1.26 [0.70-2.28],0.4422192176580281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,22389,25,2.23 [1.42-3.51],0.0004938908883719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPA1,Inositol monophosphatase 1,25641,25,1.05 [0.58-1.90],0.8751333912631007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPACT,Protein IMPACT,22469,25,1.37 [0.70-2.68],0.3557998238094063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,21797,24,1.01 [0.29-3.54],0.9841309508325528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ING1,Inhibitor of growth protein 1,25155,25,0.94 [0.41-2.16],0.8836969864585547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,22039,23,3.13 [1.58-6.18],0.0010307981980632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,25809,26,2.43 [0.93-6.34],0.0693256828964783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP1,Inositol polyphosphate 1-phosphatase,25691,26,1.44 [0.78-2.65],0.2435216612227717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",21934,25,2.43 [1.44-4.10],0.0009212125272145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",22479,24,1.16 [0.56-2.41],0.6943724324012802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",25691,26,1.36 [0.96-1.93],0.0883518847984826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL3,Insulin-like 3,22469,25,0.50 [0.31-0.80],0.0041969673885217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,22389,25,1.35 [0.82-2.23],0.2432075399953703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,22409,24,1.78 [1.26-2.51],0.0010243189261216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,21882,23,3.66 [0.38-35.58],0.2639823246420585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,25601,25,1.50 [0.99-2.25],0.0533611567149641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,25691,26,1.79 [1.02-3.15],0.0441622314637145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",25337,26,1.00 [0.66-1.50],0.9824316477263252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK1,Interleukin-1 receptor-associated kinase 1,25307,25,1.60 [0.99-2.60],0.0565302749375113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK4,Interleukin-1 receptor-associated kinase 4,25772,24,1.45 [0.99-2.13],0.0572970420048346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,24855,24,0.45 [0.17-1.23],0.1203852609465652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM1,Isthmin-1,25772,24,1.49 [0.60-3.70],0.3930837162808955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM2,Isthmin-2,22510,25,0.75 [0.28-1.99],0.5656147722487799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IST1,IST1 homolog,22253,23,1.35 [0.89-2.05],0.1602064439276637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,25772,24,0.33 [0.12-0.87],0.0258987157160148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA2,Integrin alpha-2,22039,23,0.60 [0.19-1.94],0.3964233069882219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,25809,26,5.56 [1.69-18.30],0.004732924005365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA6,Integrin alpha-6,25772,24,1.01 [0.52-1.99],0.965743982726024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAL,Integrin alpha-L,21882,23,2.74 [1.04-7.19],0.0407253129852257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAM,Integrin alpha-M,25809,26,2.07 [0.73-5.89],0.1702683680247978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAV,Integrin alpha-V,26026,27,0.65 [0.29-1.43],0.2818810403022109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAX,Integrin alpha-X,22092,25,1.06 [0.56-2.02],0.8571348525020761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1,Integrin beta-1,25771,27,0.87 [0.47-1.62],0.6643637958338899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP1,Integrin beta-1-binding protein 1,25213,25,0.62 [0.26-1.48],0.2833307231396316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP2,Integrin beta-1-binding protein 2,25337,26,1.23 [0.89-1.71],0.2135295150360735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,25646,26,5.39 [2.04-14.24],0.0006702338245899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB5,Integrin beta-5,25902,27,1.13 [0.47-2.71],0.7786758931595895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,25307,25,2.62 [0.78-8.77],0.1195440338445645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,26026,27,2.29 [1.25-4.18],0.0071675736118554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,22510,25,4.46 [2.03-9.80],0.000198394590106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,22555,24,2.74 [0.44-17.18],0.2824639762873137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,25899,27,2.34 [0.93-5.91],0.0711405607913813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,22555,24,0.76 [0.17-3.45],0.7191435223727154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,22389,25,2.18 [1.43-3.33],0.0002848186685753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITM2A,Integral membrane protein 2A,25772,24,0.77 [0.42-1.43],0.4148428967253761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPA,Inosine triphosphate pyrophosphatase,21807,24,1.66 [0.95-2.90],0.0731290667794019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",21934,25,1.36 [0.89-2.06],0.1533437113356605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",21797,24,1.65 [0.84-3.24],0.1470055007684101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",25203,25,1.20 [0.61-2.38],0.5976422264195486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IZUMO1,Izumo sperm-egg fusion protein 1,21705,24,0.74 [0.27-2.06],0.5669406310446814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,26036,26,7.88 [3.52-17.66],5.230432773984972e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,22039,23,2.75 [1.65-4.57],0.0001041953814913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JCHAIN,Immunoglobulin J chain,25307,25,1.52 [0.87-2.68],0.1430942093895331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,21705,24,0.93 [0.43-2.01],0.8467186691911203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JPT2,Jupiter microtubule associated homolog 2,22409,24,1.64 [1.02-2.62],0.0407769626579205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JUN,Transcription factor AP-1,25307,25,1.39 [0.84-2.30],0.1967792449999449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,25691,26,2.52 [1.09-5.87],0.0315549193867217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZN,Kazrin,22409,24,1.38 [0.95-2.02],0.0929900433668036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,21797,24,1.38 [0.87-2.19],0.1650315184188457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,21886,25,1.05 [0.64-1.70],0.8561368325924283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNIP4,Kv channel-interacting protein 4,25203,25,0.32 [0.11-0.87],0.0255471205310718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,22052,25,1.83 [1.17-2.86],0.0086492736962465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDM3A,Lysine-specific demethylase 3A,21882,23,0.93 [0.57-1.53],0.7866550804115046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDR,Vascular endothelial growth factor receptor 2,25902,27,0.42 [0.12-1.47],0.1746038882703282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KEL,Kell blood group glycoprotein,25203,25,1.00 [0.38-2.65],0.992795403165302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHDC3L,KH domain-containing protein 3,21705,24,1.24 [0.79-1.93],0.3551588325513841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHK,Ketohexokinase,21934,25,1.35 [0.74-2.48],0.3287479342436346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA0319,Dyslexia-associated protein KIAA0319,22469,25,1.83 [0.78-4.32],0.1656189582015638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549,UPF0606 protein KIAA1549,22092,25,0.81 [0.45-1.44],0.470389636332334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549L,UPF0606 protein KIAA1549L,22092,25,1.12 [0.33-3.79],0.8515540022123355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA2013,Uncharacterized protein KIAA2013,22389,25,0.57 [0.21-1.57],0.2785410400606141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,21807,24,2.01 [1.25-3.24],0.0041948042901314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF20B,Kinesin-like protein KIF20B,21797,24,1.43 [1.03-1.98],0.0339100868675764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF22,Kinesin-like protein KIF22,21807,24,1.48 [1.02-2.13],0.0368815004530372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIFBP,KIF-binding protein,25691,26,1.34 [0.86-2.08],0.1990854139378659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,22389,25,1.31 [0.86-1.99],0.2106893551034688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,25213,25,0.92 [0.59-1.42],0.7083376583543377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,22409,24,0.78 [0.60-1.02],0.0718765129397872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,25213,25,1.01 [0.77-1.34],0.9254976086596232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,21705,24,0.68 [0.33-1.42],0.3056202481813324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL1,Kin of IRRE-like protein 1,21797,24,0.91 [0.44-1.91],0.8071305942376564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL2,Kin of IRRE-like protein 2,25203,25,0.76 [0.30-1.93],0.5679817694371436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,25854,27,0.61 [0.39-0.97],0.0385669481881845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KITLG,Kit ligand,25813,27,0.82 [0.32-2.07],0.6714602864696142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLB,Beta-klotho,25203,25,1.16 [0.72-1.86],0.5380863645650028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLF4,Krueppel-like factor 4,21797,24,2.02 [0.93-4.42],0.0764462481139823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLHL41,Kelch-like protein 41,22479,24,1.86 [1.13-3.07],0.0149955929845222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK1,Kallikrein-1,25557,27,0.94 [0.72-1.22],0.6279717929016901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK10,Kallikrein-10,25817,27,1.05 [0.46-2.43],0.9011618488287422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,25662,27,2.48 [1.45-4.24],0.0008979874335552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK12,Kallikrein-12,25213,25,0.91 [0.71-1.16],0.4359234265891814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK13,Kallikrein-13,25253,26,0.93 [0.44-1.98],0.8526557225647787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK14,Kallikrein-14,26026,27,0.55 [0.26-1.17],0.1199396077395142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK15,Kallikrein-15,22351,25,1.30 [0.68-2.47],0.4326971876037919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK3,Prostate-specific antigen,22510,25,0.54 [0.28-1.03],0.0609667468559984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,26026,27,2.33 [1.56-3.47],3.386097039590244e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK6,Kallikrein-6,25864,26,1.56 [0.49-4.94],0.4518037337551008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK7,Kallikrein-7,21454,23,0.92 [0.32-2.64],0.8781505051288274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK8,Kallikrein-8,24964,27,1.41 [0.58-3.42],0.4447029205656919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLKB1,Plasma kallikrein,22099,23,0.63 [0.14-2.95],0.5611144048441834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,26083,26,9.12 [4.59-18.12],2.738616825324662e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,21797,24,0.86 [0.41-1.83],0.7022265925358506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,26083,26,2.30 [1.17-4.54],0.0162268228823821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,21882,23,1.92 [1.26-2.91],0.0022013860810958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,22469,25,2.79 [1.52-5.09],0.0008778092951831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT14,"Keratin, type I cytoskeletal 14",24388,25,0.67 [0.16-2.73],0.5746067604030134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT17,"Keratin, type I cytoskeletal 17",21807,24,0.84 [0.27-2.63],0.7596618668008641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",25691,26,1.66 [1.18-2.32],0.0034094311191573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",25736,24,2.78 [1.91-4.04],1.0040415955940341e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT5,"Keratin, type II cytoskeletal 5",25203,25,0.71 [0.32-1.55],0.3883955128982372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT6C,"Keratin, type II cytoskeletal 6C",21807,24,1.77 [1.06-2.98],0.0306091669165056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",21797,24,1.62 [1.29-2.04],3.3287769002226855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,25769,27,1.39 [0.80-2.44],0.2458540456355866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYNU,Kynureninase,26083,26,1.22 [0.59-2.53],0.5936519620643919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L1CAM,Neural cell adhesion molecule L1,25902,27,0.62 [0.19-1.98],0.417351269578287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,22521,25,1.16 [0.76-1.78],0.4830360418772964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACRT,Extracellular glycoprotein lacritin,22348,25,0.81 [0.60-1.11],0.196155034490729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACTB2,Endoribonuclease LACTB2,25813,27,1.50 [0.91-2.48],0.1138607784149283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,25691,26,1.99 [1.01-3.91],0.0468446240684832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25823,25,4.31 [2.56-7.25],3.906635707365491e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,25641,25,1.42 [0.97-2.07],0.0702798560385781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA1,Laminin subunit alpha-1,21807,24,1.00 [0.48-2.09],0.9926848521697572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA4,Laminin subunit alpha-4,25944,25,2.46 [0.92-6.60],0.0734192827235708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,21934,25,4.14 [1.15-14.90],0.0298432528491541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP1,Lysosome-associated membrane glycoprotein 1,21878,25,0.85 [0.18-3.90],0.8328245574665349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP2,Lysosome-associated membrane glycoprotein 2,25028,24,1.04 [0.14-7.70],0.9686937996642736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,26039,26,2.17 [1.14-4.13],0.0178719415274476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMTOR5,Ragulator complex protein LAMTOR5,22389,25,0.82 [0.30-2.25],0.6992433571374874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAP3,Cytosol aminopeptidase,25307,25,1.34 [0.71-2.52],0.3633038188396469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LARP1,La-related protein 1,22389,25,1.23 [0.79-1.92],0.3534728947234169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT,Linker for activation of T-cells family member 1,26083,26,1.42 [0.86-2.35],0.1680219478671829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT2,Linker for activation of T-cells family member 2,25691,26,1.29 [0.98-1.70],0.0698953466092536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LATS1,Serine/threonine-protein kinase LATS1,21882,23,1.71 [1.08-2.70],0.0212165955202293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,25593,25,7.54 [4.12-13.78],5.197851516623684e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,25899,27,1.53 [0.88-2.68],0.1311024746350381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBR,Delta(14)-sterol reductase LBR,26036,26,1.36 [0.89-2.07],0.1597706131377248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCAT,Phosphatidylcholine-sterol acyltransferase,22523,24,0.77 [0.14-4.20],0.7621516990434205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,22479,24,1.92 [1.45-2.54],5.927229473683231e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,25025,27,3.63 [2.07-6.35],6.465327812657483e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCP1,Plastin-2,22510,25,1.39 [0.65-2.95],0.3945176181169195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLR,Low-density lipoprotein receptor,25880,26,0.86 [0.44-1.70],0.67027187336823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,22479,24,1.62 [1.07-2.44],0.0217563718421207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,22521,25,1.68 [1.05-2.70],0.031603750391049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,25983,27,1.11 [0.58-2.13],0.7488754672150679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEG1,Protein LEG1 homolog,21260,22,0.93 [0.52-1.66],0.8104333286100618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LELP1,Late cornified envelope-like proline-rich protein 1,21797,24,0.92 [0.57-1.49],0.736743875523266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEO1,RNA polymerase-associated protein LEO1,22479,24,1.77 [0.97-3.22],0.0634817041846958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEP,Leptin,25813,27,1.23 [0.66-2.30],0.521076913822983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEPR,Leptin receptor,25813,27,1.76 [0.71-4.36],0.2191442837638281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,22479,24,2.56 [1.61-4.06],7.173845902845346e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,25813,27,6.87 [3.44-13.76],5.12815270638284e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,25871,26,4.25 [2.53-7.14],4.7191649356289494e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,22555,24,2.70 [1.40-5.18],0.0028877359625941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,25823,25,5.81 [3.70-9.13],1.9570864594865457e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,25730,27,2.01 [1.12-3.60],0.0184861125806233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS8,Galectin-8,26036,26,1.11 [0.63-1.95],0.7074619855447972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,25817,25,8.49 [3.57-20.14],1.2468144235818087e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGMN,Legumain,25944,25,2.22 [0.85-5.78],0.1014054680829585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHB,Lutropin subunit beta,25213,25,0.87 [0.53-1.40],0.5590882704487685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,25862,25,1.00 [0.56-1.79],0.99818991112244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIF,Leukemia inhibitory factor,25203,25,1.12 [0.55-2.26],0.7518917120608852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,25772,24,6.40 [2.54-16.09],8.10456867798979e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,25809,26,1.77 [0.65-4.87],0.2654542796632781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,22510,25,0.75 [0.64-0.87],0.0001389202114039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,21807,24,1.73 [1.08-2.78],0.0222580304522029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,25769,27,5.07 [1.77-14.49],0.0024789099302741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,22521,25,1.54 [0.89-2.67],0.1266609868205569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,26127,27,2.81 [0.79-9.95],0.109695342309062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,25997,26,2.06 [0.71-6.03],0.1856419015637456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25307,25,4.46 [2.37-8.40],3.543232831193433e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,26127,27,1.70 [0.95-3.06],0.0753783445735679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIPF,Gastric triacylglycerol lipase,21934,25,0.81 [0.43-1.53],0.5143671416929367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB1,Lamin-B1,22367,24,0.81 [0.40-1.62],0.5535140643714855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,22469,25,5.25 [2.75-10.03],5.272067123983701e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,22479,24,3.33 [2.22-5.01],7.1222264504490964e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD2,Leiomodin-2,21797,24,0.65 [0.30-1.41],0.2798540796634771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LONP1,"Lon protease homolog, mitochondrial",21934,25,1.48 [0.98-2.25],0.0636388516071506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPA,Apolipoprotein(a),22010,24,1.26 [0.99-1.59],0.0560101869178286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,25691,26,1.32 [0.73-2.41],0.3610186239496843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPL,Lipoprotein lipase,25813,27,0.63 [0.32-1.24],0.18355927869931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,25021,25,2.13 [1.29-3.53],0.0032175474324718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPP,Lipoma-preferred partner,21807,24,1.59 [0.88-2.88],0.1234444741336275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,21807,24,1.91 [1.26-2.90],0.0022851126276088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,21886,25,1.07 [0.49-2.31],0.869882139993317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRG1,Leucine-rich alpha-2-glycoprotein,22555,24,2.04 [0.45-9.32],0.3554671922121554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,25948,27,1.47 [0.55-3.95],0.4465525593261952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,21796,23,1.54 [0.60-3.90],0.3676175482238564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,25691,26,1.07 [0.30-3.88],0.9154712925923956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,25813,27,8.54 [4.01-18.17],2.6137465056965484e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2,Low-density lipoprotein receptor-related protein 2,21886,25,1.07 [0.41-2.82],0.8933002984168229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2BP,LRP2-binding protein,21886,25,1.01 [0.67-1.54],0.9517048472307332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,26036,26,1.13 [0.66-1.94],0.6427880131332749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,25691,26,2.54 [1.59-4.05],9.701860345533027e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,22409,24,2.37 [0.95-5.86],0.0628788323031422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC38,Leucine-rich repeat-containing protein 38,21886,25,1.57 [0.93-2.66],0.0934211986352707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC59,Leucine-rich repeat-containing protein 59,22521,25,1.71 [0.88-3.30],0.1133169571297383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,22389,25,1.40 [0.69-2.83],0.3500142894640983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,25307,25,0.36 [0.14-0.93],0.0354546574333394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,21886,25,1.29 [0.57-2.94],0.5374407365315195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,22479,24,1.03 [0.24-4.46],0.965274609480556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,25213,25,1.09 [0.61-1.93],0.7684363255336637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,22092,25,0.69 [0.37-1.31],0.2595557601358864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,25772,24,2.65 [1.22-5.76],0.0139463348277275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA,Lymphotoxin-alpha,25772,24,1.09 [0.45-2.67],0.8422643545431177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA4H,Leukotriene A-4 hydrolase,26026,27,0.77 [0.42-1.43],0.4103084980065854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTB,Lymphotoxin-beta,22389,25,0.82 [0.24-2.76],0.7505290702346974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,26127,27,5.92 [2.58-13.57],2.695373848431497e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,25213,25,1.86 [1.29-2.70],0.001017107390132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,25702,25,8.97 [3.74-21.50],8.59079927210462e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTO1,Protein LTO1 homolog,25307,25,0.47 [0.17-1.27],0.1354183293722276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LUZP2,Leucine zipper protein 2,22389,25,1.64 [0.98-2.76],0.0599646514747222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LXN,Latexin,25530,25,0.85 [0.48-1.48],0.5589255638823387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,25695,25,2.71 [1.37-5.35],0.004191107595974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,25772,24,3.36 [1.17-9.63],0.0238421956931826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,25536,26,5.68 [2.12-15.20],0.0005450466211977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,25641,25,1.99 [0.83-4.76],0.1225623236069445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYAR,Cell growth-regulating nucleolar protein,25213,25,1.15 [0.62-2.14],0.659723886020927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYN,Tyrosine-protein kinase Lyn,25691,26,1.33 [0.87-2.04],0.1926172830360172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD1,Ly6/PLAUR domain-containing protein 1,25203,25,0.46 [0.17-1.25],0.1267059645989207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD3,Ly6/PLAUR domain-containing protein 3,25700,27,0.89 [0.32-2.44],0.8135583503093228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,25213,25,1.51 [0.95-2.39],0.0826552163936227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPLA2,Acyl-protein thioesterase 2,21797,24,0.96 [0.66-1.41],0.851749734433052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,21886,25,0.81 [0.52-1.25],0.3369369875234844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,22555,24,18.46 [3.77-90.31],0.0003193993943465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYZL2,Lysozyme-like protein 2,21705,24,1.41 [0.52-3.82],0.5003597439998148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LZTFL1,Leucine zipper transcription factor-like protein 1,22039,23,1.63 [0.95-2.80],0.0776211418674053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,M6PR,Cation-dependent mannose-6-phosphate receptor,21934,25,0.84 [0.28-2.52],0.7575326172576325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,25551,25,1.93 [1.33-2.79],0.0004983330866259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAEA,E3 ubiquitin-protein transferase MAEA,25213,25,1.24 [0.56-2.76],0.5965737688786796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAG,Myelin-associated glycoprotein,21886,25,1.65 [0.84-3.22],0.146300599696576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGEA3,Melanoma-associated antigen 3,22092,25,0.84 [0.56-1.24],0.3733104625541281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGED1,Melanoma-associated antigen D1,25213,25,1.23 [0.61-2.46],0.5643495085508516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,22521,25,2.34 [0.89-6.10],0.0831798152242953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC4,Apical endosomal glycoprotein,22389,25,0.98 [0.48-2.00],0.9547434013492474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",21934,25,1.23 [0.26-5.85],0.7988693991527992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN2B2,Epididymis-specific alpha-mannosidase,22521,25,1.32 [0.70-2.50],0.3956923879894687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",21705,24,1.58 [0.94-2.65],0.0856895454146127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,25944,25,1.28 [0.91-1.80],0.1563011541611756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,25902,27,4.63 [1.54-13.97],0.0064788549344607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC4,MANSC domain-containing protein 4,21807,24,1.47 [0.90-2.40],0.1253108405555187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,21797,24,1.57 [0.51-4.89],0.4343942522924141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,21807,24,0.74 [0.31-1.74],0.4841326022436513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,22469,25,2.01 [1.09-3.71],0.0245494769889298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,22409,24,2.20 [1.26-3.83],0.0055775102586462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,25772,24,1.12 [0.78-1.61],0.5509313290287459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,25213,25,0.95 [0.66-1.38],0.8010601344575375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,25593,25,1.27 [0.92-1.77],0.146976393927772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK13,Mitogen-activated protein kinase 13,21705,24,2.02 [1.14-3.59],0.0164520872377529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK9,Mitogen-activated protein kinase 9,25772,24,1.37 [0.58-3.22],0.4732764084738241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPKAPK2,MAP kinase-activated protein kinase 2,22092,25,1.41 [0.86-2.33],0.1727195821844546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,21705,24,0.84 [0.58-1.22],0.3610548139176355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPT,Microtubule-associated protein tau,25203,25,1.49 [0.76-2.92],0.2438070363917531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARCO,Macrophage receptor MARCO,25813,27,3.47 [0.98-12.26],0.053544441085003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",21995,23,1.40 [0.88-2.24],0.1552484352694074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MASP1,Mannan-binding lectin serine protease 1,25593,25,1.55 [0.35-6.89],0.5615074852854658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,25867,25,1.81 [0.57-5.77],0.3124837151321547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN3,Matrilin-3,25601,25,0.35 [0.13-0.98],0.0465836616332707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAVS,Mitochondrial antiviral-signaling protein,25213,25,1.09 [0.74-1.60],0.6611591834650619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAX,Protein max,25203,25,1.30 [0.93-1.82],0.1286327889706341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,26127,27,3.13 [2.14-4.59],5.080081977856167e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MBL2,Mannose-binding protein C,22227,24,1.21 [0.83-1.76],0.3181335579375229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCAM,Cell surface glycoprotein MUC18,25899,27,0.60 [0.23-1.53],0.2827674259600543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",22479,24,1.62 [1.00-2.61],0.0495682912772193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEMP1,Mast cell-expressed membrane protein 1,21882,23,1.23 [0.81-1.88],0.3356589548119039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,25709,27,3.26 [1.54-6.94],0.0020916574733798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCTS1,Malignant T-cell-amplified sequence 1,22409,24,1.60 [0.68-3.76],0.2849552766859997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,25641,25,1.51 [0.90-2.52],0.1164374058207626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDH1,"Malate dehydrogenase, cytoplasmic",22387,24,2.60 [1.30-5.21],0.0070275110978091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,25826,27,1.87 [1.39-2.52],3.333406850752653e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDM1,Nuclear protein MDM1,21886,25,1.22 [0.37-4.03],0.7469792063544516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",21934,25,1.45 [0.97-2.18],0.072562269272315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED18,Mediator of RNA polymerase II transcription subunit 18,25213,25,1.14 [0.71-1.82],0.5880625799234755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED21,Mediator of RNA polymerase II transcription subunit 21,21807,24,0.99 [0.43-2.27],0.9792837585516704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,25823,25,2.03 [0.80-5.16],0.1385060877339748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,21807,24,1.90 [0.92-3.93],0.0841033699911966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,26043,27,0.73 [0.13-4.16],0.7217836233499788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MELTF,Melanotransferrin,22521,25,1.69 [0.47-6.03],0.4218046167288463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,22039,23,0.42 [0.20-0.90],0.0251572607782708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1A,Meprin A subunit alpha,22409,24,1.72 [1.04-2.82],0.0335103728596566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1B,Meprin A subunit beta,25813,27,0.75 [0.58-0.96],0.0242896725466425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEPE,Matrix extracellular phosphoglycoprotein,25823,25,0.46 [0.16-1.33],0.1539548363061742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MERTK,Tyrosine-protein kinase Mer,26083,26,2.66 [0.84-8.39],0.0960503281868167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MESD,LRP chaperone MESD,25809,26,1.14 [0.85-1.52],0.373600778779845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MET,Hepatocyte growth factor receptor,25886,26,0.64 [0.32-1.27],0.2008984734609424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1,Methionine aminopeptidase 1,25203,25,1.02 [0.29-3.65],0.9730514879363732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",25772,24,1.36 [0.89-2.09],0.1517113037741538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP2,Methionine aminopeptidase 2,25983,27,1.84 [0.96-3.51],0.0649813169509436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3,Microfibril-associated glycoprotein 3,25337,26,1.15 [0.59-2.23],0.6833054027488823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3L,Microfibrillar-associated protein 3-like,21886,25,0.69 [0.32-1.50],0.3513624391652183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,22039,23,6.12 [1.87-20.03],0.0027501333763618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP5,Microfibrillar-associated protein 5,26127,27,3.71 [1.65-8.34],0.0015030037731359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,25809,26,7.85 [4.14-14.88],2.6126371662046165e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGLL,Monoglyceride lipase,25901,25,1.26 [0.82-1.94],0.2848677194140333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,25772,24,1.21 [0.88-1.68],0.2393193806770884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIA,Melanoma-derived growth regulatory protein,25902,27,0.81 [0.32-2.08],0.6630246273732832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICALL2,MICAL-like protein 2,21886,25,1.27 [0.78-2.07],0.3442723454962697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,25772,24,1.57 [0.98-2.52],0.0597986244450131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIF,Macrophage migration inhibitory factor,25773,26,1.41 [0.82-2.42],0.2110406080180389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,25307,25,3.01 [1.78-5.08],3.748305566633649e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,22389,25,1.14 [0.80-1.63],0.4701396360428483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINK1,Misshapen-like kinase 1,22469,25,1.43 [0.93-2.20],0.1035703309186689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MITD1,MIT domain-containing protein 1,25641,25,1.22 [0.84-1.79],0.2993356771536594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MKI67,Proliferation marker protein Ki-67,21882,23,0.92 [0.31-2.79],0.8894220403687723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLLT1,Protein ENL,21705,24,0.89 [0.48-1.66],0.72257640919744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,25772,24,1.38 [0.91-2.09],0.1331394536434491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,25691,26,1.88 [1.32-2.69],0.000524939670134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP1,Interstitial collagenase,24818,26,1.72 [1.11-2.65],0.0147596768107583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,25780,25,2.10 [1.33-3.30],0.0013253539812918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,25821,27,3.92 [2.47-6.23],7.57008303473166e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP13,Collagenase 3,25203,25,1.01 [0.34-2.99],0.9840780964220104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP15,Matrix metalloproteinase-15,22521,25,1.64 [1.11-2.42],0.0123155928086587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,25809,26,2.32 [1.43-3.77],0.0006542012115991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,25293,26,3.96 [1.99-7.88],9.068923995736143e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP8,Neutrophil collagenase,25992,26,1.53 [1.00-2.34],0.0511608247615473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP9,Matrix metalloproteinase-9,25761,26,1.71 [0.96-3.06],0.0699001827437285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",21807,24,1.32 [0.61-2.84],0.4765500374891048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MN1,Transcriptional activator MN1,21886,25,1.31 [0.76-2.24],0.329606852722717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNAT1,CDK-activating kinase assembly factor MAT1,22092,25,1.16 [0.48-2.80],0.7469174463014498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNDA,Myeloid cell nuclear differentiation antigen,25775,27,1.02 [0.73-1.43],0.9075617057420016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOCS2,Molybdopterin synthase catalytic subunit,22039,23,1.46 [0.83-2.56],0.1848242740676628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOG,Myelin-oligodendrocyte glycoprotein,26026,27,1.34 [0.47-3.79],0.5799766670260488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORC3,MORC family CW-type zinc finger protein 3,22469,25,1.63 [0.48-5.54],0.4320980045959067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L1,Mortality factor 4-like protein 1,22092,25,0.98 [0.37-2.61],0.9613807174923532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L2,Mortality factor 4-like protein 2,21705,24,0.65 [0.18-2.35],0.5111915324526688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORN4,MORN repeat-containing protein 4,21705,24,0.99 [0.59-1.67],0.982226740934458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPHOSPH8,M-phase phosphoprotein 8,25337,26,1.37 [0.88-2.11],0.1619657661809936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPI,Mannose-6-phosphate isomerase,25691,26,1.34 [0.90-2.00],0.1515621030229637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,25901,25,1.22 [0.74-2.02],0.4290822793527599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPO,Myeloperoxidase,25809,26,1.08 [0.51-2.27],0.8442025052164481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPRIP,Myosin phosphatase Rho-interacting protein,22346,25,0.70 [0.28-1.77],0.4514339028656084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,22523,24,6.52 [2.44-17.45],0.0001857293547773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRI1,Methylthioribose-1-phosphate isomerase,21886,25,1.26 [0.69-2.33],0.4498728746837924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL24,"39S ribosomal protein L24, mitochondrial",21807,24,1.43 [0.71-2.88],0.3179274900796378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL28,"39S ribosomal protein L28, mitochondrial",22479,24,1.21 [0.54-2.70],0.6498109354324944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL46,"39S ribosomal protein L46, mitochondrial",25203,25,2.20 [0.86-5.62],0.0979905527325183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL52,"39S ribosomal protein L52, mitochondrial",21669,24,5.55 [2.51-12.28],2.364654394468487e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",22479,24,1.04 [0.60-1.80],0.8811672849452354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPS16,"28S ribosomal protein S16, mitochondrial",21882,23,0.52 [0.09-2.89],0.4553342696910905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,25655,26,2.51 [1.50-4.21],0.0004916263940773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLNL,Mesothelin-like protein,21886,25,0.99 [0.36-2.74],0.982735371505246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,25720,26,2.89 [2.02-4.13],6.790243895808441e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,26036,26,3.99 [2.24-7.10],2.602691040407616e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,25902,27,1.28 [0.79-2.06],0.3177920474345702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MST1,Hepatocyte growth factor-like protein,22172,23,3.65 [1.10-12.07],0.0340283337651532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSTN,Growth/differentiation factor 8,25337,26,1.13 [0.57-2.23],0.7255280076193769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTDH,Protein LYRIC,21882,23,1.72 [1.15-2.58],0.0088012408989389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",22469,25,1.59 [0.61-4.12],0.340486171874297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,22092,25,1.22 [0.87-1.72],0.2476321748243008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",22409,24,1.36 [0.89-2.08],0.1551290283508007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTPN,Myotrophin,25337,26,0.58 [0.17-2.00],0.3851926392155099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTR,Methionine synthase,21807,24,0.91 [0.46-1.78],0.7811389744685218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS1,Protein MTSS 1,22409,24,1.25 [0.88-1.76],0.210226900714975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS2,Protein MTSS 2,22389,25,1.35 [0.94-1.96],0.1071949626997771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTUS1,Microtubule-associated tumor suppressor 1,22092,25,1.55 [0.95-2.53],0.0782460668321855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,25203,25,5.92 [3.80-9.24],4.5068540795803105e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC16,Mucin-16,25691,26,0.95 [0.80-1.14],0.6024475949379344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC2,Mucin-2,22510,25,1.60 [1.08-2.38],0.0203920863489002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUCL3,Mucin-like protein 3,21705,24,1.31 [0.72-2.37],0.3816759989225203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,25307,25,2.06 [1.45-2.93],5.231892669233341e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,22039,23,0.37 [0.10-1.37],0.1365437196351355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",22521,25,2.76 [1.99-3.83],1.0994803038073623e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",21934,25,1.44 [1.11-1.88],0.0057893813918217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,22479,24,1.22 [0.76-1.95],0.4075815426131828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYDGF,Myeloid-derived growth factor,22521,25,1.68 [1.14-2.47],0.0086729012325267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH4,Myosin-4,21807,24,0.54 [0.17-1.71],0.2972323025464782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH7B,Myosin-7B,21705,24,0.55 [0.18-1.65],0.2854437791703527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH9,Myosin-9,22510,25,1.29 [0.92-1.82],0.1342739672198578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",21807,24,1.31 [0.84-2.05],0.2255175831607835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,21934,25,2.83 [1.80-4.44],5.877744736715191e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL4,Myosin light chain 4,21934,25,1.58 [0.97-2.58],0.0672073422437996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL6B,Myosin light chain 6B,21886,25,0.85 [0.53-1.38],0.5153966752001773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",21886,25,2.16 [1.52-3.07],1.5402121915236447e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO6,Unconventional myosin-VI,22479,24,1.51 [0.74-3.07],0.2577410752991043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO9B,Unconventional myosin-IXb,25307,25,0.81 [0.45-1.45],0.472219444331631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOC,Myocilin,25809,26,0.70 [0.32-1.50],0.3541513773961563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM1,Myomesin-1,21797,24,1.24 [0.66-2.35],0.5020746311408164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM2,Myomesin-2,21807,24,1.67 [0.91-3.05],0.0968887066758316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,22039,23,1.56 [1.02-2.38],0.0412866660300091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,25910,25,1.89 [1.02-3.51],0.043885815614356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZT1,Mitotic-spindle organizing protein 1,25213,25,0.81 [0.38-1.74],0.589738325705915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA10,N-alpha-acetyltransferase 10,21807,24,1.43 [0.67-3.03],0.3511294704508257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA80,N-alpha-acetyltransferase 80,21886,25,1.33 [0.96-1.84],0.0857473356156307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,25517,25,0.98 [0.52-1.85],0.9555972589596858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NACC1,Nucleus accumbens-associated protein 1,22389,25,1.31 [0.68-2.50],0.4189062010431011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NADK,NAD kinase,25813,27,1.36 [0.80-2.31],0.2534503589760745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGA,Alpha-N-acetylgalactosaminidase,21838,23,0.75 [0.30-1.85],0.5279868527620601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGK,N-acetyl-D-glucosamine kinase,21894,25,0.80 [0.40-1.62],0.5385900879429246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,22039,23,4.89 [0.77-31.31],0.0934842572842712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAMPT,Nicotinamide phosphoribosyltransferase,25213,25,1.18 [0.70-1.98],0.5384182648531892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAP1L4,Nucleosome assembly protein 1-like 4,22372,24,2.21 [0.80-6.13],0.1271283561262159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAPRT,Nicotinate phosphoribosyltransferase,22469,25,1.98 [0.86-4.59],0.1106399533382573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",22479,24,3.61 [1.62-8.08],0.0017436934326016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,25902,27,17.29 [6.77-44.19],2.6216252299919323e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBN,Nibrin,25307,25,0.88 [0.40-1.92],0.74296563726832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM1,Neural cell adhesion molecule 1,25899,27,0.43 [0.13-1.45],0.1733620610164645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM2,Neural cell adhesion molecule 2,25809,26,0.43 [0.12-1.55],0.1948060123409407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,26036,26,0.68 [0.47-0.97],0.0333369968845776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCF2,Neutrophil cytosol factor 2,25738,24,0.90 [0.57-1.43],0.6596350094381183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCK2,Cytoplasmic protein NCK2,25944,25,1.36 [0.97-1.91],0.0778505758046482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCLN,Nicalin,25307,25,0.53 [0.17-1.69],0.2827521418560815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,25733,24,5.36 [2.40-11.96],4.130414156061114e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,22409,24,7.07 [3.67-13.61],4.880691802630806e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,26026,27,13.21 [4.64-37.58],1.30662815403609e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDRG1,Protein NDRG1,25203,25,1.07 [0.69-1.68],0.7521433398849674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,22389,25,0.72 [0.34-1.53],0.3912244432564951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,21844,23,2.33 [0.85-6.36],0.0997141919587936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,22409,24,1.43 [0.93-2.18],0.1002922536473323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",25213,25,1.51 [1.16-1.96],0.0020601379110087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEB,Nebulin,21807,24,1.91 [1.03-3.52],0.0392794637173829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECAP2,Adaptin ear-binding coat-associated protein 2,21807,24,1.45 [0.91-2.31],0.1185340065736844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN1,Nectin-1,21882,23,0.38 [0.09-1.56],0.1774978261013634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,25769,27,18.16 [8.58-38.39],3.293035463748973e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,25902,27,6.23 [3.37-11.52],5.438614496474265e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,21882,23,1.47 [0.62-3.51],0.3817930677257417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD9,Enhancer of filamentation 1,21882,23,0.94 [0.28-3.18],0.9151170428139352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,25120,25,4.89 [3.37-7.08],4.976911938013047e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEK7,Serine/threonine-protein kinase Nek7,22092,25,0.87 [0.50-1.52],0.618923252706854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,25902,27,0.60 [0.43-0.84],0.003133226382814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL2,Protein kinase C-binding protein NELL2,25944,25,0.83 [0.23-3.00],0.7741375354034349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NENF,Neudesin,22389,25,0.83 [0.53-1.30],0.4115280014350927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEO1,Neogenin,22479,24,2.26 [0.77-6.68],0.1399070571142707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEXN,Nexilin,22523,24,1.21 [0.71-2.08],0.4791627252577534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,26083,26,32.02 [13.28-77.22],1.1844079867212452e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFAT5,Nuclear factor of activated T-cells 5,21882,23,1.05 [0.66-1.66],0.8371195870341102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",25772,24,1.22 [0.84-1.76],0.2941462523054892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",25307,25,1.41 [0.81-2.46],0.2195077171943389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFE2,Transcription factor NF-E2 45 kDa subunit,21934,25,1.40 [0.86-2.29],0.1733567165265065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFIC,Nuclear factor 1 C-type,22479,24,1.32 [0.67-2.59],0.4179033380303696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,21807,24,1.83 [1.12-3.01],0.0164073081296358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,22092,25,0.66 [0.25-1.75],0.4061095330529557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKBIE,NF-kappa-B inhibitor epsilon,25213,25,1.62 [0.84-3.11],0.1484180291632113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",22409,24,1.43 [0.98-2.09],0.0660611727818474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFX1,Transcriptional repressor NF-X1,21807,24,1.66 [1.00-2.77],0.0513082283163505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFYA,Nuclear transcription factor Y subunit alpha,21807,24,1.50 [0.69-3.24],0.3055058899486352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGF,Beta-nerve growth factor,25641,25,1.68 [0.11-25.19],0.7085590530922827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,22521,25,2.46 [1.27-4.80],0.0079580281540245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,22469,25,5.39 [3.17-9.15],4.6563292911324144e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,21505,23,7.18 [1.93-26.79],0.0033215350581128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID1,Nidogen-1,25808,27,1.36 [0.59-3.12],0.466610390329738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID2,Nidogen-2,25809,26,1.03 [0.66-1.62],0.8880362332290502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NINJ1,Ninjurin-1,25213,25,1.24 [0.77-1.99],0.3765635353823086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT1,Deaminated glutathione amidase,21934,25,1.55 [0.64-3.73],0.3283691807170361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT2,Omega-amidase NIT2,22445,25,1.63 [0.97-2.73],0.0636362563326294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN1,Neuroligin-1,21886,25,0.98 [0.55-1.77],0.9587668023047892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN2,Neuroligin-2,21797,24,0.73 [0.27-1.98],0.5300580291568517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME1,Nucleoside diphosphate kinase A,21882,23,0.87 [0.13-5.59],0.8805569796814735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME3,Nucleoside diphosphate kinase 3,25867,25,0.80 [0.43-1.47],0.4703686542877584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMI,N-myc-interactor,22314,25,1.20 [0.72-2.00],0.48090143385737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,25641,25,1.14 [0.74-1.78],0.549668535914102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMRK2,Nicotinamide riboside kinase 2,21705,24,0.48 [0.13-1.85],0.2883188028393801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,22479,24,1.11 [0.67-1.83],0.6869115740581142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,25809,26,5.43 [2.61-11.32],6.297481040803348e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOP56,Nucleolar protein 56,21807,24,1.10 [0.81-1.48],0.5457883288031369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",25203,25,3.97 [2.44-6.44],2.5570461145962608e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS2,"Nitric oxide synthase, inducible",21807,24,0.53 [0.17-1.65],0.2731334802065942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",25203,25,1.80 [1.36-2.38],4.161457115086349e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,26127,27,9.07 [1.31-62.88],0.0255957455121614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,22510,25,3.53 [0.86-14.52],0.0802933695504889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH3,Neurogenic locus notch homolog protein 3,26127,27,1.28 [0.48-3.42],0.6160580005568683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,22126,25,1.75 [1.23-2.48],0.0018403338445643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,25813,27,0.61 [0.19-1.99],0.4121370568986825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS1,Nephrin,21882,23,0.40 [0.11-1.47],0.1673997392968518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS2,Podocin,21882,23,1.05 [0.74-1.50],0.7889644594676781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPL,N-acetylneuraminate lyase,22521,25,2.86 [1.64-5.00],0.0002276183343814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,25337,26,1.02 [0.78-1.32],0.909264732625224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPC,C-type natriuretic peptide,25772,24,1.45 [0.69-3.06],0.3275925566847337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPR1,Atrial natriuretic peptide receptor 1,21807,24,1.35 [0.60-3.04],0.4711097971129518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTN,Neuroplastin,25213,25,1.28 [0.94-1.75],0.1109767228951881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,25809,26,2.63 [1.22-5.66],0.0136617020519637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX2,Neuronal pentraxin-2,22510,25,1.60 [0.50-5.13],0.4256541741344529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTXR,Neuronal pentraxin receptor,25813,27,0.78 [0.28-2.19],0.6422010252727437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,26026,27,4.99 [2.68-9.29],4.0474271208620413e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,25813,27,4.84 [2.05-11.40],0.0003144813108248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRGN,Neurogranin,22523,24,1.43 [0.93-2.17],0.0995644261257067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRN1,Neuritin,22479,24,1.14 [0.43-2.99],0.7963182655125616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,25944,27,4.26 [1.33-13.63],0.014715226621752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP2,Neuropilin-2,25809,26,1.44 [0.46-4.56],0.5302546938121091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRTN,Neurturin,25307,25,1.40 [0.82-2.39],0.2179774556227131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRXN3,Neurexin-3,21886,25,1.23 [0.46-3.33],0.6821486387891724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NSFL1C,NSFL1 cofactor p47,26036,26,1.30 [0.77-2.17],0.3228069812709477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",22521,25,1.60 [0.95-2.72],0.0791033905480462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,22469,25,2.68 [2.02-3.57],1.0424062224956928e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,25735,24,1.16 [0.76-1.76],0.4942282471712141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5E,5'-nucleotidase,25902,27,0.98 [0.54-1.77],0.948928146121704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,25772,24,1.62 [0.76-3.45],0.2078551498480116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF4,Neurotrophin-4,25213,25,0.75 [0.26-2.15],0.5873829402985893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK2,BDNF/NT-3 growth factors receptor,25813,27,3.22 [0.87-11.97],0.0802819009447225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK3,NT-3 growth factor receptor,26036,26,0.56 [0.31-1.00],0.0510987758400743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,25813,27,1.61 [1.20-2.15],0.0014092770600219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUB1,NEDD8 ultimate buster 1,25772,24,1.27 [0.84-1.91],0.2613669869040751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,22389,25,0.72 [0.43-1.19],0.1983474655303636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,25978,27,3.67 [1.64-8.24],0.0015954955251553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDC,Nuclear migration protein nudC,26083,26,1.56 [0.86-2.81],0.1410143698670583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,21934,25,0.54 [0.09-3.32],0.5085664468485971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,21807,24,0.65 [0.24-1.73],0.3845572143295515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT16,U8 snoRNA-decapping enzyme,22369,24,1.42 [0.91-2.22],0.1189664502205603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],25691,26,1.00 [0.54-1.88],0.9930649464966184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT5,ADP-sugar pyrophosphatase,25809,26,1.75 [1.00-3.06],0.0505881274392327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUMB,Protein numb homolog,21882,23,1.68 [1.03-2.76],0.0386471463185089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUP50,Nuclear pore complex protein Nup50,21807,24,0.57 [0.13-2.48],0.450734273417019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPE4,NXPE family member 4,21807,24,1.07 [0.36-3.23],0.8995941694960552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH1,Neurexophilin-1,25203,25,1.57 [0.69-3.61],0.2839350710565951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH3,Neurexophilin-3,21882,23,3.88 [1.16-12.95],0.0276814547698962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OBP2B,Odorant-binding protein 2b,25559,25,1.33 [0.77-2.31],0.3052304777539936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,22479,24,4.78 [2.94-7.77],2.6403761366058017e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ODAM,Odontogenic ameloblast-associated protein,25161,25,0.65 [0.32-1.33],0.2366273324799038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OFD1,Oral-facial-digital syndrome 1 protein,22092,25,0.70 [0.34-1.47],0.3488894076747288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGA,Protein O-GlcNAcase,22409,24,1.57 [0.91-2.69],0.1027935893124752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGFR,Opioid growth factor receptor,25691,26,4.44 [1.82-10.84],0.0010832722794136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,25809,26,5.79 [3.21-10.45],5.5205761600792735e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,22092,25,0.80 [0.39-1.66],0.551817148592286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,21213,21,1.68 [1.18-2.38],0.00389639288256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLR1,Oxidized low-density lipoprotein receptor 1,25559,27,1.24 [0.73-2.13],0.4239403165087773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,25944,25,0.50 [0.25-1.00],0.0492280008003546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,25691,26,0.51 [0.29-0.89],0.0168270012857841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMP,Olfactory marker protein,21797,24,1.46 [0.79-2.70],0.2294439124751487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPHN1,Oligophrenin-1,22469,25,1.41 [0.98-2.03],0.0605763814951241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPLAH,5-oxoprolinase,21934,25,1.64 [0.97-2.76],0.0656359980904142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPTC,Opticin,25691,26,1.32 [0.70-2.47],0.3881342922129694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ORM1,Alpha-1-acid glycoprotein 1,22476,24,1.34 [0.19-9.36],0.7673477758392974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSBPL2,Oxysterol-binding protein-related protein 2,22469,25,1.28 [0.60-2.72],0.5254213096934917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,25867,25,4.16 [1.45-11.95],0.0081400153750204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSM,Oncostatin-M,25651,24,1.90 [1.17-3.11],0.0100741424133353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,25944,27,2.63 [0.51-13.49],0.2466146924673211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSTN,Osteocrin,21886,25,0.64 [0.21-1.99],0.4399473739290964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTOA,Otoancorin,21797,24,1.54 [0.96-2.47],0.0730937472799354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD6B,Deubiquitinase OTUD6B,22409,24,1.60 [0.85-3.00],0.1477510980226031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD7B,OTU domain-containing protein 7B,22479,24,2.05 [1.13-3.72],0.0179426551496931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",21934,25,1.34 [0.78-2.32],0.2906905493890663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,26036,26,1.48 [1.14-1.91],0.0033023231630154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,P4HB,Protein disulfide-isomerase,25701,27,2.32 [0.99-5.43],0.0520968525982633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PACS2,Phosphofurin acidic cluster sorting protein 2,21807,24,2.46 [1.41-4.28],0.0014299070764938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI2,Protein-arginine deiminase type-2,25307,25,0.88 [0.42-1.82],0.7225551179115235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI4,Protein-arginine deiminase type-4,25161,25,0.77 [0.45-1.33],0.3467865327262569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAEP,Glycodelin,25641,25,1.16 [0.85-1.58],0.3443052777130386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,22479,24,0.89 [0.59-1.34],0.5833522989255236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",22092,25,1.20 [0.58-2.48],0.6248301180223386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,25337,26,2.62 [1.73-3.97],4.870989847973464e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,21934,25,1.53 [0.82-2.85],0.1795676186004662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,21667,24,1.27 [0.61-2.63],0.5265511199329722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAK4,Serine/threonine-protein kinase PAK 4,25203,25,1.18 [0.67-2.08],0.5729571863187428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALLD,Palladin,21882,23,1.37 [0.67-2.79],0.390973620029143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,22294,24,6.46 [3.92-10.65],2.612024227324385e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,22469,25,5.54 [3.43-8.94],2.3433560592064014e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM3,Paralemmin-3,21807,24,0.82 [0.40-1.67],0.5815031573879667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,25981,26,1.20 [0.33-4.42],0.7846438845050341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAMR1,Inactive serine protease PAMR1,25809,26,1.00 [0.28-3.64],0.9972708085237452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAPPA,Pappalysin-1,25307,25,0.89 [0.40-1.97],0.7714624054613932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARD3,Partitioning defective 3 homolog,22092,25,1.17 [0.75-1.83],0.478123755319421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARK7,Parkinson disease protein 7,25809,26,1.38 [0.71-2.68],0.3367042835143758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARP1,Poly [ADP-ribose] polymerase 1,25772,24,1.31 [0.80-2.15],0.2835861357188955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAXX,Protein PAXX,22039,23,2.34 [1.15-4.76],0.019129977876897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,21705,24,0.93 [0.25-3.49],0.9173606653860732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBLD,Phenazine biosynthesis-like domain-containing protein,25203,25,1.04 [0.59-1.84],0.8815017921866762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,22409,24,2.22 [1.24-3.95],0.0071096510246776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCARE,Photoreceptor cilium actin regulator,21797,24,1.43 [1.10-1.87],0.0076439878441309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,21997,23,1.26 [0.57-2.76],0.570827831688248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBP2,Poly(rC)-binding protein 2,22479,24,1.57 [0.91-2.73],0.1063296033698818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH1,Protocadherin-1,26000,26,2.60 [0.89-7.59],0.0793295819349625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH12,Protocadherin-12,22479,24,1.00 [0.22-4.48],0.9957863359171304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,25813,27,5.60 [2.95-10.65],1.488101904564655e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,22409,24,2.04 [1.20-3.49],0.0089774598148367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,22409,24,2.71 [1.06-6.93],0.0377284715660997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDHB15,Protocadherin beta-15,22389,25,1.07 [0.43-2.67],0.8837231462245921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCNA,Proliferating cell nuclear antigen,21705,24,1.38 [0.91-2.07],0.1266878631429275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,22389,25,1.57 [0.82-2.98],0.1709813019885194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,26127,27,4.16 [1.90-9.13],0.0003759065510806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,22409,24,1.42 [0.85-2.37],0.1754592148350234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,22521,25,1.58 [1.07-2.34],0.0216127610796499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,25989,27,3.04 [1.97-4.67],4.618442419883454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,25691,26,3.87 [2.14-6.98],7.147083650147693e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD5,Programmed cell death protein 5,26036,26,2.01 [1.15-3.49],0.0134774769097907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD6,Programmed cell death protein 6,25813,27,2.48 [1.13-5.44],0.0231972234573524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCL2,Phosducin-like protein 2,21705,24,0.49 [0.17-1.39],0.1802139889253353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",21705,24,1.06 [0.50-2.23],0.8857755886542807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",21807,24,0.46 [0.15-1.38],0.1639418253025962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",22039,23,1.28 [0.85-1.94],0.2326492046198725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFA,Platelet-derived growth factor subunit A,26127,27,1.13 [0.71-1.82],0.6015092737238678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFB,Platelet-derived growth factor subunit B,25944,25,1.12 [0.74-1.71],0.5893314832588639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFC,Platelet-derived growth factor C,25213,25,1.42 [0.45-4.52],0.553574029657552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,25813,27,7.21 [3.42-15.21],2.1199562876005586e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRB,Platelet-derived growth factor receptor beta,26127,27,1.43 [0.53-3.86],0.4819619585929819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA2,Protein disulfide-isomerase A2,21705,24,0.99 [0.36-2.71],0.978836965730606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,22039,23,0.98 [0.18-5.43],0.9835628054835612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA4,Protein disulfide-isomerase A4,22510,25,1.55 [0.87-2.78],0.1398381181727702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA5,Protein disulfide-isomerase A5,21705,24,0.91 [0.47-1.77],0.7883843720281456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM5,PDZ and LIM domain protein 5,22479,24,1.29 [0.90-1.85],0.1602198837325374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM7,PDZ and LIM domain protein 7,25944,25,1.14 [0.87-1.51],0.3376425494458229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",25213,25,0.64 [0.26-1.58],0.3306489300338903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDRG1,p53 and DNA damage-regulated protein 1,21886,25,0.99 [0.47-2.08],0.9843190266001566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,21705,24,0.45 [0.13-1.61],0.2211549170003645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZD2,PDZ domain-containing protein 2,21807,24,0.86 [0.42-1.76],0.683734764521283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,21882,23,2.37 [1.31-4.29],0.0043767561896335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEAR1,Platelet endothelial aggregation receptor 1,26127,27,1.31 [0.27-6.34],0.7401485992912699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEBP1,Phosphatidylethanolamine-binding protein 1,25809,26,1.53 [0.86-2.72],0.1484621005376068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECAM1,Platelet endothelial cell adhesion molecule,25809,26,0.78 [0.25-2.50],0.6800442828802983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,21934,25,0.43 [0.09-2.06],0.2903458793722479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,22039,23,1.91 [1.17-3.14],0.0103627625409589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEPD,Xaa-Pro dipeptidase,22523,24,0.49 [0.11-2.07],0.329694424823468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PER3,Period circadian protein homolog 3,21882,23,1.30 [0.96-1.77],0.0924887205911686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PF4,Platelet factor 4,22389,24,1.45 [1.00-2.09],0.0520141071998148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN2,Prefoldin subunit 2,25203,25,0.95 [0.48-1.86],0.8764944857124826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN4,Prefoldin subunit 4,21705,24,1.02 [0.49-2.09],0.964906119266129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN6,Prefoldin subunit 6,21886,25,1.26 [0.86-1.85],0.2316869796378536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",25647,26,1.39 [0.89-2.17],0.1449089624073839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGA4,Pepsin A-4,22523,24,0.93 [0.57-1.50],0.7624811090475108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",22521,25,1.84 [0.96-3.53],0.0655910211686365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,26083,26,2.58 [0.37-17.91],0.337163286597714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,25997,26,2.89 [1.65-5.04],0.0001897039063245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,22261,24,1.91 [0.52-7.02],0.3300710032573808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP4,Peptidoglycan recognition protein 4,21807,24,1.00 [0.52-1.90],0.9935224951008552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGM2,Phosphoglucomutase-2,21886,25,1.01 [0.50-2.03],0.9798942060804656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGR,Progesterone receptor,21882,23,0.75 [0.39-1.43],0.3797596320861353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHACTR2,Phosphatase and actin regulator 2,22479,24,1.32 [0.93-1.86],0.1183546150209588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,22409,24,2.89 [1.69-4.96],0.0001098231412135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB2,Pleckstrin homology-like domain family B member 2,21705,24,1.11 [0.78-1.57],0.5594104411743275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,25641,25,4.57 [2.66-7.84],3.6977180995820245e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,22039,23,1.62 [0.62-4.22],0.3244856858896534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI16,Peptidase inhibitor 16,22523,24,8.29 [1.77-38.78],0.0072177058427363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,25456,25,2.45 [1.77-3.38],6.183278544602837e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",22479,24,1.44 [0.88-2.35],0.1497592435512273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,25473,26,9.73 [4.53-20.88],5.260604638277555e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,25772,24,1.04 [0.58-1.85],0.9035983970813962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,25809,26,12.78 [6.38-25.57],6.145562873818619e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,21882,23,1.27 [0.66-2.45],0.4814041382867514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,25809,26,10.23 [4.97-21.06],2.8020709929124287e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,25813,27,7.70 [3.92-15.11],3.064619365003954e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,22039,23,0.56 [0.35-0.90],0.0159210364411432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PITHD1,PITH domain-containing protein 1,21667,24,0.90 [0.52-1.56],0.7189140117205151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,22521,25,6.87 [1.82-25.93],0.0044583244370189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,21807,24,2.20 [1.36-3.56],0.001268415475599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKLR,Pyruvate kinase PKLR,25864,25,1.04 [0.62-1.73],0.8842652024404339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKN3,Serine/threonine-protein kinase N3,22092,25,1.37 [0.89-2.11],0.1517280002227669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,25641,25,1.52 [0.85-2.70],0.1570689559195993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,25902,27,4.84 [1.46-16.03],0.0098462606423706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,26080,27,0.72 [0.51-1.00],0.0469002218725638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G2A,"Phospholipase A2, membrane associated",25735,27,1.12 [0.67-1.87],0.6724963292020664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G4A,Cytosolic phospholipase A2,25944,25,1.44 [0.95-2.16],0.0826659374489396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,25809,26,0.67 [0.43-1.04],0.0711366905001173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAT,Tissue-type plasminogen activator,26043,27,1.09 [0.57-2.08],0.7974611054646221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAU,Urokinase-type plasminogen activator,25809,26,0.38 [0.11-1.36],0.1383214886707251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,25653,25,21.85 [8.64-55.30],7.441544995629038e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",22469,25,0.39 [0.22-0.72],0.0023490022449733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",21882,23,1.12 [0.50-2.51],0.7891342578801336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",22469,25,1.56 [1.04-2.36],0.032528969945725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,22469,25,1.72 [1.05-2.82],0.0321983004218821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLG,Plasminogen,21972,24,0.96 [0.15-6.08],0.9688742270623646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,25203,25,2.87 [1.90-4.35],6.403010199109983e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,25813,27,3.62 [1.94-6.76],5.209685293441039e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLPBP,Pyridoxal phosphate homeostasis protein,25813,27,1.41 [0.86-2.33],0.1773020455062857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,22434,25,2.63 [1.47-4.70],0.0011674798446085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLTP,Phospholipid transfer protein,26033,26,0.73 [0.27-1.96],0.53322043962501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC1,Plexin domain-containing protein 1,25213,25,0.80 [0.22-2.88],0.7323846580625883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,22469,25,1.45 [0.45-4.71],0.5365782531818184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNA4,Plexin-A4,25772,24,1.31 [0.85-2.02],0.2196771676479181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,26006,27,2.11 [1.36-3.28],0.0008638441670151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB3,Plexin-B3,25732,27,1.36 [0.66-2.77],0.4056767730148931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,25676,27,1.09 [0.89-1.33],0.4079456953350567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMCH,Pro-MCH,21807,24,0.79 [0.43-1.47],0.4571007083396684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMM2,Phosphomannomutase 2,21807,24,1.30 [0.69-2.47],0.4170309255209457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMS1,PMS1 protein homolog 1,21886,25,1.63 [0.89-3.00],0.1164552509287048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMVK,Phosphomevalonate kinase,25162,25,1.02 [0.74-1.42],0.8918002165808657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIP,Pancreatic triacylglycerol lipase,22523,24,0.92 [0.50-1.72],0.8050441325919143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,22469,25,1.23 [0.75-2.02],0.4043152429151541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP2,Pancreatic lipase-related protein 2,25823,25,1.05 [0.91-1.20],0.5115755559558319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA1,Paraneoplastic antigen Ma1,21934,25,1.44 [0.77-2.70],0.2494122961310561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA2,Paraneoplastic antigen Ma2,21797,24,0.93 [0.37-2.36],0.8779067739412689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",25307,25,1.19 [0.91-1.55],0.2094807287305503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL,Podocalyxin,25691,26,1.34 [0.13-13.30],0.8041927732154599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL2,Podocalyxin-like protein 2,25902,27,1.49 [0.44-5.07],0.5254510555352099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,21882,23,1.64 [1.18-2.28],0.0033380459946408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,21882,23,0.40 [0.09-1.78],0.2292629191645934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",25691,26,2.48 [1.58-3.90],7.526271943834409e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POMC,Pro-opiomelanocortin,21934,25,0.70 [0.40-1.22],0.2043702785044812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,22523,24,0.56 [0.30-1.01],0.0550890148621617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON2,Serum paraoxonase/arylesterase 2,25337,26,1.37 [0.53-3.56],0.5176099104573675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,25944,25,0.65 [0.48-0.88],0.0055821806678975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POSTN,Periostin,22510,25,0.56 [0.20-1.56],0.2669853438426496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPBP,Platelet basic protein,22392,24,1.28 [0.80-2.05],0.3054430756982533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,26036,26,1.34 [0.65-2.78],0.4262653308510269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,25826,26,1.35 [0.91-1.99],0.133600355073386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,22092,25,0.42 [0.15-1.15],0.0908402596432087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",22510,25,1.26 [0.75-2.09],0.3810760548422308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,21882,23,2.58 [1.44-4.63],0.0014560881626211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1A,Protein phosphatase 1A,25213,25,0.76 [0.21-2.72],0.6764840266582928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1B,Protein phosphatase 1B,21882,23,1.19 [0.65-2.18],0.5773610869973627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1F,Protein phosphatase 1F,22521,25,1.77 [0.86-3.63],0.1202838834700477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPME1,Protein phosphatase methylesterase 1,25691,26,1.57 [0.90-2.74],0.1105119454197059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,22389,25,1.40 [0.89-2.18],0.1415551513060778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,25902,27,1.29 [0.92-1.80],0.1384597608419321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,22092,25,1.20 [0.78-1.84],0.4024737691592884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,22479,24,1.28 [0.89-1.86],0.1858213609165512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,22479,24,2.10 [1.31-3.36],0.0020220560305772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R2,Protein phosphatase inhibitor 2,25813,27,1.46 [0.96-2.22],0.0755227092797275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R9B,Neurabin-2,26083,26,1.25 [0.87-1.80],0.2267770127262029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,22409,24,1.41 [1.03-1.94],0.0308244068775762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP3R1,Calcineurin subunit B type 1,25641,25,1.43 [0.61-3.36],0.4114081566945354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPT1,Palmitoyl-protein thioesterase 1,21886,25,1.33 [0.92-1.93],0.1268124773909942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,25807,27,1.27 [0.92-1.75],0.1422022962555818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PQBP1,Polyglutamine-binding protein 1,25213,25,0.96 [0.48-1.92],0.9027721726707192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAME,Melanoma antigen preferentially expressed in tumors,21705,24,0.74 [0.15-3.72],0.7106278463740388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,22510,25,33.36 [11.76-94.67],4.347056786533186e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRC1,Protein regulator of cytokinesis 1,22389,25,0.70 [0.20-2.37],0.5622242178090129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,25965,27,3.27 [2.18-4.90],1.0400561747741344e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX1,Peroxiredoxin-1,25124,25,1.13 [0.77-1.68],0.530565055735494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,22143,23,0.86 [0.46-1.61],0.6349637289628851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",25307,25,1.49 [0.95-2.33],0.0809576624795133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX5,"Peroxiredoxin-5, mitochondrial",26083,26,1.17 [0.69-2.01],0.5599632956459972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,26026,27,0.77 [0.44-1.36],0.36574737014361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,25307,25,1.59 [0.63-3.99],0.326497245124436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,25823,25,4.84 [1.98-11.86],0.0005618740695274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,22510,25,2.73 [1.47-5.04],0.0013949301771089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG3,Proteoglycan 3,22510,25,0.80 [0.37-1.76],0.5841732594072129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,25307,25,1.53 [0.88-2.65],0.1344268938883081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,21886,25,1.11 [0.36-3.40],0.8563004408583224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,25813,27,1.35 [0.89-2.05],0.1641194429380574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,22430,25,1.72 [1.06-2.80],0.0281422810715884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKCQ,Protein kinase C theta type,25307,25,1.42 [0.75-2.68],0.2793966512166522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKD2,Serine/threonine-protein kinase D2,21807,24,1.36 [0.77-2.37],0.2877907770588217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKG1,cGMP-dependent protein kinase 1,22039,23,1.25 [0.90-1.72],0.1762112037054427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,25213,25,1.68 [1.04-2.72],0.0344396015328999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRL,Prolactin,26036,26,0.93 [0.59-1.48],0.7683407719719451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRND,Prion-like protein doppel,22469,25,1.55 [0.84-2.89],0.1637289435895006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROC,Vitamin K-dependent protein C,25854,27,0.38 [0.10-1.45],0.155354317705786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROCR,Endothelial protein C receptor,21807,24,1.23 [0.47-3.21],0.6723894736155598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROK1,Prokineticin-1,25772,24,0.96 [0.53-1.73],0.8903797420093871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROS1,Vitamin K-dependent protein S,22555,24,0.85 [0.20-3.70],0.831803187301603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR4,Proline-rich protein 4,21885,23,1.17 [0.68-2.03],0.5651786974621819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR5,Proline-rich protein 5,21882,23,0.99 [0.43-2.32],0.985869158572766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,21934,25,3.67 [1.57-8.58],0.0026947458493675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS2,Trypsin-2,25899,27,0.96 [0.50-1.85],0.9036107255190596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,21882,23,2.05 [1.39-3.01],0.0002721531363569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,25729,27,3.23 [1.48-7.03],0.003166823738004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS53,Serine protease 53,22469,25,0.36 [0.13-1.03],0.056504596691322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,25730,25,5.78 [2.84-11.79],1.3788539843531242e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,25203,25,1.18 [0.84-1.66],0.3363193671483893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,26026,27,2.76 [0.77-9.86],0.11894640081643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,25139,26,2.11 [1.40-3.18],0.0003331296132447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRUNE2,Protein prune homolog 2,22092,25,1.59 [0.52-4.87],0.4190840189144066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,22292,25,3.49 [2.15-5.67],4.656945271471246e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAPL1,Proactivator polypeptide-like 1,22409,24,1.25 [0.61-2.55],0.5448960794866815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSCA,Prostate stem cell antigen,22409,24,1.13 [0.95-1.34],0.1624027096559627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,25641,25,2.21 [1.54-3.17],1.816198251928854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSIP1,PC4 and SFRS1-interacting protein,25772,24,1.60 [1.10-2.33],0.0143888714717392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMA1,Proteasome subunit alpha type-1,25213,25,1.10 [0.50-2.40],0.8123666395081424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMC3,26S proteasome regulatory subunit 6A,21705,24,0.84 [0.22-3.27],0.8005022683360814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,22479,24,1.52 [0.79-2.92],0.2048496627737184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,21886,25,1.00 [0.49-2.02],0.9980002184006368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,25691,26,1.37 [0.78-2.41],0.2715565260323563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME1,Proteasome activator complex subunit 1,25603,25,1.67 [0.67-4.22],0.2738572167159655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME2,Proteasome activator complex subunit 2,25521,25,2.79 [1.13-6.85],0.0256864667165262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG3,Proteasome assembly chaperone 3,25772,24,1.26 [0.64-2.48],0.5088523235909369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG4,Proteasome assembly chaperone 4,21882,23,1.31 [0.70-2.47],0.3970195169175348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSPN,Persephin,25772,24,1.07 [0.76-1.50],0.7017630497520218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSRC1,Proline/serine-rich coiled-coil protein 1,25213,25,1.79 [1.14-2.80],0.0113265059191851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,21234,22,1.23 [0.81-1.85],0.3313922552206013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",25203,25,1.31 [0.40-4.30],0.6538238955808382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,25601,26,5.86 [3.40-10.10],1.9705834539651767e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGES2,Prostaglandin E synthase 2,21706,23,1.95 [1.02-3.72],0.0421519449077038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGR1,Prostaglandin reductase 1,22521,25,0.99 [0.63-1.54],0.9505827181843604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH,Parathyroid hormone,21886,25,1.28 [0.84-1.95],0.2554167749501717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,25772,24,1.49 [0.85-2.62],0.1608226606803436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,25203,25,2.91 [1.56-5.40],0.0007399013117018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTN,Pleiotrophin,25337,26,1.77 [0.94-3.35],0.0781449919873145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,21882,23,1.00 [0.48-2.08],0.9961538221920204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,25641,25,1.19 [0.76-1.86],0.4424887125470694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,25901,25,1.27 [0.82-1.97],0.2873386519438927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,21836,23,2.32 [1.39-3.90],0.001393002507241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,22521,25,3.23 [1.55-6.73],0.0017467451760468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,22510,25,8.25 [3.73-18.24],1.8768660573517415e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,26127,27,0.80 [0.25-2.60],0.7147846219841651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,22409,24,0.82 [0.35-1.89],0.6380847538611689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,22409,24,3.34 [1.38-8.06],0.0073461116883582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,25731,24,0.39 [0.09-1.72],0.2131751464542581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,25553,25,2.94 [1.08-8.00],0.0345060260407444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,22469,25,2.46 [1.02-5.92],0.0451151968258438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,26127,27,2.74 [0.65-11.56],0.1711479311230098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,22521,25,1.09 [0.34-3.52],0.8849277291081993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,22039,23,1.58 [0.81-3.08],0.1765494741508879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,25093,25,1.47 [0.87-2.47],0.1465086965198274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTTG1,Securin,22092,25,0.48 [0.16-1.42],0.1860857596297916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTX3,Pentraxin-related protein PTX3,25772,24,1.86 [0.78-4.43],0.1638671197659822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVALB,Parvalbumin alpha,25902,27,1.08 [0.79-1.48],0.6230415703622054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,26036,26,2.88 [1.40-5.91],0.0040228276700782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXDNL,Peroxidasin-like protein,22389,25,0.71 [0.29-1.76],0.4609181281792964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXN,Paxillin,25203,25,1.40 [0.78-2.51],0.2568392421422656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYDC1,Pyrin domain-containing protein 1,21934,25,1.20 [0.52-2.77],0.6742062113288859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,21807,24,2.37 [1.74-3.23],5.1586668844620244e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,22555,24,0.39 [0.19-0.77],0.0064343960379712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QDPR,Dihydropteridine reductase,25691,27,1.74 [0.80-3.80],0.1644999208093892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,25845,27,4.96 [2.56-9.59],2.022954764701204e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,22097,23,1.51 [0.88-2.57],0.1312763195141117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB10,Ras-related protein Rab-10,22521,25,1.54 [0.80-2.99],0.1965324579521247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB11FIP3,Rab11 family-interacting protein 3,22521,25,1.40 [0.98-2.00],0.0660833702072626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB27B,Ras-related protein Rab-27B,22521,25,1.55 [0.91-2.62],0.105525981952522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB2B,Ras-related protein Rab-2B,22389,25,1.41 [0.78-2.53],0.2562542728803653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB33A,Ras-related protein Rab-33A,21807,24,1.42 [0.81-2.48],0.2156860693292686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB37,Ras-related protein Rab-37,25307,25,1.42 [1.02-1.98],0.0400397525811288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB39B,Ras-related protein Rab-39B,21807,24,0.75 [0.40-1.42],0.3781041883761261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,21797,24,0.98 [0.46-2.12],0.9642150815444062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB44,Ras-related protein Rab-44,22389,25,1.07 [0.44-2.60],0.8837376205878986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,25772,24,0.35 [0.17-0.71],0.0038341765751531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6B,Ras-related protein Rab-6B,25203,25,1.30 [0.71-2.41],0.3979669525820816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEP1,Rab GTPase-binding effector protein 1,22039,23,1.44 [0.88-2.35],0.1438235646180833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEPK,Rab9 effector protein with kelch motifs,25213,25,1.18 [0.67-2.08],0.5655617466593935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABGAP1L,Rab GTPase-activating protein 1-like,25307,25,1.49 [0.87-2.55],0.1412969858468229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAC3,Ras-related C3 botulinum toxin substrate 3,21886,25,0.87 [0.46-1.62],0.6546211126871749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD23B,UV excision repair protein RAD23 homolog B,25213,25,1.39 [0.67-2.85],0.3760520612499838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD51,DNA repair protein RAD51 homolog 1,22092,25,1.33 [0.81-2.18],0.2596937152990317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALB,Ras-related protein Ral-B,21882,23,1.24 [0.32-4.83],0.7538663224054353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALY,RNA-binding protein Raly,22389,25,1.24 [0.63-2.45],0.5358918509023995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP1,Ran-specific GTPase-activating protein,21934,25,1.93 [1.04-3.57],0.0367054237773913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP2,E3 SUMO-protein ligase RanBP2,21797,24,0.77 [0.22-2.67],0.6802500187857934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANGAP1,Ran GTPase-activating protein 1,25213,25,0.30 [0.11-0.80],0.0156368835491746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAP1A,Ras-related protein Rap-1A,21882,23,1.12 [0.71-1.75],0.6371016794594193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,22092,25,1.48 [0.80-2.74],0.2131530685259895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,25213,25,1.97 [1.16-3.35],0.0117795569745716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,25944,27,2.52 [1.59-4.00],7.962370884874654e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASA1,Ras GTPase-activating protein 1,25203,25,0.48 [0.15-1.56],0.2231418172434883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,21705,24,0.54 [0.22-1.33],0.1787655437993494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASSF2,Ras association domain-containing protein 2,25213,25,1.27 [0.78-2.07],0.3301236469412321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,22479,24,2.84 [2.12-3.81],3.192125841312962e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBKS,Ribokinase,25212,25,1.19 [0.60-2.35],0.6251634595835329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM17,Splicing factor 45,22479,24,1.25 [0.76-2.06],0.3820125220455168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM19,Probable RNA-binding protein 19,21807,24,0.82 [0.30-2.23],0.6982328225053851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM25,RNA-binding protein 25,21705,24,0.70 [0.28-1.75],0.445237963945976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP1,Retinol-binding protein 1,21886,25,0.91 [0.49-1.71],0.781006721554343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,25691,26,2.25 [1.54-3.27],2.519831694005068e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,25691,26,2.22 [1.40-3.53],0.0007291427279172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,22409,24,1.96 [1.23-3.11],0.0044987537000342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS,RNA-binding protein with multiple splicing,21882,23,1.00 [0.53-1.87],0.999028925965846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS2,RNA-binding protein with multiple splicing 2,21934,25,1.22 [0.85-1.75],0.2760185268501613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCC1,Regulator of chromosome condensation,22389,25,1.30 [0.72-2.36],0.3849289718962879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCOR1,REST corepressor 1,25337,26,0.70 [0.24-2.03],0.5165566445491232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,21934,25,1.11 [0.15-8.11],0.9199129175278864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REEP4,Receptor expression-enhancing protein 4,22479,24,1.23 [0.69-2.19],0.4799573994769021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,25644,26,3.69 [2.58-5.28],8.16583236004967e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,26127,27,2.87 [2.02-4.08],3.705681137283743e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,26127,27,3.00 [2.05-4.40],1.8841936413917943e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3G,Regenerating islet-derived protein 3-gamma,22389,25,1.17 [0.47-2.89],0.7383691419601848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,25867,25,5.70 [3.36-9.69],1.2243212559714291e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELB,Transcription factor RelB,21882,23,1.28 [0.66-2.49],0.4572207918442846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,25809,26,11.32 [5.13-24.99],1.913344490814152e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,25813,27,2.37 [1.86-3.02],4.446337653280061e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REPS1,RalBP1-associated Eps domain-containing protein 1,21882,23,0.96 [0.34-2.71],0.9422926942823748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REST,RE1-silencing transcription factor,21705,24,0.81 [0.51-1.30],0.3850370422945649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,25691,26,2.35 [1.03-5.37],0.0430832688334764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,25744,26,3.79 [2.24-6.41],6.689543140401495e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REXO2,"Oligoribonuclease, mitochondrial",21807,24,1.25 [0.63-2.49],0.5211527782759162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RFC4,Replication factor C subunit 4,22389,25,1.57 [0.31-7.93],0.5857248590343531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGCC,Regulator of cell cycle RGCC,22479,24,1.35 [0.81-2.25],0.2565711804972547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,22092,25,1.24 [0.74-2.08],0.4085497655674968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMA,Repulsive guidance molecule A,26036,26,3.03 [1.03-8.94],0.0444807568743654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,26036,26,9.22 [3.50-24.31],7.0586703151829725e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS10,Regulator of G-protein signaling 10,22479,24,1.54 [0.88-2.69],0.1314215567232083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS8,Regulator of G-protein signaling 8,25307,25,0.96 [0.55-1.67],0.8908975547158094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RHOC,Rho-related GTP-binding protein RhoC,25469,25,1.29 [0.92-1.79],0.135134595488822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RICTOR,Rapamycin-insensitive companion of mTOR,21882,23,0.49 [0.16-1.53],0.2213022100631583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,22039,23,1.56 [0.78-3.11],0.2055542079981905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILP,Rab-interacting lysosomal protein,25948,27,1.43 [0.83-2.48],0.2008087497561433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILPL2,RILP-like protein 2,22521,25,1.29 [0.86-1.93],0.221401160343835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,21807,24,0.79 [0.40-1.57],0.5052010219796017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN1,Prorelaxin H1,22479,24,0.71 [0.27-1.85],0.4835519226482532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN2,Prorelaxin H2,22000,23,1.27 [0.92-1.76],0.1458233203425878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,22523,24,4.21 [3.01-5.89],4.828816603167933e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,21934,25,2.32 [1.73-3.10],1.8474298235426183e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE3,Eosinophil cationic protein,25691,27,1.15 [0.87-1.53],0.3319148590999106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,21768,24,4.38 [2.34-8.18],3.773648279499352e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,22355,24,2.97 [2.16-4.10],3.0587990700523994e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASEH2A,Ribonuclease H2 subunit A,22479,24,1.36 [0.73-2.54],0.331369907985577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,26001,27,5.39 [3.44-8.44],1.9060938633349293e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,21934,25,3.07 [2.23-4.24],8.446477182795649e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF168,E3 ubiquitin-protein ligase RNF168,21882,23,1.54 [0.73-3.23],0.253997146765369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF31,E3 ubiquitin-protein ligase RNF31,21882,23,0.70 [0.18-2.66],0.5960511407364812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF4,E3 ubiquitin-protein ligase RNF4,22092,25,0.89 [0.47-1.67],0.7092104239539287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF41,E3 ubiquitin-protein ligase NRDP1,25213,25,1.30 [0.78-2.19],0.3164278837755402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF43,E3 ubiquitin-protein ligase RNF43,22092,25,1.01 [0.54-1.89],0.9799380147328056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF5,E3 ubiquitin-protein ligase RNF5,21934,25,1.28 [0.74-2.23],0.3770296665424307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,25867,25,5.48 [2.14-14.03],0.0003925931340242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO2,Roundabout homolog 2,26036,26,0.88 [0.19-4.08],0.8680017120765845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO4,Roundabout homolog 4,21934,25,1.09 [0.12-9.93],0.9420611514597734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,25813,27,6.27 [2.29-17.19],0.0003625494694495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RP2,Protein XRP2,25691,26,1.50 [0.69-3.27],0.3116248786139367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPA2,Replication protein A 32 kDa subunit,21882,23,0.79 [0.22-2.82],0.7212294857637449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPE,Ribulose-phosphate 3-epimerase,22092,25,1.07 [0.62-1.86],0.8045701355797893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,21886,25,0.98 [0.41-2.34],0.9581820159290582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPL14,60S ribosomal protein L14,21934,25,2.04 [1.18-3.55],0.0112248514592998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPS10,40S ribosomal protein S10,21807,24,1.25 [0.53-2.93],0.6146936557222229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRAS,Ras-related protein R-Ras,21886,25,1.21 [0.91-1.60],0.1910989454421269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,25213,25,1.16 [0.67-2.03],0.592167948407871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,25213,25,0.99 [0.58-1.69],0.9737539341983498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRP15,RRP15-like protein,21797,24,0.81 [0.55-1.20],0.2969277149552833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO1,R-spondin-1,25641,25,1.50 [0.59-3.80],0.3982374127721132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,26026,27,3.48 [1.53-7.91],0.0029325455857421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTBDN,Retbindin,25691,26,2.64 [0.99-7.07],0.0530649180647274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTKN2,Rhotekin-2,21807,24,1.02 [0.51-2.05],0.952414019589723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",22479,24,1.28 [0.84-1.94],0.2461689860861983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,26026,27,3.52 [2.42-5.12],4.7948311696581596e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RUVBL1,RuvB-like 1,25213,25,1.07 [0.79-1.45],0.659708373923698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RWDD1,RWD domain-containing protein 1,26036,26,1.56 [0.91-2.68],0.1059076212600212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RYR1,Ryanodine receptor 1,21807,24,0.80 [0.21-3.04],0.7456055362997935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A11,Protein S100-A11,25604,27,1.45 [0.82-2.55],0.1976707257764295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A12,Protein S100-A12,25461,26,1.37 [0.88-2.12],0.1585806378430033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A13,Protein S100-A13,21882,23,2.46 [1.26-4.83],0.0087110992778238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A14,Protein S100-A14,22479,24,1.27 [0.66-2.44],0.4735948553699106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A16,Protein S100-A16,25161,25,1.25 [0.73-2.14],0.4067238808895606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A3,Protein S100-A3,22389,25,0.73 [0.24-2.22],0.5774552111434959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A4,Protein S100-A4,25902,27,1.44 [0.78-2.65],0.2490163960868277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100G,Protein S100-G,22479,24,0.71 [0.28-1.77],0.460892553787257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,25337,26,2.01 [1.37-2.95],0.0003850494765991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAA4,Serum amyloid A-4 protein,22555,24,0.86 [0.16-4.67],0.8650674849342936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAFB2,Scaffold attachment factor B2,22479,24,1.65 [0.59-4.64],0.3435445410786769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAG,S-arrestin,21797,24,1.41 [0.76-2.61],0.2790669085839696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,25772,24,1.40 [0.86-2.29],0.1750017758306186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAP18,Histone deacetylase complex subunit SAP18,22092,25,1.00 [0.59-1.68],0.9987132145870148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SARG,Specifically androgen-regulated gene protein,22428,25,1.70 [1.17-2.46],0.0052027461636998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,21807,24,1.69 [0.96-2.98],0.0689095817907081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT1,Diamine acetyltransferase 1,21807,24,1.01 [0.48-2.11],0.9801698269747606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT2,Thialysine N-epsilon-acetyltransferase,22092,25,1.22 [0.76-1.97],0.4128260244427983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SATB1,DNA-binding protein SATB1,22479,24,1.68 [0.64-4.44],0.2958250538918653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SBSN,Suprabasin,22470,25,1.21 [0.41-3.55],0.7327684650235418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,25691,26,1.60 [1.09-2.35],0.0171730260428682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,26036,26,13.83 [7.01-27.26],3.4266658987477866e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB1,Scavenger receptor class B member 1,25203,25,1.38 [0.91-2.12],0.1335317461266061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,25172,25,6.96 [3.81-12.70],2.5367100745800896e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,26127,27,2.85 [1.36-5.98],0.0055391591298655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,26036,26,5.59 [2.13-14.64],0.0004688507390207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,25900,27,9.12 [4.14-20.12],4.292101554293516e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG3,Secretogranin-3,25867,25,0.69 [0.25-1.91],0.4715162586710483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB1A1,Uteroglobin,25857,25,1.82 [0.93-3.57],0.0808586195384762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB2A2,Mammaglobin-A,21807,24,0.45 [0.10-2.02],0.2966481408006681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A1,Secretoglobin family 3A member 1,22039,23,2.21 [0.44-11.12],0.3342250502424584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A2,Secretoglobin family 3A member 2,25901,25,1.13 [0.82-1.55],0.4708314612415012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,25307,25,2.48 [1.41-4.37],0.0017022128756672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCIN,Adseverin,21797,24,1.49 [1.01-2.19],0.0424910576187861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCLY,Selenocysteine lyase,25948,27,1.23 [0.61-2.46],0.5667761026128058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2A,Sodium channel protein type 2 subunit alpha,21797,24,1.03 [0.49-2.15],0.9364789200993908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2B,Sodium channel subunit beta-2,21886,25,0.60 [0.14-2.52],0.4842001611256915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3A,Sodium channel protein type 3 subunit alpha,21886,25,1.33 [0.59-3.01],0.4965201577219885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3B,Sodium channel subunit beta-3,21797,24,0.56 [0.19-1.65],0.2953367380770292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,21934,25,4.88 [2.69-8.86],1.917539892152879e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCP2,Non-specific lipid-transfer protein,25213,25,1.21 [0.80-1.83],0.3686442663137239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,21845,25,1.99 [1.00-3.94],0.048660553433809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,22521,25,4.44 [2.39-8.24],2.317884236459877e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRIB,Protein scribble homolog,21934,25,1.18 [0.82-1.71],0.3758708290615896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRN1,Secernin-1,25772,24,1.35 [0.76-2.39],0.3009990882034776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCT,Secretin,21886,25,1.12 [0.51-2.46],0.7821622699831243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,25813,27,2.58 [1.50-4.44],0.0006556846774927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC4,Syndecan-4,25813,27,0.96 [0.47-1.97],0.9077306187586948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDCCAG8,Serologically defined colon cancer antigen 8,22389,25,1.27 [0.92-1.77],0.1502540972584579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDHB,Succinate dehydrogenase,22409,24,1.05 [0.60-1.81],0.87263975369965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDK2,Protein sidekick-2,22039,23,1.29 [0.45-3.67],0.6329312341317315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEC31A,Protein transport protein Sec31A,21934,25,1.62 [0.94-2.80],0.0808141252432849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,21934,25,2.73 [1.81-4.13],1.7996620365841904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,26127,27,1.70 [0.85-3.40],0.1320590658055072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELENOP,Selenoprotein P,22555,24,1.04 [0.19-5.74],0.9631527411888884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELL,L-selectin,22555,24,0.70 [0.13-3.82],0.6784161766600809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELP,P-selectin,25899,27,1.31 [0.73-2.37],0.3664003490842006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,25772,24,4.42 [1.44-13.55],0.0093687661359466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,25813,27,12.86 [4.42-37.45],2.816491421457931e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3G,Semaphorin-3G,22039,23,1.69 [0.69-4.14],0.2518006801293169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4C,Semaphorin-4C,25691,26,1.25 [0.37-4.19],0.7191092641021333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4D,Semaphorin-4D,26036,26,1.80 [0.54-6.00],0.3369478602841468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,21882,23,2.20 [1.05-4.63],0.0371733393795012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,26043,27,3.60 [2.00-6.46],1.802953702565525e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN3,Neuronal-specific septin-3,22479,24,1.16 [0.71-1.92],0.5501278337662274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN7,Septin-7,22092,25,0.97 [0.47-2.00],0.9388255713915516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,22423,25,1.61 [1.14-2.27],0.0073808916769023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN9,Septin-9,25691,26,1.65 [0.54-5.07],0.38272826191183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,22116,23,26.07 [2.96-229.72],0.0033100573413144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA11,Serpin A11,26127,27,1.59 [0.68-3.68],0.2821150613401226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA12,Serpin A12,25058,26,0.86 [0.58-1.28],0.4563165682339017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA3,Alpha-1-antichymotrypsin,22463,24,1.30 [0.09-19.16],0.8486320116251238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA4,Kallistatin,22140,24,1.88 [0.35-10.09],0.4617787604841465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA5,Plasma serine protease inhibitor,22222,24,1.43 [0.49-4.17],0.5169282092263943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,22555,24,1.10 [0.09-13.31],0.94134078350021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA7,Thyroxine-binding globulin,22555,24,5.76 [1.30-25.51],0.0211116031844314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,25557,26,2.09 [1.45-3.00],7.182927907802106e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB1,Leukocyte elastase inhibitor,25725,26,1.15 [0.78-1.70],0.4665084805379286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB5,Serpin B5,25337,26,0.73 [0.39-1.37],0.3312346986138016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB6,Serpin B6,25955,26,1.32 [0.74-2.38],0.3488327211214301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB8,Serpin B8,26083,26,1.56 [1.03-2.35],0.0337900816625592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB9,Serpin B9,25641,25,1.84 [0.77-4.40],0.1701928772877819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINC1,Antithrombin-III,22508,24,1.20 [0.08-17.24],0.895138801687662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPIND1,Heparin cofactor 2,22508,24,2.79 [0.68-11.39],0.1535328993492924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE1,Plasminogen activator inhibitor 1,26127,27,1.53 [0.89-2.64],0.1213797836490162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE2,Glia-derived nexin,22521,25,1.06 [0.59-1.90],0.8529178601643341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,22218,23,8.62 [3.62-20.53],1.1311669318738162e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF2,Alpha-2-antiplasmin,22132,23,0.53 [0.03-10.36],0.6734911942418182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPING1,Plasma protease C1 inhibitor,22508,24,0.66 [0.08-5.47],0.6972125170731174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINH1,Serpin H1,22092,25,1.29 [0.97-1.73],0.084384083522649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI1,Neuroserpin,21995,23,0.57 [0.15-2.26],0.4278326830973472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI2,Serpin I2,22409,24,0.63 [0.29-1.33],0.2231733000485131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,25203,25,1.17 [0.70-1.97],0.5471840817278795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,25566,25,0.63 [0.21-1.90],0.4162306321237439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6,Seizure protein 6 homolog,21886,25,1.68 [0.58-4.86],0.3358157379508124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,25902,27,2.26 [0.66-7.69],0.1921380836570339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L2,Seizure 6-like protein 2,25691,26,0.80 [0.19-3.37],0.7603293757352625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SF3B4,Splicing factor 3B subunit 4,25691,26,1.10 [0.70-1.75],0.6805347067263302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,25561,25,2.10 [1.19-3.69],0.0100685511825677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,22039,23,3.07 [1.19-7.93],0.0207352384988123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA1,Pulmonary surfactant-associated protein A1,25213,25,1.30 [0.79-2.14],0.3095894992034115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA2,Pulmonary surfactant-associated protein A2,25213,25,1.06 [0.55-2.05],0.853060035612386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPD,Pulmonary surfactant-associated protein D,25813,27,1.46 [0.87-2.45],0.1487003406359071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SGSH,N-sulphoglucosamine sulphohydrolase,22124,25,1.58 [0.90-2.79],0.1126952508745377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2B3,SH2B adapter protein 3,25213,25,1.25 [0.86-1.81],0.2335487705550064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2D1A,SH2 domain-containing protein 1A,25772,24,1.61 [1.06-2.44],0.0252039429749732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,21797,24,1.27 [0.76-2.13],0.3534679899059088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BP1,SH3 domain-binding protein 1,22409,24,1.35 [0.69-2.62],0.3772875662233959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GL3,Endophilin-A3,21978,25,1.27 [0.80-1.99],0.3076650465216929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GLB2,Endophilin-B2,22469,25,1.21 [0.70-2.11],0.4976443101132289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,22523,24,0.92 [0.46-1.82],0.8083719413382049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHC1,SHC-transforming protein 1,21705,24,1.01 [0.72-1.43],0.93846348113058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHD,SH2 domain-containing adapter protein D,21763,24,1.01 [0.65-1.59],0.9495393741841764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHH,Sonic hedgehog protein,21882,23,0.92 [0.37-2.30],0.8632767006052935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,22510,25,4.96 [3.49-7.04],3.3587951780889202e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",25901,25,1.24 [0.81-1.88],0.3219387652143207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHPK,Sedoheptulokinase,22092,25,1.18 [0.56-2.49],0.6559516034933732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIAE,Sialate O-acetylesterase,25859,27,1.83 [0.93-3.61],0.0805886663079786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,25944,25,3.75 [1.97-7.12],5.515814149800553e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,25772,24,4.36 [2.15-8.86],4.603628190409035e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,25203,25,1.15 [0.79-1.66],0.4724186649590528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,25809,26,1.87 [1.20-2.92],0.0060158982831216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,26026,27,3.52 [1.86-6.66],0.0001071152429247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,25813,27,9.43 [4.13-21.52],9.86554075664825e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,21934,25,1.91 [0.85-4.31],0.1179910332668241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,25991,27,1.95 [0.61-6.23],0.259229213901007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIL1,Nucleotide exchange factor SIL1,21934,25,1.37 [0.54-3.53],0.5077493152243495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,25878,26,5.84 [2.37-14.40],0.0001272766429701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,25786,25,5.45 [2.83-10.51],4.219883989038635e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,21882,23,0.81 [0.41-1.61],0.5448250464843656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,25691,26,1.40 [0.94-2.09],0.0995059588633651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",25203,25,0.73 [0.34-1.59],0.432159686767246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,25307,25,3.39 [1.89-6.08],4.320392968222493e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP1,Src kinase-associated phosphoprotein 1,25593,25,1.62 [1.06-2.47],0.0254645677712437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP2,Src kinase-associated phosphoprotein 2,25944,25,1.26 [0.91-1.76],0.1693338092400141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKIV2L,Helicase SKI2W,21807,24,0.71 [0.24-2.12],0.5404797006231701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLA2,Src-like-adapter 2,22479,24,1.28 [0.89-1.86],0.1815474421341564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,25307,25,1.91 [1.14-3.20],0.014119680261189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,25213,25,3.97 [1.99-7.92],9.443502346431968e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,25772,24,1.59 [0.91-2.78],0.1032369374328799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,25213,25,3.07 [1.80-5.23],3.817645844663661e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC12A2,Solute carrier family 12 member 2,21807,24,1.38 [0.54-3.55],0.5042006579131237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC13A1,Solute carrier family 13 member 1,22389,25,1.36 [0.87-2.12],0.1725930974391561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,25203,25,1.53 [1.08-2.17],0.0166527725065118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC1A4,Neutral amino acid transporter A,21886,25,1.78 [1.12-2.84],0.014712270888423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC27A4,Long-chain fatty acid transport protein 4,25203,25,1.23 [0.79-1.91],0.3533683261391585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC28A1,Sodium/nucleoside cotransporter 1,21705,24,0.69 [0.30-1.61],0.396076623438076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,21705,24,0.31 [0.11-0.88],0.0273803313586961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A14,Zinc transporter ZIP14,25203,25,2.17 [0.97-4.82],0.0577665859565607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,25772,24,1.44 [0.93-2.24],0.1038839171412846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC44A4,Choline transporter-like protein 4,21886,25,1.14 [0.73-1.76],0.5711109901361908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC4A1,Band 3 anion transport protein,22510,25,1.51 [0.70-3.29],0.2940248909515246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC51B,Organic solute transporter subunit beta,21807,24,1.01 [0.60-1.68],0.9842044237170676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,22039,23,1.55 [0.98-2.46],0.0594290965414501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,22409,24,1.59 [1.12-2.25],0.0095820852717896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",21705,24,1.07 [0.63-1.83],0.7923847669657658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIT2,Slit homolog 2 protein,25203,25,1.16 [0.59-2.26],0.662084368817579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK1,SLIT and NTRK-like protein 1,21882,23,1.24 [0.35-4.37],0.738820516957757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,26026,27,1.05 [0.43-2.57],0.9066188827997724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,25337,26,3.29 [1.69-6.40],0.0004578669830202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLK,STE20-like serine/threonine-protein kinase,22092,25,0.55 [0.24-1.26],0.1601831554947216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,22409,24,1.55 [1.02-2.35],0.0405882355286319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,22347,25,1.89 [1.17-3.06],0.0092998493729269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD1,Mothers against decapentaplegic homolog 1,25213,25,1.34 [0.88-2.03],0.1704329291565809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD2,Mothers against decapentaplegic homolog 2,22389,25,1.66 [1.03-2.69],0.0383317939869259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD3,Mothers against decapentaplegic homolog 3,22389,25,1.19 [0.59-2.40],0.6203606226973796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD5,Mothers against decapentaplegic homolog 5,25691,26,1.17 [0.22-6.19],0.8539168197871094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMARCA2,Probable global transcription activator SNF2L2,25203,25,1.29 [0.83-2.01],0.2657435392020416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMC3,Structural maintenance of chromosomes protein 3,21705,24,1.20 [0.67-2.14],0.5376198877367815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,22409,24,1.37 [0.83-2.25],0.2164436146091473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,26026,27,5.29 [2.39-11.68],3.83472317929908e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,25944,25,3.22 [1.63-6.36],0.0007542016910741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,25915,25,1.74 [0.85-3.57],0.1311413744904435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD3,Sphingomyelin phosphodiesterase 3,21882,23,1.57 [1.00-2.47],0.0506383747569415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,25907,25,0.58 [0.35-0.98],0.0404256666757907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,22389,25,0.59 [0.26-1.34],0.2046995021151726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMS,Spermine synthase,21797,24,0.93 [0.47-1.83],0.8284966266572577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,22429,25,1.24 [0.87-1.77],0.241374262055512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP23,Synaptosomal-associated protein 23,25813,27,1.43 [0.93-2.19],0.1014775104352431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP25,Synaptosomal-associated protein 25,21797,24,1.73 [0.79-3.79],0.1707794419490684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP29,Synaptosomal-associated protein 29,25902,27,1.27 [0.87-1.85],0.2175051282614554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAPIN,SNARE-associated protein Snapin,22479,24,0.95 [0.48-1.86],0.877462056145792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCA,Alpha-synuclein,22039,23,1.23 [0.86-1.76],0.2498325823280892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,25641,25,2.90 [1.77-4.75],2.3365674797106174e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",21934,25,2.07 [0.94-4.57],0.0721369168919742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',22469,25,1.96 [1.38-2.80],0.000183585433381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNU13,NHP2-like protein 1,21807,24,1.07 [0.62-1.83],0.8160766024254036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX15,Sorting nexin-15,22039,23,1.73 [0.86-3.49],0.1227668562630702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX18,Sorting nexin-18,22409,24,1.54 [0.72-3.30],0.2642422885343307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX2,Sorting nexin-2,22389,25,1.39 [0.95-2.03],0.0925779119234282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX5,Sorting nexin-5,21934,25,1.68 [0.53-5.35],0.3815637518071532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX9,Sorting nexin-9,25813,27,1.78 [1.12-2.84],0.015210490138838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD1,Superoxide dismutase [Cu-Zn],25274,26,1.43 [0.73-2.81],0.2997820824029169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",25809,26,1.37 [0.60-3.10],0.4508932902054705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD3,Extracellular superoxide dismutase,22523,24,0.56 [0.21-1.51],0.2518257620975675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,22479,24,0.38 [0.09-1.62],0.1910696565292906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,25213,25,4.76 [2.81-8.07],6.9700044839436835e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORD,Sorbitol dehydrogenase,25907,27,0.83 [0.51-1.37],0.4709367619440107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORT1,Sortilin,25769,27,1.51 [0.61-3.75],0.3724442737697897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOST,Sclerostin,25769,27,2.44 [1.06-5.60],0.0361780797324526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,21886,25,0.84 [0.37-1.93],0.6874453732490466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX2,Transcription factor SOX-2,22443,24,0.48 [0.09-2.65],0.3971467523561951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,21886,25,6.73 [2.30-19.68],0.0005037941308629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,22479,24,1.74 [0.68-4.46],0.2453221486252107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPAG1,Sperm-associated antigen 1,22479,24,1.42 [0.86-2.36],0.1711846111678223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARC,SPARC,25902,27,1.24 [0.74-2.07],0.4159318880953485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARCL1,SPARC-like protein 1,25822,27,0.89 [0.25-3.10],0.8530748527291993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPART,Spartin,22039,23,1.43 [0.87-2.37],0.1611854226222203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPESP1,Sperm equatorial segment protein 1,22521,25,1.58 [0.43-5.76],0.4896839233703903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,25809,26,3.44 [2.29-5.17],2.842588975495971e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK2,Serine protease inhibitor Kazal-type 2,22039,23,2.62 [1.01-6.76],0.0467897566521287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,25772,24,3.48 [2.47-4.90],9.84481221131733e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK5,Serine protease inhibitor Kazal-type 5,25809,26,1.77 [0.65-4.85],0.2654864455851418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK6,Serine protease inhibitor Kazal-type 6,26026,27,2.63 [1.33-5.21],0.0054341643226683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK8,Serine protease inhibitor Kazal-type 8,21807,24,0.90 [0.28-2.82],0.8507640735319439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,25732,25,1.97 [0.54-7.14],0.3037563018382213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,25944,25,3.16 [1.40-7.15],0.005615311766976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT3,Kunitz-type protease inhibitor 3,22409,24,0.75 [0.58-0.97],0.0268486844761127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPOCK1,Testican-1,25641,25,0.64 [0.37-1.11],0.1099271997407856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,25867,25,2.92 [1.67-5.13],0.0001835505171979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,25688,27,11.20 [5.21-24.04],5.79496903566722e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPP1,Osteopontin,26081,26,1.43 [0.70-2.93],0.3249592767354369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",21882,23,0.94 [0.35-2.54],0.9038997859686592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRING1,SREBP regulating gene protein,21705,24,0.87 [0.40-1.90],0.7349055108104509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR1B,Cornifin-B,22092,25,1.04 [0.66-1.63],0.8775858583722311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,22469,25,1.97 [1.24-3.13],0.0043255522865579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRY2,Protein sprouty homolog 2,25307,25,1.19 [0.84-1.70],0.3257122118229342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",21797,24,1.84 [0.87-3.90],0.1113120571468659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTLC1,Serine palmitoyltransferase 1,22469,25,1.63 [0.85-3.14],0.143224604572743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRC,Proto-oncogene tyrosine-protein kinase Src,25859,27,1.16 [0.87-1.56],0.3049746482752865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRP14,Signal recognition particle 14 kDa protein,25691,26,1.77 [1.10-2.86],0.018808296648126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPK2,SRSF protein kinase 2,25772,24,1.46 [1.01-2.12],0.0468797876910877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,22521,25,3.69 [1.36-10.04],0.0104121093822603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSB,Lupus La protein,25203,25,1.41 [0.94-2.10],0.0938123103035444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",21882,23,1.15 [0.39-3.34],0.8020243016728007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,25769,27,0.94 [0.70-1.27],0.6989181677414265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,25899,27,1.48 [0.65-3.35],0.3497543897920894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSH3,Protein phosphatase Slingshot homolog 3,21705,24,2.15 [0.84-5.52],0.1100191865930103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,22409,24,1.99 [1.08-3.69],0.0278719934236013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST13,Hsc70-interacting protein,22039,23,1.63 [0.81-3.27],0.1699488887194699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",25691,26,1.35 [0.65-2.79],0.4182124413168181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",26127,27,5.34 [1.82-15.70],0.0023108762857056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",21882,23,1.50 [0.82-2.77],0.1907504955068391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,22510,25,2.42 [0.76-7.73],0.1370471072418739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAM,Signal transducing adapter molecule 1,22389,25,0.76 [0.26-2.29],0.6297287023782911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAMBP,STAM-binding protein,25593,25,1.44 [0.83-2.52],0.1945741602435337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT2,Signal transducer and activator of transcription 2,21882,23,1.58 [0.97-2.57],0.0653790751022521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT5B,Signal transducer and activator of transcription 5B,25691,26,1.27 [0.98-1.65],0.0703197842255693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,21705,24,0.54 [0.23-1.23],0.1428906430879247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,26036,26,3.46 [1.90-6.31],5.297652543056157e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,25774,26,1.26 [0.32-4.95],0.744076632072451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STEAP4,Metalloreductase STEAP4,21797,24,1.19 [0.76-1.87],0.4377817937881616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STIP1,Stress-induced-phosphoprotein 1,25773,26,1.46 [0.88-2.43],0.1467184176708766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK11,Serine/threonine-protein kinase STK11,25337,26,1.62 [1.04-2.53],0.0339620382182976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK24,Serine/threonine-protein kinase 24,25203,25,1.50 [0.86-2.63],0.1530341544958742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK4,Serine/threonine-protein kinase 4,25813,27,1.31 [0.88-1.95],0.180057831277314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STOML2,"Stomatin-like protein 2, mitochondrial",21705,24,0.69 [0.41-1.17],0.1702815991237737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX16,Syntaxin-16,25213,25,0.89 [0.46-1.73],0.7281319755237288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX1B,Syntaxin-1B,21886,25,1.26 [0.58-2.74],0.5675801658412014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX3,Syntaxin-3,22469,25,0.80 [0.26-2.50],0.7061930983086638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,25691,26,1.39 [0.91-2.13],0.1325930155004034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX5,Syntaxin-5,21882,23,1.23 [0.56-2.73],0.6027989431905457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX6,Syntaxin-6,25213,25,1.07 [0.62-1.86],0.8058147019970328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX7,Syntaxin-7,21882,23,2.16 [0.97-4.81],0.0596711516038329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX8,Syntaxin-8,25772,24,1.80 [0.94-3.43],0.0745576768421145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP1,Syntaxin-binding protein 1,22479,24,1.45 [0.86-2.45],0.168438652278768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP3,Syntaxin-binding protein 3,25213,25,0.94 [0.41-2.16],0.8814648968786822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGP1,SURP and G-patch domain-containing protein 1,22409,24,1.54 [0.65-3.67],0.3313076292278587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGT1,Protein SGT1 homolog,25213,25,1.41 [0.89-2.22],0.1421958731533207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT1A1,Sulfotransferase 1A1,26036,26,1.11 [0.84-1.46],0.4756425349434345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,25772,24,1.34 [0.83-2.17],0.2348506512183426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF1,Formylglycine-generating enzyme,21882,23,1.22 [0.80-1.86],0.3514705670334038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,26036,26,1.78 [0.88-3.63],0.1101089388092651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUOX,"Sulfite oxidase, mitochondrial",22479,24,1.45 [0.86-2.45],0.1666738041121466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD1,Sushi domain-containing protein 1,25337,26,1.59 [0.81-3.13],0.1781488631436671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,25809,26,2.09 [0.78-5.60],0.1430093525838979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,22389,25,2.02 [1.19-3.43],0.0089153881902923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD5,Sushi domain-containing protein 5,21906,23,2.51 [0.78-8.08],0.1236341690454508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SV2A,Synaptic vesicle glycoprotein 2A,21886,25,1.61 [1.04-2.50],0.0313017070564153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SWAP70,Switch-associated protein 70,22409,24,2.50 [1.25-4.99],0.0097381845142318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYAP1,Synapse-associated protein 1,22039,23,1.33 [0.68-2.59],0.4028045585429591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,21797,24,0.92 [0.42-2.04],0.8428187310852187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYT1,Synaptotagmin-1,22469,25,1.56 [0.85-2.84],0.1504192806095737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYTL4,Synaptotagmin-like protein 4,22521,25,1.39 [0.88-2.21],0.1570853154838727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,22092,25,1.21 [0.84-1.74],0.2989172546137363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACC3,Transforming acidic coiled-coil-containing protein 3,25691,26,1.23 [0.91-1.67],0.184264262218556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,22874,21,1.47 [0.56-3.88],0.4366460568005755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TADA3,Transcriptional adapter 3,22389,25,2.51 [1.05-5.97],0.0375343021033096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,25691,26,5.38 [2.65-10.91],3.1278229696499937e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAGLN3,Transgelin-3,21705,24,0.86 [0.42-1.74],0.667113087220807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TALDO1,Transaldolase,22416,25,2.25 [1.08-4.71],0.0306215312944553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TANK,TRAF family member-associated NF-kappa-B activator,25307,25,1.63 [1.00-2.65],0.0501323897236084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAP1,Antigen peptide transporter 1,22092,25,0.71 [0.31-1.64],0.4266546203347904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARBP2,RISC-loading complex subunit TARBP2,25203,25,1.28 [0.82-2.00],0.2826071842570624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",21886,25,0.62 [0.30-1.28],0.197680806374428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",22389,25,1.09 [0.38-3.14],0.878279749936102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAX1BP1,Tax1-binding protein 1,22469,25,1.50 [0.90-2.49],0.1158023738135743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D17,TBC1 domain family member 17,25203,25,1.44 [0.82-2.52],0.2091388864595015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D23,TBC1 domain family member 23,25691,26,1.16 [0.79-1.69],0.4462479673755638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D5,TBC1 domain family member 5,25772,24,0.97 [0.61-1.55],0.9015425941236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCA,Tubulin-specific chaperone A,22039,23,1.63 [1.04-2.57],0.0334231356750831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCB,Tubulin-folding cofactor B,25641,25,1.28 [0.88-1.88],0.1950933426585488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCC,Tubulin-specific chaperone C,25641,25,1.34 [0.86-2.09],0.2006837952837497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,25213,25,1.27 [0.83-1.96],0.2720813108461222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBR1,T-box brain protein 1,21886,25,0.93 [0.39-2.19],0.8646227927737049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,25598,25,0.93 [0.65-1.35],0.7188063128305568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1B,T-cell leukemia/lymphoma protein 1B,25337,26,0.71 [0.38-1.30],0.2647749791852399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN1,Transcobalamin-1,22059,23,1.87 [0.64-5.49],0.2523281716212432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,26081,26,3.26 [1.90-5.61],1.827207074491995e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,22521,25,1.99 [0.93-4.24],0.0752383477711775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCP11,T-complex protein 11 homolog,22092,25,0.63 [0.23-1.69],0.3554342023373131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCTN3,Tectonic-3,22521,25,1.13 [0.32-4.00],0.8502353537859091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDGF1,Teratocarcinoma-derived growth factor 1,25203,25,0.94 [0.74-1.21],0.6400178689913976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDO2,"Tryptophan 2,3-dioxygenase",21886,25,0.60 [0.17-2.09],0.422426079255656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,22389,25,0.64 [0.30-1.36],0.2427725053738929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDRKH,Tudor and KH domain-containing protein,25203,25,1.41 [0.98-2.03],0.06526107352855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEF,Thyrotroph embryonic factor,21807,24,1.48 [0.75-2.93],0.2614269568616869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,25902,27,5.84 [1.42-23.98],0.0142479766807806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TERF1,Telomeric repeat-binding factor 1,21882,23,0.71 [0.18-2.83],0.6309613228167348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TET2,Methylcytosine dioxygenase TET2,22049,24,1.23 [0.93-1.64],0.1417042370948718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX101,Testis-expressed protein 101,21886,25,1.11 [0.41-3.03],0.8406067937036668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX33,Testis-expressed protein 33,22092,25,0.93 [0.32-2.73],0.8945966293970665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TF,Serotransferrin,22555,24,1.67 [0.27-10.33],0.5828511820522875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFAP2A,Transcription factor AP-2-alpha,21797,24,0.69 [0.31-1.53],0.3566687988638376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,25677,26,2.67 [1.95-3.65],7.333963334980614e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,25901,25,3.58 [2.30-5.57],1.564005781654504e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,25780,27,2.61 [1.95-3.49],1.1839627893204642e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI,Tissue factor pathway inhibitor,25724,27,0.96 [0.63-1.47],0.8671564674871414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,25816,27,1.74 [1.08-2.82],0.0232134236014737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,25908,27,1.54 [0.67-3.55],0.3141842772842653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TG,Thyroglobulin,22389,25,1.20 [0.91-1.58],0.2053412896671157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,25772,24,2.98 [1.66-5.35],0.000255012758595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,26039,26,2.81 [1.45-5.44],0.0021818347741335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB2,Transforming growth factor beta-2 proprotein,22389,25,1.13 [0.55-2.32],0.7348132573087713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,25641,26,0.85 [0.24-2.98],0.7955618330019596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,21882,23,2.88 [1.19-6.95],0.0187149025651032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,25902,27,6.28 [3.59-10.97],1.0910717168537836e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,26127,27,3.16 [1.17-8.53],0.0235616477876451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,25775,27,1.29 [0.83-1.99],0.2577685178619345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,22523,24,11.68 [4.45-30.68],6.040577529558737e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,21667,24,0.65 [0.35-1.22],0.179166897121161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,25813,27,9.75 [3.69-25.71],4.21268037154467e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,25809,26,3.28 [1.81-5.94],9.092852178385924e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS4,Thrombospondin-4,25808,27,1.35 [0.67-2.70],0.398508484427755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THOP1,Thimet oligopeptidase,25688,27,1.74 [0.63-4.81],0.2839265047733249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THPO,Thrombopoietin,25337,26,1.25 [0.51-3.09],0.6216431401885714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THRAP3,Thyroid hormone receptor-associated protein 3,21807,24,0.52 [0.26-1.03],0.0592870563173918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THSD1,Thrombospondin type-1 domain-containing protein 1,21712,23,0.79 [0.48-1.29],0.3456735114106939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THTPA,Thiamine-triphosphatase,22356,25,1.27 [0.82-1.98],0.2893582606190548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,26036,26,6.78 [2.67-17.24],5.8536115827722505e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIA1,Nucleolysin TIA-1 isoform p40,25052,25,1.32 [0.99-1.75],0.0548795660271473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIE1,Tyrosine-protein kinase receptor Tie-1,26127,27,2.10 [0.73-6.03],0.1691232971926393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",25155,25,1.05 [0.48-2.32],0.8975328981722852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,22092,25,2.45 [1.56-3.87],0.0001075276597828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,25899,27,1.65 [0.79-3.43],0.182980988613339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,22521,25,2.19 [0.96-5.01],0.0631270332742542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,22469,25,1.32 [0.85-2.04],0.2144208688026777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,25515,27,5.19 [2.81-9.58],1.466307619363074e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP2,Metalloproteinase inhibitor 2,22521,25,1.80 [1.11-2.92],0.0168849066365643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP3,Metalloproteinase inhibitor 3,25944,25,1.05 [0.81-1.36],0.7056545395250636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP4,Metalloproteinase inhibitor 4,25809,26,1.25 [0.55-2.87],0.5904714001831579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,25722,27,8.22 [2.05-32.94],0.0029362112797656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJAP1,Tight junction-associated protein 1,25902,27,1.24 [0.83-1.85],0.302913165027752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJP3,Tight junction protein ZO-3,21797,24,1.04 [0.43-2.50],0.9371130381302012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TK1,"Thymidine kinase, cytosolic",22092,25,1.14 [0.52-2.49],0.7446159820292058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,21882,23,2.91 [0.96-8.85],0.0599935094390735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR2,Toll-like receptor 2,22092,25,2.66 [0.51-13.88],0.2466748655422951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR3,Toll-like receptor 3,26083,26,0.68 [0.41-1.13],0.1396726240933824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR4,Toll-like receptor 4,21882,23,0.53 [0.13-2.14],0.3684901153750114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,21886,25,1.24 [0.65-2.38],0.5197936633247613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED1,Transmembrane emp24 domain-containing protein 1,22092,25,1.17 [0.62-2.18],0.627396385241582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED10,Transmembrane emp24 domain-containing protein 10,21807,24,0.87 [0.34-2.20],0.7603958943526598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED4,Transmembrane emp24 domain-containing protein 4,21807,24,0.82 [0.37-1.80],0.6156814316790638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED8,Protein TMED8,22409,24,1.46 [0.98-2.17],0.0620054166982452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM106A,Transmembrane protein 106A,22389,25,1.19 [0.73-1.93],0.4780028345120226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM132A,Transmembrane protein 132A,21934,25,1.45 [0.82-2.56],0.1976112040418706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM25,Transmembrane protein 25,22479,24,1.39 [0.78-2.46],0.2615093477600106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMOD4,Tropomodulin-4,21705,24,1.58 [0.66-3.79],0.3006415352350372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11B,Transmembrane protease serine 11B,21797,24,0.57 [0.28-1.17],0.1243245870706744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,22423,25,2.46 [1.62-3.74],2.4366274512693325e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,25691,26,1.76 [1.20-2.60],0.004174171462024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS5,Transmembrane protease serine 5,25521,25,0.78 [0.31-1.97],0.6056145344376649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,25809,26,2.11 [1.32-3.39],0.0018736644994872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNC,Tenascin,25899,27,1.26 [0.62-2.53],0.5213045870101651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,25293,26,2.11 [1.54-2.89],2.8946796702002866e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,22409,24,2.23 [1.24-4.02],0.0072691380166434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,25307,25,1.14 [0.44-3.00],0.7866230398629612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,22039,23,1.27 [0.70-2.33],0.4290260516841638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,25641,25,3.53 [2.53-4.95],1.8717636934524098e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,25641,25,1.74 [1.40-2.16],8.052886161835906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,25860,26,3.10 [1.41-6.81],0.0048289133119003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,26083,26,9.61 [5.65-16.35],7.072875812993204e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,25823,25,5.50 [2.25-13.43],0.0001813877585948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,25902,27,10.78 [6.37-18.25],8.200506231088606e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,25867,25,3.10 [2.00-4.81],4.267286140441356e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,25307,25,2.21 [1.35-3.62],0.0016320759044959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,25867,25,13.94 [6.46-30.07],1.8423492907753987e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,22039,23,3.07 [1.26-7.47],0.0132734341473995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,26026,27,5.58 [2.83-10.98],6.524445254574377e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,25809,26,13.98 [7.22-27.06],5.152652079901789e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25809,26,2.16 [1.63-2.86],7.361895232521948e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,26036,26,4.09 [1.36-12.27],0.012157979393147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,26039,26,4.70 [2.91-7.59],2.3022752456331954e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,25641,25,2.41 [1.67-3.48],2.9900306848819206e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,26036,26,2.95 [1.81-4.80],1.305772042429805e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,25641,25,3.26 [2.29-4.64],5.21926988963756e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,26083,26,0.84 [0.50-1.41],0.5103065938903439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,25772,24,0.62 [0.34-1.13],0.1199295938314059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,26083,26,0.31 [0.10-1.02],0.0546752305007131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,25944,25,4.83 [1.43-16.32],0.0111040340326849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,26083,27,1.26 [0.40-3.98],0.6944133979414205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,25641,25,1.70 [0.95-3.05],0.0728216859101083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,22510,25,4.37 [2.51-7.63],2.059621833641388e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNIP1,TNFAIP3-interacting protein 1,22469,25,1.36 [0.90-2.05],0.1454929206458211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,22510,25,1.27 [0.54-2.99],0.5763516835438964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",25337,26,1.64 [1.00-2.68],0.048403077198349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNPO1,Transportin-1,22092,25,0.50 [0.15-1.66],0.2572157942094721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNR,Tenascin-R,25641,25,0.86 [0.37-1.99],0.7195811957695237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNXB,Tenascin-X,25809,26,0.72 [0.41-1.24],0.2354376314693155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,22521,25,1.85 [1.20-2.86],0.005515967517677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1,DNA topoisomerase 1,22409,24,1.31 [0.91-1.86],0.1428544943888673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1MT,"DNA topoisomerase I, mitochondrial",21705,24,0.68 [0.26-1.75],0.4261222702321252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP2B,DNA topoisomerase 2-beta,21882,23,1.71 [1.11-2.62],0.0141159826206208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOR1AIP1,Torsin-1A-interacting protein 1,21934,25,1.80 [1.13-2.86],0.0133330527246382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53,Cellular tumor antigen p53,25213,25,1.47 [0.66-3.30],0.3444890339358369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53BP1,TP53-binding protein 1,21882,23,1.10 [0.69-1.76],0.6955628821041859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53I3,Quinone oxidoreductase PIG3,21567,23,2.39 [1.21-4.70],0.011913198886344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,25337,26,0.72 [0.20-2.61],0.6199834585352337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP73,Tumor protein p73,21886,25,0.73 [0.26-2.05],0.5439059807665618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPBGL,Trophoblast glycoprotein-like,21886,25,0.94 [0.37-2.42],0.903635342223456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPD52L2,Tumor protein D54,22039,23,1.31 [0.88-1.95],0.1787142665582903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPK1,Thiamin pyrophosphokinase 1,22521,25,0.76 [0.19-3.13],0.706493531229808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPM3,Tropomyosin alpha-3 chain,21807,24,1.70 [0.87-3.33],0.1198382146375544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPMT,Thiopurine S-methyltransferase,25213,25,0.93 [0.57-1.53],0.7753698632873511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,25648,25,1.98 [1.10-3.56],0.0220145466888142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP2,Tubulin polymerization-promoting protein family member 2,22092,25,0.72 [0.40-1.27],0.2525370242520933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP3,Tubulin polymerization-promoting protein family member 3,25203,25,1.47 [0.81-2.67],0.2112802552844432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,21807,24,1.53 [1.00-2.34],0.0498904977320265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPRKB,EKC/KEOPS complex subunit TPRKB,21705,24,0.96 [0.49-1.87],0.899663796668639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSAB1,Tryptase alpha/beta-1,26040,26,1.36 [0.70-2.67],0.3653033286893187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSD1,Tryptase delta,22479,24,1.30 [0.58-2.90],0.52525394745123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSG1,Tryptase gamma,21882,23,1.89 [0.57-6.29],0.301451566015931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPT1,Translationally-controlled tumor protein,25307,25,0.57 [0.26-1.24],0.1580067154000786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF2,TNF receptor-associated factor 2,25772,24,1.08 [0.65-1.80],0.7669907984952197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",21882,23,1.45 [0.78-2.72],0.2441273817401594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,21807,24,1.18 [0.54-2.58],0.6794690260677947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,22092,25,1.20 [0.82-1.77],0.3409605742865119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,22510,25,1.36 [0.82-2.28],0.2372829393658828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,25823,25,1.51 [0.79-2.87],0.2094268047436817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML1,Trem-like transcript 1 protein,22523,24,1.51 [0.75-3.02],0.2491477805530068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML2,Trem-like transcript 2 protein,25809,26,1.88 [0.67-5.24],0.2301645692993797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,26026,27,1.67 [0.99-2.80],0.0523399789560998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,25772,24,1.38 [0.84-2.27],0.2004133266143924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM24,Transcription intermediary factor 1-alpha,22051,25,1.54 [0.94-2.50],0.0851064303395525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,22409,24,1.34 [0.93-1.92],0.1140958922322839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM26,Tripartite motif-containing protein 26,21705,24,0.98 [0.48-2.04],0.9669267995849706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM40,E3 ubiquitin ligase TRIM40,21886,25,1.48 [0.91-2.40],0.1176315120695395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM5,Tripartite motif-containing protein 5,25772,24,1.12 [0.73-1.72],0.5946277079610371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,22389,25,1.41 [0.91-2.17],0.1211112211868653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,21807,24,0.87 [0.38-2.02],0.7497033704915372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC1,Hamartin,21882,23,0.86 [0.43-1.73],0.6785400799929491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC22D1,TSC22 domain family protein 1,22479,24,1.65 [1.12-2.45],0.012237739155028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSHB,Thyrotropin subunit beta,25813,27,0.93 [0.63-1.37],0.7225058382984115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSLP,Thymic stromal lymphopoietin,25337,26,0.86 [0.46-1.62],0.6424303893686796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSNAX,Translin-associated protein X,21807,24,1.94 [0.77-4.86],0.1577797520262366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN1,Tetraspanin-1,25337,26,2.02 [1.09-3.73],0.0249711330777658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN15,Tetraspanin-15,21807,24,0.63 [0.23-1.71],0.3594035122596515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN7,Tetraspanin-7,21797,24,0.98 [0.63-1.52],0.9316071462917622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,22409,24,1.61 [1.12-2.31],0.0100860805350938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPYL1,Testis-specific Y-encoded-like protein 1,21882,23,1.67 [0.79-3.54],0.1835338452080764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TST,Thiosulfate sulfurtransferase,25156,25,1.24 [0.78-1.99],0.357969963918741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTF2,Transcription termination factor 2,21886,25,1.40 [0.70-2.84],0.3439373533748771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTN,Titin,21807,24,1.30 [0.82-2.06],0.2575234304948307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTR,Transthyretin,22300,24,1.07 [0.23-4.95],0.9340610269399956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TUBB3,Tubulin beta-3 chain,21797,24,1.96 [0.62-6.21],0.2531912559240075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TWF2,Twinfilin-2,22510,25,1.62 [1.04-2.52],0.0327466256978585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXK,Tyrosine-protein kinase TXK,22092,25,1.01 [0.60-1.70],0.960638369747143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXLNA,Alpha-taxilin,25641,25,1.53 [1.01-2.30],0.042764877003169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXN,Thioredoxin,22145,24,1.74 [0.95-3.17],0.0720802641155557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC15,Thioredoxin domain-containing protein 15,25902,27,2.48 [0.77-8.05],0.1297585567459258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,26036,26,1.82 [1.13-2.94],0.0144620420212494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC9,Thioredoxin domain-containing protein 9,22469,25,1.78 [0.96-3.31],0.06840046979168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNL1,Thioredoxin-like protein 1,21750,24,0.69 [0.39-1.22],0.201290037195169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",25809,26,1.70 [0.83-3.50],0.1492130650661331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYMP,Thymidine phosphorylase,25647,27,1.60 [0.96-2.67],0.071776081018248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,25813,27,1.49 [0.43-5.17],0.5291805164315775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",21882,23,2.25 [1.14-4.46],0.0197467466738425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBAC1,Ubiquitin-associated domain-containing protein 1,25691,26,1.26 [0.47-3.33],0.6450870382267797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,22389,25,1.50 [0.46-4.86],0.4982678360088022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,22521,25,2.12 [1.19-3.77],0.0102469919061632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,21882,23,1.23 [0.66-2.28],0.5230448887410153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBQLN3,Ubiquilin-3,21807,24,0.58 [0.19-1.83],0.3564313305375772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBXN1,UBX domain-containing protein 1,22039,23,1.92 [1.13-3.27],0.0162388665898223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,22409,24,1.28 [0.95-1.70],0.1000953615416631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UGDH,UDP-glucose 6-dehydrogenase,21807,24,1.02 [0.68-1.53],0.9212771238282804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,21807,24,0.68 [0.17-2.62],0.57104248746166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,25641,25,5.75 [2.94-11.27],3.341593088758171e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,26056,27,0.64 [0.50-0.83],0.0005671554927242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC5D,Netrin receptor UNC5D,21882,23,1.34 [0.32-5.64],0.68658737528024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC79,Protein unc-79 homolog,21705,24,1.35 [0.73-2.51],0.3374731409549147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNG,Uracil-DNA glycosylase,22389,25,2.46 [1.21-5.01],0.0129939414763671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPB1,Beta-ureidopropionase,22521,25,1.24 [0.83-1.85],0.2988099477535992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3A,Uroplakin-3a,21797,24,0.81 [0.34-1.93],0.6338800386519101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3BL1,Uroplakin-3b-like protein 1,22055,25,1.12 [0.59-2.13],0.7343356510856056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROD,Uroporphyrinogen decarboxylase,22039,23,1.95 [1.13-3.39],0.0171536646311537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROS,Uroporphyrinogen-III synthase,21886,25,1.10 [0.67-1.81],0.6961122660692896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USO1,General vesicular transport factor p115,25691,26,1.46 [0.99-2.16],0.0550558083654925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,22389,25,1.73 [1.03-2.93],0.0399728020404535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,22469,25,2.17 [1.25-3.78],0.0060741148386732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,21807,24,1.17 [0.77-1.78],0.4713080370746358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,25337,26,1.45 [1.03-2.03],0.032508693005025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UXS1,UDP-glucuronic acid decarboxylase 1,25213,25,1.05 [0.61-1.80],0.8534699212716992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP5,Vesicle-associated membrane protein 5,25337,26,1.26 [0.78-2.03],0.3441813530871467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP8,Vesicle-associated membrane protein 8,21882,23,1.31 [0.84-2.06],0.2333559610180669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,25772,24,1.52 [1.00-2.33],0.0505797741062769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASN,Vasorin,25398,26,1.97 [0.54-7.19],0.305350157138923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASP,Vasodilator-stimulated phosphoprotein,22523,24,1.45 [0.87-2.42],0.1560592725855638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,25691,26,0.46 [0.08-2.73],0.389666759902882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAV3,Guanine nucleotide exchange factor VAV3,21797,24,1.40 [0.94-2.08],0.0972381371080781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,25854,27,7.21 [2.76-18.84],5.501338747326152e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAN,Versican core protein,26036,26,0.58 [0.18-1.88],0.3677035974123679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCPKMT,Protein-lysine methyltransferase METTL21D,21705,24,1.00 [0.62-1.60],0.9955396646454948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,25995,26,1.94 [1.15-3.29],0.0136083085500784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,21882,23,9.09 [3.76-21.98],9.523561035821148e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFC,Vascular endothelial growth factor C,25902,27,1.41 [0.77-2.57],0.2668250178346119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,26035,26,3.45 [1.36-8.70],0.0088907961212846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VGF,Neurosecretory protein VGF,22479,24,7.06 [2.65-18.78],8.975905593559132e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIM,Vimentin,25337,26,1.15 [0.83-1.58],0.411580996678209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,21934,25,0.64 [0.11-3.71],0.6221784961129175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIT,Vitrin,22521,25,1.22 [0.44-3.39],0.7090468137449217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,25691,26,2.15 [1.23-3.76],0.0070532527925539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN1,Pantetheinase,22523,24,1.05 [0.62-1.78],0.8612725149585294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN2,Vascular non-inflammatory molecule 2,25691,26,2.56 [1.04-6.31],0.041879906038812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,22092,25,1.36 [0.81-2.27],0.2447200218768856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS37A,Vacuolar protein sorting-associated protein 37A,25691,26,1.50 [0.99-2.26],0.0544667940827221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS4B,Vacuolar protein sorting-associated protein 4B,22389,25,1.20 [0.81-1.78],0.3595199096741168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,25691,26,1.28 [0.84-1.95],0.2565310712284048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,22389,25,1.40 [0.51-3.81],0.5132193636251161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,21807,24,2.00 [0.92-4.36],0.0802886408211407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,22389,25,2.85 [1.89-4.32],6.970520583270753e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,25774,26,4.62 [2.79-7.66],2.899256685500777e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,25775,27,1.65 [1.04-2.64],0.034375539971112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSNL1,Visinin-like protein 1,22469,25,0.49 [0.16-1.48],0.2040792971748024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,25203,25,1.96 [1.09-3.53],0.0254409034110417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,22092,25,0.44 [0.11-1.75],0.2458632078990381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,25337,26,1.54 [1.09-2.18],0.014246644979605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,26036,26,1.28 [0.80-2.05],0.2981725831760445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,25213,25,0.78 [0.25-2.49],0.6781464955691863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,22039,23,1.73 [0.95-3.14],0.0712039721251491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,25983,27,2.26 [1.01-5.05],0.0474661568956561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA5A,von Willebrand factor A domain-containing protein 5A,21705,24,1.09 [0.72-1.66],0.6760060480169623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,25553,25,4.31 [1.85-10.08],0.0007369664445815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,22479,24,1.08 [0.49-2.36],0.8504231173433762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,26127,27,1.55 [0.97-2.48],0.0674544589404771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",25809,26,1.29 [0.50-3.32],0.5928595790044509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WAS,Wiskott-Aldrich syndrome protein,25307,25,0.72 [0.41-1.26],0.2463029779945666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,25337,26,1.45 [1.01-2.07],0.042166151173425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,25203,25,1.11 [0.73-1.70],0.6256858606477869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASHC3,WASH complex subunit 3,22469,25,1.52 [1.00-2.32],0.0506458139389287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASL,Neural Wiskott-Aldrich syndrome protein,21882,23,0.85 [0.43-1.68],0.638968113793738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WDR46,WD repeat-containing protein 46,22389,25,1.10 [0.38-3.17],0.8558009574706453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,21951,25,1.58 [1.16-2.17],0.0042520786540571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,25991,27,1.73 [1.08-2.78],0.023262477867635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,24486,26,6.49 [4.06-10.39],5.845349575635905e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",25566,25,0.36 [0.16-0.82],0.0152024726325086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",25867,25,0.63 [0.23-1.74],0.3740085771463092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,26026,27,0.69 [0.46-1.03],0.0714575223454742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,25307,25,3.91 [2.36-6.50],1.349562311900391e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,25641,25,1.14 [0.59-2.19],0.7011541922751033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,26026,27,1.49 [0.97-2.31],0.0704009937071667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,25995,27,4.75 [3.22-7.00],3.242158325313956e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XIAP,E3 ubiquitin-protein ligase XIAP,21882,23,1.90 [1.03-3.52],0.0402796620654875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,25902,27,0.54 [0.37-0.78],0.0011796437828897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XRCC4,DNA repair protein XRCC4,25203,25,1.16 [0.44-3.01],0.7663897418129664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,22469,25,8.57 [5.00-14.70],5.9232039054972685e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",22409,24,1.34 [0.99-1.81],0.0552553018008145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YES1,Tyrosine-protein kinase Yes,25691,26,1.34 [0.99-1.82],0.0608269178865913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YJU2,Splicing factor YJU2,22389,25,1.52 [0.60-3.85],0.3773073481986958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YOD1,Ubiquitin thioesterase OTU1,21807,24,1.28 [0.71-2.30],0.4048803431603917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YTHDF3,YTH domain-containing family protein 3,25307,25,1.28 [0.87-1.90],0.2138514738060095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YWHAQ,14-3-3 protein theta,22039,23,1.63 [0.97-2.74],0.0638953487000533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YY1,Transcriptional repressor protein YY1,21882,23,0.62 [0.14-2.81],0.5315967169434117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBP1,Z-DNA-binding protein 1,21882,23,0.86 [0.26-2.83],0.8088731102483261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,25213,25,1.26 [0.79-2.02],0.3389292781640443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,25337,26,2.36 [1.49-3.73],0.0002352840795438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,21807,24,1.11 [0.63-1.97],0.7198702033074552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZFYVE19,Abscission/NoCut checkpoint regulator,22409,24,1.62 [1.05-2.50],0.0277066096935263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZHX2,Zinc fingers and homeoboxes protein 2,22469,25,2.04 [1.12-3.72],0.0195992533076687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF174,Zinc finger protein 174,21882,23,2.04 [1.29-3.22],0.0023279745246727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF75D,Zinc finger protein 75D,22092,25,0.54 [0.24-1.20],0.1290867094791424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF830,Zinc finger protein 830,22389,25,1.17 [0.74-1.83],0.5000014469459126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,22409,24,1.74 [1.07-2.82],0.0257550721919614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,22389,25,1.38 [0.72-2.66],0.3283333293407131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP3,Zona pellucida sperm-binding protein 3,21934,25,1.04 [0.90-1.21],0.581734003878382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP4,Zona pellucida sperm-binding protein 4,21705,24,0.85 [0.25-2.92],0.7971498443662659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZPR1,Zinc finger protein ZPR1,21797,24,1.18 [0.85-1.62],0.3193562972024966
